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Summary 
 
Our intestinal tract is densely populated by different microbes, collectively called 
microbiota, of which the majority are bacteria. Research focusing on the intestinal 
microbiota often use fecal samples as a representative of the bacteria that inhabit the 
end of the large intestine. These studies revealed that the intestinal bacteria 
contribute to our health, which has stimulated the interest in understanding their 
dynamics and activities. However, bacterial communities in fecal samples are 
different compared to microbial communities at other locations in the intestinal tract, 
such as the small intestine. Despite that the small intestine is the first region where 
our food and intestinal microbiota meet, we know little about the bacteria in the small 
intestine and how they influence our overall well-being. This is mainly attributable to 
difficulties in obtaining samples with the small intestine being located between the 
stomach and the large intestine. Therefore, the work in this thesis aimed at providing 
a better understanding of the composition and dynamics of the human small 
intestinal microbiota and to provide insight in the metabolic potential as well as 
immunomodulatory properties of some of its typical commensal inhabitants. Small 
intestinal samples used in the work described in this thesis were collected from 
ileostomy subjects, individuals that had their large intestine surgically removed and 
the end of the small intestine connected to an abdominal stoma, providing access to 
luminal content of the small intestine. 
Considering the importance of molecular techniques in contemporary ecological 
surveys of microbial communities, first of all, two technologies, barcoded 
pyrosequencing and phylogenetic microarray analysis were compared in terms of 
their capacity to determine the bacterial composition in fecal and small intestinal 
samples from human individuals. As PCR remains a crucial step in sample 
preparation for both techniques, the use of different primer pairs in the amplification 
step was assessed in terms of its impact on the outcome of microbial profiling. The 
analyses revealed that the different primer pairs and the two profiling technologies 
provide overall similar results for samples of fecal and terminal ileum origin. In 
contrast, the microbial profiles obtained for small intestinal samples by barcoded 
pyrosequencing and phylogenetic microarray analyses differed considerably. This is 
most likely attributable to the constraints that are intrinsic to the use of the microarray 
to enable the detection of predefined microbiota members only, which is due to the 
probe design that is largely based on large intestinal microbiota communities. 
However, the pyrosequencing technology also allows for identification of bacteria that 
were not in advance known to inhabit our intestinal tract.  
The pyrosequencing technology was used as the method of choice to study the total 
and active small intestinal communities in ileostoma effluent samples from four 
different subjects through sequencing the 16S ribosomal RNA gene (rDNA) and 
ribosomal RNA (rRNA) content combined with metatranscriptome analysis by 
Illumina sequencing of cDNA derived from enriched mRNA of the same sample set to 
 
 
 
 
 
 
 
investigate the activities of the small intestinal bacteria. The composition of the small 
intestinal bacterial communities as assessed from rDNA, rRNA, and mRNA patterns 
appeared to be similar, indicating that the dominant bacteria in the small intestine are 
also highly active in this ecosystem. Streptococcus spp. were among the bacterial 
species that were detected in each ileostoma effluent sample, albeit that their 
abundance varied greatly between samples from the same subject as well as 
samples from different subjects. Veillonella spp. frequently co-occurred with 
Streptococcus spp., indicating that the Streptococcus and Veillonella populations 
play a prominent role in the human small intestine ecosystem and their co-
occurrence suggests a metabolic relation between these genera. 
Therefore, cultivation and molecular typing methodologies were employed to zoom-in 
on these groups, which revealed that the richness of the small intestinal streptococci 
strongly exceeded the diversity that could be estimated on basis of 16S rRNA 
analyses, and could be extended to the genomic lineage level (anticipated to 
resemble strain-level). From ileostoma samples 3 different Streptococcus species 
were recovered belonging to the S. mitis group, S. bovis group, and S. salivarius 
group, which could be further divided in 7 genomic lineages. Notably, the 
Streptococcus lineages that were isolated displayed distinct carbohydrate utilization 
capacities, which may imply that their growth and relative community composition 
may respond quite strongly to differences in the dietary intake of simple 
carbohydrates over time. This notion is in good agreement with the observation that 
the Streptococcus lineage populations fluctuated in time with only one Streptococcus 
lineage being cultivated from both ileostoma samples collected in a one-year time 
frame. Conversely, the cultivated Veillonella isolates from samples during that same 
time-interval consistently encompassed a single lineage. Furthermore, this Veillonella 
lineage could be isolated from both the oral cavity as well as the ileostoma effluent. 
Analogously, three Streptococcus lineages that belong to a single phylotype also 
appeared to be present in bacterial communities from the oral cavity as well as the 
small intestine. These observations suggest the representatives of the Veillonella and 
Streptococcus genera that are encountered in the oral and small intestinal microbial 
ecosystems are closely related and indicate that the oral microbiota may serve as an 
inoculum for the upper GI tract. 
The metabolic capacity of 6 small intestinal Streptococcus lineages, that were 
obtained from a single ileostoma effluent sample, was further investigated through 
the determination of genomic sequences of these lineages. The small-intestinal 
Streptococcus genomes were found to encode different carbohydrate transporters 
and the necessary enzymes to metabolize different sugars, which was in excellent 
agreement with what carbohydrates could be used by representative strains of the 
Streptococcus lineages.  
To further our understanding how the different streptococci as representatives of the 
dominant small intestinal bacterial populations may influence our immune system, 
human dendritic cells were stimulated with strains of the different Streptococcus 
 
 
 
 
 
 
 
lineages to study their immunomodulatory properties. The Streptococcus lineages 
differed significantly in their capacity to modulate cytokine responses of blood-
monocyte derived immature dendritic cells. As Streptococcus and Veillonella 
frequently co-occur in the small intestinal ecosystem, pair-wise combinations of 
strains of these two species were also tested for their combined immunomodulatory 
properties. This resulted in considerably different cytokine responses as those that 
could be predicted from the stimulations with either Streptococcus or Veillonella, 
indicating that it is not trivial to predict gut mucosal associated immune responses 
and that the composition of the intestinal microbiota as a whole may have a distinct 
influence on an individual’s immune status. 
In conclusion, the work described this thesis provides an expansion to the 
accumulating knowledge on the human intestine microbiota. Whereas most studies 
focus on the microbiota present in the distal regions of the intestinal tract, this study 
targeted the microbiota of the poorly proximal regions of the intestine and also 
addressed its capacity to interact with the local mucosal tissue. The data presented 
here can be exploited to guide the design of future studies that aim to elucidate the 
interplay between diet, microbiota and the mucosal tissues in the human small 
intestinal tract. 
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Abstract 
 
The mammalian gastrointestinal (GI) tract is inhabited by a myriad of microbes, 
dominated by bacteria. Different GI tract locations of the human gut harbor distinct 
bacterial communities, which increase in density and diversity along the longitudinal 
axes. The collective microbial community, also termed microbiota, is known to 
contribute to host health, which has stimulated the interest in understanding its 
dynamics and activities. Large-scale and in-depth characterization of the intestinal 
microbial community composition requires application of (high-throughput) 16S rRNA 
gene-based technologies. Further insights into the functional capabilities of the 
intestinal microbiota can be obtained through (functional) metagenomic approaches. 
Comprehensive interpretation of the data from these approaches requires advanced 
bioinformatic and systems biology approaches to decipher the role of the intestinal 
(micro)biological system in relation with human health and disease. This review 
describes recent developments and applications for quantitative and qualitative 
determination of the microbiota community composition in GI tract samples, as well 
as culture-based and metagenomic strategies to unravel their functional properties. 
This chapter ends with an outline of the thesis chapters that follow the General 
Introduction.  
General introduction 
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Introduction 
The human gastrointestinal (GI) tract is inhabited by microorganisms that as a whole 
are referred to as the gastrointestinal microbiota (115, 203). Although the presence of 
Eukarya (289) and Archaea (74, 80) in the human GI tract has been reported, their 
absolute numbers as well as their diversity are relatively low. In addition, meta-
analysis revealed a complex viral community of 1,200 genotypes in human feces 
obtained from adult subjects (34).  
The highly diverse bacterial community residing in the human GI tract (Figure 1.1) is 
dominated by phylotypes belonging to the Firmicutes, Bacteroidetes, and 
Actinobacteria (15, 80, 268). Although Firmicutes are found in the intestine of all 
mammals, each mammalian species harbors a distinct microbial composition (205). 
Clustering of the mammalian fecal microbiota composition based on dietary habits 
established distinct grouping of carnivores, omnivores and herbivores, which can be 
roughly characterized by increasing microbiota diversity, respectively. This indicates 
that bacterial diversity is at least partially mediated by the host’s diet composition. 
Furthermore, the fecal microbiota composition could also be correlated to host 
phylogeny and intestinal morphology (e.g. fore- and hindgut herbivores), establishing 
the role of these factors in the determination of intestinal microbiota composition. 
Based on these observations it is not surprising that the human intestinal microbiota 
resembles that of omnivorous primates (205, 206). 
 
 
Figure 1.1. Schematic representation of the predominant microbiota composition and density 
at different regions in the human GI tract. 
 
To eventually understand the factors that are involved in determination of intestinal 
microbial community composition will require advanced methodologies to assess this 
composition at phylogenetic as well as functional level. Here we discuss the recent 
developments in the qualitative and quantitative strategies to determine the 
composition of the inhabitants of the GI tract as well as their functional properties.  
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The emerging insights into the human intestinal microbiota in relation to health and 
disease may eventually provide microbiota-based diagnostic markers. Moreover, 
such insight may open avenues towards the rationalization of diet or microbial 
intervention strategies to prevent or treat human and animal diseases via 
modulations of the intestinal microbiota composition and/or function.  
 
Characterization of the gastrointestinal microbiota 
Up to two decades ago, studying microbial communities and identifying individual 
microbial inhabitants as well as their biological and physiological characterization 
depended on the ability to culture bacteria (8). Escherichia coli, originally named 
Bacterium coli by its discoverer Theodor Escherich, was the first bacterial isolate 
obtained from the human GI tract (95). Together with improved anaerobic culturing 
techniques by Hungate (148, 265), rich media facilitate cultivation of a plethora of 
bacteria species. However, most bacteria cultivated on these media are fast growing 
and belong to the readily cultivable fraction of complex microbial communities. 
Selective culture media enable the enrichment of the cultured fraction for bacteria of 
interest by hindering growth of unwanted bacteria. This cultivation strategy has been 
successfully used to isolate bacteria such as Streptococcus ((43, 340); Chapter 4), 
Veillonella (274, 275), Enterococcus, Lactobacillus (5), and Bifidobacterium (91) from 
environmental samples. This approach also led to the isolation of Akkermansia 
muciniphila from feces using anaerobic medium with gastric mucin as the carbon 
source (67). In addition, targeted cultivation can yield bacterial isolates of distinct 
bacterial groups, such as butyrate producers (78). Recently, gnotobiotic mice 
transplanted with bacterial communities from a human host were used to enrich for 
community members that are more suited to a certain diet. This microbial community 
could be clonally archived in a multi-well format to create collections of a subjects’ 
microbiota for further phylogenetic and genetic analysis (110). Although cultivation 
approaches are time-consuming, laborious, and costly, analysis of obtained isolates 
yields an important source of knowledge on their physiological characteristics (67, 
340, 380), functional properties through (comparative) analysis of their genomes (25, 
175, 343) as well as provides the opportunity to study their immunomodulatory 
properties (233, 335, 336). During the last decades hundreds of gastrointestinal 
isolates were obtained (see (265) for a review), albeit that most of them originate 
from stool samples and the number of isolates from the upper GI tract is limited. 
Recent innovations in the area of microbial cultivation, such as anopore-based 
microdish culture chips (152), may yield micro-colony isolates of previously 
uncultured bacteria. Microdroplet-based approaches (see (142) for a review) offers 
the means to compartmentalize cells in micro-droplets for subsequent (clonal) growth 
of micro-colonies and isolation of bacteria, including rare and so far uncultured 
phylotypes (374). Furthermore, confinement of multiple cells within the microdroplets 
offers avenues to investigate cell–cell interactions and facilitate isolation of obligate 
syntrophic bacteria (253, 374).  
Despite these efforts to obtain cultured representatives of the intestinal microbiota, 
molecular technologies revealed that the majority of bacteria in the intestinal 
General introduction 
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ecosystem cannot readily be cultured under laboratory conditions (309, 382) and, 
therefore, there is a clear need for advanced culture-independent techniques for 
comprehensive characterization of the human intestinal microbiota. 
Most culture-independent approaches are based on the universal bacterial 
phylogenetic marker, 16S ribosomal rRNA (rRNA) or its encoding gene. A variety of 
16S rRNA approaches has been developed, including classical cloning and 
sequencing, DGGE/TGGE, FISH, and qPCR. These classical methods differ in terms 
of sensitivity, selectivity and phylogenetic resolution and have been employed to 
determine bacterial-community structures, or detect and/or quantify specific bacterial 
groups within a variety of samples derived from the human intestine (see (378) for a 
review). Over the past years, the 16S rRNA targeting methodologies for microbial 
profiling of ecosystems have evolved rapidly and technologies, such as phylogenetic 
microarray analysis and barcoded pyrosequencing, were developed to enable high-
throughput and in-depth characterization of the microbiota (see (120) for a review). 
Phylogenetic microarrays commonly contain 16S rRNA-targeting oligonucleotide 
probes immobilized on a carrier surface (in many cases glass slides) and enable 
high-throughput, semi-quantitative characterization of microbial communities (68, 
251, 266). They have shown to be of value for assessing the composition and 
population dynamics of the microbiota (see (382) for a review). Phylogenetic array 
data-processing is not trivial and requires robust mathematical and statistical 
procedures to prevent artifacts (120). In addition, phylogenetic arrays are constrained 
to the detection of phylogenetic groups that are represented in the array design 
(252), which is illustrated by the incomplete coverage of the small intestinal 
microbiota by arrays designed on basis of predominantly fecal sequences (31). This 
shortcoming may be overcome by the use of flexible array design platforms (266), or 
by sequence based de novo community profiling technologies like barcoded illumina 
sequencing (39, 50) and 454 pyrosequencing (9). The latter technologies allow high-
throughput analyses, provide phylogenetic resolution, and are not restricted to 16S 
rRNA gene sequences that are known beforehand. Importantly, deep 
pyrosequencing and phylogenetic microarray analysis of the microbial community of 
fecal samples generated comparable results (49, 339). Data interpretation of illumina 
sequencing and pyrosequencing is challenging due to the vast number of sequences 
obtained and requires stringent quality control of individual sequence reads (149) and 
effective sequences profiling tools, as well as advanced visualization and 
interpretation software suites to handle the datasets. 
Moreover, the amount of the generated sequences determines the level of detection 
and for any quantification to be performed requires a sequence excess of the 
required depth. Sequence based community profiling technologies and any other 
PCR based approach, as well as FISH, require universal or selective oligonucleotide 
primers and probes for the bacterial group targeted, which can be based on the 
conserved and variable regions of the corresponding 16S rRNA gene sequences 
(42). However, the continuous expansion of 16S rRNA gene databases tends to 
outdate previously designed primers and/or probes, requiring constant updating of 
these molecular tools (16). This notion is exemplified by surveys (16, 138) and our 
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unpublished assessments of published universal 16S rRNA primers, demonstrating 
profound differences in their coverage of Bacteria (Figure 1.2) and/or other specific 
bacterial groups. Moreover, PCR based technologies that target highly conserved 
genes like the 16S rRNA gene may suffer from the formation of chimeric amplicons 
as an intrinsic artifact during amplification, which may contaminate the databases 
with biologically irrelevant sequences that are falsely assigned to specific bacterial 
groups (12). Therefore, it is imperative to screen obtained 16S rRNA gene 
sequences using appropriate tools (13, 82, 139) to identify chimeras and exclude 
them from analysis and deposition to the DNA databases. 
While illumina based community profiling needs further optimization (50), 
pyrosequencing efforts in the recent years have made a considerable contribution in 
comprehensive characterization and comparison of microbial communities in a 
variety of body habitats (147), including the human oral cavity (169), throat, stomach 
(9), as well as in fecal samples (49, 69, 329). It is expected that illumina platform in 
the upcoming years will complement these compositional studies with greater depth 
of analysis due to the vast amount of sequence reads that are obtained with this 
technology. 
 
 
Figure 1.2. Overview of relative coverage of Bacteria by published universal 16S rRNA primers. 
 
The human gastrointestinal microbiota 
The bacterial community is not evenly distributed in the GI tract and increases in 
density along the longitudinal axes. Bacterial colonization density in the human 
stomach is low, i.e., less than 104 bacteria per gram of contents, which is due to the 
stringent acidic conditions that kill most bacteria (115, 203). Additionally, the diversity 
of the stomach microbiota is relatively low, featuring merely 128 phylotypes in a 
collection of gastric biopsy specimens obtained from 23 human individuals (23). 
Bacterial numbers increase along the small intestine from 104 bacteria in the 
duodenum and jejunum to approximately 108 bacteria per gram of contents in the 
ileum (115, 203). Despite its relatively low community density (relative to the large 
General introduction 
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intestinal microbiota, see below), this microbial community may play an important role 
in the bioavailability and conversion of dietary components, especially since the 
major part of food digestion and absorption occurs in the small intestine. Moreover, 
the small intestine is the dominant intestinal site to study interactions between the 
intestinal microbiota and the host immune system, due to the presence of unique 
elements that are involved in confinement of the microbiota to the intestinal lumen 
and luminal sampling of bacteria (see (75) for a review). Paneth cells, for example, 
secrete antimicrobial peptides (22), which diffuse in the mucus layer produced by 
goblet cells. This layer controls contact between the luminal microbiota and the 
underlying epithelium (75). Other important elements, primarily localized to the small 
intestine, include Peyer’s patches that are involved in sampling luminal bacteria 
through overlying Microfold cells (M cells) (75, 217, 242). Bacteria are transported via 
transcytosis to the peyer’s patches and loaded on dendritic cells (DC) that play a key 
role in bacterial handling and subsequent immune responses (see (55) for a review). 
Otherwise, there is evidence that DCs can sample luminal bacteria directly by 
establishing tight-junction-like structures with intestinal epithelial cells and directly 
sample bacteria by protruding dendrites outside the epithelium (270). 
Considering the significance of the processes taking place in the small intestine, its 
microbiota can be anticipated to have an important influence on host physiology 
(381). However, the small intestinal microbiota is relatively unexplored, attributable to 
sampling difficulties of this poorly accessible region of the GI tract. Therefore, 
elucidation of this bacterial community is imperative for a better understanding of the 
microbial interactions and metabolic processes as well as the microbiota-immune 
system interactions that occur in the small intestine (32, 203). Efforts to study the 
small intestinal microbiota are dependent on biopsy specimens obtained during 
(emergency) surgery (3) or samples collected from sudden death victims at autopsy 
(128). Microbial analysis of biopsies from the jejunum and the distal ileum revealed a 
relatively low bacterial diversity in the jejunum mucosa with a microbial community 
dominated by Streptococcus spp. while a predominance of Bacteroidetes and 
Clostridium clusters IV and XIVa (according to the phylogeny proposed in (54)) was 
identified for the distal ileum (354). However, as a consequence of the relatively 
extensive procedures required for obtaining these samples, they may not represent 
the true small intestinal microbiota of a healthy individual and do not provide insights 
into population dynamics (32). 
One alternative to obtain small intestinal samples, which circumvents the sampling 
difficulties associated with the small intestine, makes use of individuals that 
underwent colon resection due to cancer or inflammatory bowel disease (IBD) and as 
a result have the terminal ileum connected to a stoma. This stoma provides a unique 
opportunity to non-invasively and repetitively sample the contents of the terminal 
ileum (31, 32). A recent study indicated that the microbiota in the effluent samples 
from these ileostomy subjects do not represent that of the terminal ileum in healthy 
subjects due to the penetration of oxygen (125). This study, however, seems to 
contradict with recent findings by Booijink, et al. that showed high abundance of strict 
anaerobes in ileostoma effluent samples (31). This may be explained by the fact that 
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the ileostomy subjects in the latter study had their colon removed at least 5 years 
before enrolment in the study during which anaerobic conditions in the small intestine 
are restored. The study by Booijink, et al. revealed that the small intestinal microbiota 
is different from that of the lower GI tract with a less diverse microbial community and 
greater temporal fluctuations in composition (31). Furthermore, the small intestinal 
microbial communities are enriched with Streptococcus and Veillonella (31, 381). In 
addition to the Streptococcus spp. encountered in the small intestine other members 
of the Lactic Acid Bacteria are detected, albeit that their inter-individual abundances 
fluctuate considerably (see (308) for a recent review). This is most likely due to the 
variability in available nutrients as a consequence of food consumption (308, 340).  
To assess the resemblance of ileostoma effluent to the true small intestinal 
microbiota, preliminary investigations in our laboratory employed an orally introduced 
catheter to collect small intestinal samples. This revealed that the microbial 
communities were enriched in Streptococcus and Veillonella (belonging to Bacilli and 
Clostridium cluster IX, respectively) in jejunal and proximal-ileum samples, while 
Bacteroidetes and Clostridium cluster XIVa were dominating in the more distal- or 
terminal-ileum (Figure 1.3), resembling the microbiota in ileostoma effluent and the 
colon, respectively.  
 
 
 
Figure 1.3. Relative contribution of detected phylogenetic groups present in samples derived 
from the small intestine and feces of four and two healthy individuals, respectively, and those 
from five healthy ileostomists. Profiles were generated by phylogenetic microarray analysis using 
the Human Intestinal Tract Chip (HITChip) (266). The tree represents the Euclidian clustering of the 
HITChip probe profiles. A–K encode the subjects; ileostoma effluent (eff), jejunum (jen), ileum (ile), 
terminal ileum (ter), feces (fec). In the legend, phylogenetic groups that contribute at least 2.5% to one 
of the profiles are indicated. 
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These results suggest that ileostoma effluent microbiota is not a suitable reflection of 
the community present in the lumen of the terminal ileum, but resembles more the 
community that is normally encountered in the proximal regions of the small intestine 
(381). One plausible explanation for this observation is the absence of colonic 
refluxes in the terminal ileum of ileostomy subjects. 
Bacterial numbers increase tremendously in the large intestine, reaching 1011 
bacteria per gram of contents (32, 203, 378). Often fecal samples are used to study 
the microbiota in the colon (151). However, it should be noted that the bacterial 
composition in these samples can differ significantly from that of the colonic mucosa 
(80, 201, 383). Analogous to the small intestine, the large intestine appears to 
contain an unique microbiota per person (382). In contrast to the small intestinal 
microbiota, the large intestinal microbiota of healthy individuals seems to remain 
relatively stable over time (229, 266, 376), and is much more diverse as compared to 
that of the small intestinal, with an estimated complexity that encompasses at least 
500 phylotypes (80).  
 
Homeostasis between the human host and the intestinal microbiota 
A healthy human host and its intestinal microbiota coexist in a homeostatic 
relationship (Figure 1.4) (135, 203, 217). The intestinal microbiota benefits from a 
stable environment and nutrient supply that are provided in the intestinal tract, while 
the host gains products from microbial metabolic activity and protection against 
potential pathogens (115, 203, 217, 242). The human host is only able to utilize 
simple sugars, disaccharides, and starch. The benefits of metabolic activity of the 
intestinal microbiota on the host consist in fermentation of the remaining non-
digestible dietary carbohydrates (136). The products of fermentation are gases (CO2, 
CH4, and H2) and the Short Chain Fatty Acids (SCFA) that are dominated by 
butyrate, propionate, and acetate, with butyrate being the most preferred energy 
source of the colonic epithelium (136, 203, 366). Approximately 10% of the total 
energy requirement for humans is derived from SCFA (136, 203). In addition, 
vitamins K, B12, riboflavin, biotin, folic acid, and pantothenate are synthesized by the 
intestinal microbial population. (115, 136, 282). 
 
Figure 1.4. Homeostatic relationship between the human host and its intestinal microbiota. 
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This functional uniformity of the microbiota in individuals is in apparent contradiction 
with their distinct phylogenetic composition. Nevertheless, it has been suggested that 
a phylogenetic core may be present, which may account in part for this common 
metabolic activity. However, the definition of a phylogenetic core varies between 
studies and is dependent on analysis factors, such as the techniques employed to 
determine the composition of intestinal microbiota, subject health status, 
phylogenetic depth, and the prevalence threshold (48, 120, 156, 262, 284, 317, 329). 
The phylogenetic core does not appear to include universally conserved phylotypes 
(317, 329), but can be defined on basis of phylotypes (total of only 66 OTUs) 
prevalent in a large proportion of the subjects studied (more than 50 %), and 
accounting for a large fraction of the overall community (~35 %) (317). Analogously, 
fecal microbiota profiling using phylogenetic microarrays, revealed a set of 
responding probes that were shared among the individuals (266). Inversely, the vast 
majority (~80 %) of the detected phylotypes appears to be host specific (317).  
Contrary to the individual-specific phylogenetic composition of the intestinal 
microbiota, recent random sequencing analyses of microbiota-derived DNA 
illustrated that functional grouping of sequence reads displayed remarkable 
conservation between individuals. Again, supporting the concept of a functional core 
rather than a phylogenetic core within the human intestine microbiota (188, 329). 
Furthermore, the study by Arumugam, et al. shows a remarkable high level of 
congruency in the total and core functional composition of fecal microbial 
communities among subjects of distinct geographic origins (11).  
Besides being a mutualistic partner, the human intestinal microbiota has also been 
associated with human diseases. IBD and Irritable Bowel Syndrome (IBS) are 
relatively common intestinal disorders with unclear etiology. Although these disorders 
are multifactorial, recent studies suggest that they are associated with a deregulation 
of the homeostasis between the host and its intestinal microbiota (75, 135, 217). 
Moreover, an increasing number of diseases appears associated with an aberrant 
microbiota composition, including allergic (atopic) diseases, obesity, type I and II 
diabetes, and autism (203, 265, 322). The mechanisms that underlie the observed 
associations between health and the GI tract microbiota are not yet understood. 
Nevertheless, the observed associations suggest that the intestinal microbiota may 
be an important modulator of our overall well-being and could be a potential 
diagnostic and/or therapeutic target in human health and disease. This notion is 
exemplified by a recent study by Vrieze, et al. showing that infusion of male patients 
with metabolic syndrome with the intestinal microbiota from lean individuals leads to 
an improvement in insulin sensitivity (352). 
 
Functional analysis of intestinal of microbial communities 
Although 16S rRNA gene-based technologies assess the (relative) number and 
identity of microorganisms in microbial communities, they do not provide further 
insights into their functional properties. Functional insight into the microbiota can be 
achieved by studying the genomes of bacterial isolates. The genomics era was 
initiated with the complete sequencing of the genome of Haemophilus influenza in 
General introduction 
11 
 
 1 
1995 (96). Since then there has been an exponential increase in the number 
sequenced bacterial genomes (24, 179) with over 3000 currently 
(http://www.ncbi.nlm.nih.gov/genomes; as on October 15th, 2012) available in public 
databases. While initially employing ‘classical’ Sanger sequencing technologies, the 
genomics field was drastically accelerated by the development and implementation of 
next generation sequencing platforms such as 454 (Roche), SOLEXA (Illumina), 
SOLiD (Applied Biosystems), and Helicos (Heliscope), which produce continuously 
increasing amounts of sequence information at a constantly decreasing price per 
base (see (234) for a recent review). 
Initially, bacterial genomics efforts focused on clinically relevant bacteria, such as 
Salmonella (254), Streptococcus pyogenes (92), and Helicobacter pylori (324), 
aiming to improve our understanding of their virulence factors. More recently, the 
scope has expanded to bacterial genomes of isolates from other food or intestinal 
sources, including the food microbes that are considered to confer a health benefit to 
their host when they reside in the intestinal tract like Lactobacillus (175) and 
Bifidobacterium species (see (176) for a recent review). Furthermore, the Human 
Microbiome Project (http://www.hmpdacc.org) currently sequences the genomes of 
cultured and uncultured bacteria from different human body habitats and plans to 
sequence a total of 3000 genomes, making a considerable contribution to the 
number of bacterial genomes (145). With the staggering number of sequenced 
genomes that are currently available, comparative genomics provides the means to 
understand the evolutionary relationship between bacteria (166, 344), albeit that 
these analyses may to some extent be confounded by lateral gene transfer between 
bacterial species (179). 
Although genomics has provided a wealth of knowledge, this field of study depends 
heavily on having pure bacterial cultures as starting material for DNA extraction and 
sequencing. As most bacteria are not readily cultivable (see above), their genetic 
content is barely accessible for culture dependent genome sequencing approaches, 
thereby limiting whole genome analysis of these organisms. To this end, a lot of effort 
is dedicated to the development and use of strategies that enable single cell 
genomics (47, 367), which circumvent cultivation, but to date remain technologically 
highly challenging and generally provide a relatively poor coverage of the single cell 
genomes that are determined. Nonetheless, single cell genomics may provide 
molecular clues that could enable the design of culture conditions that could 
selectively enrich for so far uncultured bacteria. 
Genomic analysis of the microbial community inhabiting a common environment can 
be achieved by applying metagenomics, which also bypasses the need for isolating 
and cultivating the individual species (44, 122). Metagenomic libraries of microbial 
communities contain information about the functional capabilities and the 
phylogenetic distribution of an ecosystem (123). Depending on the research purpose, 
metagenomic libraries can be built from short or long insert fragments. For a 
metagenomic library with short insert sizes (1-10 kb), harsh DNA extraction methods 
that shear the DNA can be used. However, depending on the microbial complexity of 
the environmental sample, a large number of clones is required to obtain adequate 
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coverage of the complete metagenome. Short insert libraries can be used for 
individual gene-function screening, e.g., identifying specific enzymatic activities 
(130). Methods for high molecular weight DNA extraction (21, 130, 276) enable the 
construction of large insert libraries (20-100 kb), which favors the discovery of 
multiple genes or operons that confer specific functional pathways to the cloning 
host. In addition, these large inserts may contain more reliable phylogenetic markers 
within the same insert as compared to the confidence of phylogenetic assignment 
that can be achieved using small sequence inserts (123). To prevent expression of 
unfavorable components in the cloning host, which is frequently Escherichia coli, 
many of the metagenomic expression libraries employ inducible promoters and are 
based on low copy number vectors (123). Still, cloning bias may significantly interfere 
with the appropriate coverage of potential counter-selected genetic elements that are 
encompassed within the metagenome of the targeted ecosystem. To circumvent the 
cloning step, next generation sequencing technologies (see above) are employed 
that allow for direct sequencing of environmental DNA extracts (296, 365). The 
added advantage of using next generation sequencing technologies is that the 
obtained sequence abundance data enables uncovering of the taxonomic and 
functional composition within an ecosystem (11, 329).  
Screening of a metagenomic library can be grouped into two main strategies: 
sequence-based screening and function-based screening (32, 122, 123, 291). 
Sequence-based screening employs large scale sequence determination and mining 
to unravel (niche specific) gene functions in order to describe the microbial 
community residing in the environment in gene-function terms (291), while function-
based screening mainly focuses on the identification of sequences that represent a 
particular function by screening for such function using a heterologous expression 
host (Figure 1.5).  
Worldwide, several metagenomic-initiatives target the human intestinal microbiota 
and/or other niches associated with the human body to eventually uncover the 
complete human microbiome (258, 330). The MetaHIT consortium, for example, 
provided an extensive gene catalogue (> 3 million non-redundant genes) of the 
human gut microbiota on basis of deep sequencing of the DNA extracted from fecal 
samples from mkore than 120 individuals (262), while a complementary and much 
smaller metagenome catalogue has recently been published for the microbiota of the 
human small intestine (381). Furthermore, the MetaHIT consortium also reported that 
the fecal microbiome composition of human individuals can be grouped in three 
distinct clusters called enterotypes, which is irrespective of their geographic origin 
and may eventually support stratification approaches of human individuals to predict 
their differential responsiveness to diet and medical treatments (11). The Human 
Microbiome Project (146) examined the microbial composition on multiple body sites 
in a large cohort of healthy human individuals to investigate the ‘normal’ microbiota 
and found that each body site harbors a distinct microbial community that remains 
stable over time (147). Nonetheless, functional analysis of samples from the same 
cohort revealed that there appears to be a small core of low abundant metabolic 
modules across different body habitats (2). 
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Figure 1.5. Schematic representation of metagenomic library construction and screening. 
 
To elucidate the activity of microorganisms in their environment, a coupling of 
genotypic and phenotypic meta-analyses will be required. These include other 
functional metagenomic approaches, such as metatranscriptomics, metaproteomics 
and metabolomics, which use biomolecules (RNA, protein, and metabolites) of 
activity as targets (Figure 1.6). 
 
Metatranscriptomics approach 
Metatranscriptomics encompasses the (complete) transcriptome analysis of a 
microbial community, or of gene-subsets within that community, in a particular 
environmental niche (356). To detect expressed genes in environmental samples, a 
rapid, robust and direct RNA isolation method is required to overcome instability 
problems associated with bacterial RNA. For fecal material, several methods have 
been described that include the use of quenching protocols to limit RNA turn-over 
and degradation or employ chemicals like RNA-later to stabilize the microbial RNA 
present in the sample (377), yielding relatively good RNA quantity and quality. Total 
bacterial RNA extracted from the environment predominantly consists of ribosomal 
RNA (> 95%), while only a minor proportion reflects actual transcript activity (mRNA, 
commonly below 5% of total RNA). Therefore, enrichment steps have been 
developed to remove the bacterial ribosomal RNA or selectively capture the mRNA. 
The first is based on ribosomal RNA removal by selective hybridization to probes that 
target highly conserved regions of the ribosomal RNA and is available in readily 
Chapter 1 
14 
 
1 
applicable commercial format (29), while the second method uses a selective and 
progressive 5’ – 3’ exonuclease reaction to digest rRNA on the basis of its 5’ 
monophosphate terminus, which is absent in unprocessed mRNAs (356). The latter 
method requires multiple steps and as a consequence is technically challenging (29). 
Capture of mRNAs is enabled by polyadenylation of mRNAs using Escherchia coli 
poly(A)polymerase. Polyadenylated mRNAs can subsequently be captured using 
oligo(dT)probes or reverse transcribed using oligo(dT) primers (304).  
 
 
 
Figure 1.6. Combining “meta-omics” technologies with systems biology to study and model 
host-microbe interactions. 
 
Transcriptome technologies for single organisms are well established and commonly 
use DNA microarrays that are designed on basis of the genome sequence and its 
annotation (61). As a consequence of the genetic diversity in many microbial 
communities, microarray design for complete metatranscriptome analyses is very 
challenging or even impossible. Nevertheless, gene catalogs of a certain ecosystem 
like the GI-tract microbiota gene-catalogue (262) may enable the design of 
ecosystem transcriptome analysis using high-density microarray designs (129). 
Alternatively, dedicated arrays may be designed that target specific gene-families of 
interest. To allow for comprehensive and quantitative data interpretation, such arrays 
require a probe design that covers the sequence-space of the targeted genes within 
the microbial community of interest, or may exploit highly conserved gene-sequence 
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elements that can detect clusters or families of genes corresponding with a particular 
function. 
Sequencing of mRNA-derived cDNA has become an effective alternative for 
microarray based methods (218), especially enabling detection of transcript 
abundance in a metagenome pool of unknown composition. Development of next 
generation sequencing platforms (see above) produce an enormous abundance of 
short reads enabling more cost- and time-efficient transcriptome sequencing (87, 
157, 238). Comparative transcriptomic sequencing for single microorganism such as 
Lactobacillus plantarum (198), Escherichia coli (323), Bacillus anthracis (255), and 
Burkholderia cenocepacia (371) under different growth conditions elucidate the 
response of an organism to its niche. Tartar, et al. (319) performed the first 
metatranscriptomic analysis in the more complex ecosystem of host-symbiont gene 
expression in the termite gut using an expressed sequence tag (EST) approach. 
Since then metatranscriptomic analysis using RNA sequencing of mRNA-derived 
cDNA clone libraries is employed to elucidate the active microbial populations in 
marine environments (99, 105), soil (17, 333), and the human GI tract (112, 331, 
381). 
Conversion of RNA into cDNA might introduce multiple biases that could interfere 
with the characterization and quantification of the transcriptome (52). Therefore, 
more accurate and high-throughput transcript analyses may be obtained by direct 
RNA sequencing (DRS), using only femtomoles of RNA without the need for cDNA 
synthesis (249). An optimized RNA sequencing protocol using HeliScope single-
molecule sequencers has been presented for Saccharomyces cerevisiae as a model 
organism, employing polyadenylated and 3’-blocked RNA capture on a solid surface 
followed by labeling and sequencing (249, 318). Although DRS has only been 
demonstrated for a eukaryotic organisms to date (249, 294), it may provide avenues 
for analysis of microbial metatranscriptomes in complex environmental samples at 
high-throughput, low cost, and without bias.  
 
Metaproteomics approach 
Metaproteomics encompasses the study of the proteome produced by the community 
in a certain environment, addressing presence, relative abundance, and/or 
modification state of the community proteome. This approach may become a very 
powerful strategy for understanding overall microbial-ecosystem functioning (364). 
Classical proteome analyses employ two-dimensional (2D) gel electrophoresis (247), 
but this technology is not straightforward, labor intensive, and does not allow high-
throughput analysis. Development of high-efficiency chromatographic peptide 
separation coupled with advanced mass spectrometry (MS) using improved 
ionization procedures, overcame initial difficulties in protein identification. This 
development in combination with advanced bioinformatics tools for reverse genetics 
and protein identification, including post-translational modifications, has paved the 
way for high-throughput protein identification using MS information (221).  
Metaproteomic studies of microbiota in the human infant GI tract by combining 2D gel 
electrophoresis and matrix assisted laser desorption ionization-time of flight mass 
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spectometry (MALDI-TOF MS) (173) demonstrated the application of this technique 
for complex microbial communities. Comparison with the database revealed a 
peptide sequence with high similarity to bifidobacterial transadolase. The 
development of novel high-throughput, gel-free (shotgun), non-targeted mass 
spectrometry (MS; see for a (298) recent review) enables a high level of protein 
identification. The principle is based on separation of peptides generated by 
enzymatic digestion using liquid chromatography and direct infusion into rapid 
scanning tandem mass spectrometers (2D-LC-MS/MS) through electronspray 
ionization followed by sequence comparison to the database. This approach has, for 
example, been used to detect and identify all proteins in the human distal gut 
microbiota without gel-based separation and revealed a high abundance of microbial 
proteins involved in translation, energy production and carbohydrate metabolism. 
Moreover, microbial activity interpretation in functional pathways demonstrated a 
complex interplay between the human host and its associated microbes (348).  
To improve the accuracy of peptide identification, Rooijers, et al. demonstrated an 
iterative workflow with a combination of a synthetic metagenome, from known gut 
inhabitants, and metagenomic databases as reference for MS/MS spectra. Using this 
approach, the proteome of A. muciniphila-like bacteria in a fecal metaproteome was 
explored, identifying the predicted role in mucin degradation of these bacteria in the 
intestinal tract (277). Recently, Kolmeder and colleagues developed a new high-
throughput metaproteomics analysis pipeline. Application of this pipeline to study the 
fecal metaproteome of three healthy individuals revealed that the metaproteome is 
host specific and remains relatively stable over time, analogous to what is observed 
for the intestinal microbiota composition (see above) (178). 
For complex protein mixtures or limited protein samples, Fourier-transform ion 
cyclotron resonance mass spectrometry (FTICR-MS) improves metaproteomic 
analysis by providing high accuracy mass measurement, with unprecedented 
sensitivity, and resolution power (208). This technology recently enabled 
comprehensive analysis of the human breast milk proteome, identifying over 300 
proteins that could be grouped to different functional categories. Despite the high 
accuracy with FTICR-MS, low abundant polypeptides were not characterized, 
indicating that the human milk proteome is not fully elucidated (259). 
 
Metabolomics – metabonomics approach 
Metabolite profiling can be divided into two areas, namely metabolomics and 
metabonomics. Metabolomics aims to characterize and quantify small metabolite 
molecules in complex biological samples, while metabonomics broadly aims to 
measure the global, dynamic metabolic response of multicellular biological systems 
to environmental factors or genetic manipulations (244) (Figure 1.6). Metabolomic 
and metabonomic studies employ the same analytical procedures which can be 
divided into targeted and non-targeted approaches. Targeted approaches focus on 
known metabolites while non-targeted approaches investigate all possible 
metabolites, covering changes in core metabolome as well as detection of unknown 
metabolites (248). The analytical platforms used in these studies, include nuclear 
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magnetic resonance (NMR) spectroscopy and gas chromatography-MS platforms, 
which are suited for mapping global biochemical changes in a non-targeted 
approach, and/or LC-electrochemistry arrays (LCECA) for mapping neurotransmitter 
pathways and oxidative stress pathways in both targeted and non-targeted studies 
(161). Variation in human metabolic phenotypes is associated to several factors, 
such as host genotype, age, sex, lifestyle, nutrition and their commensal microbial 
communities (248). Correlation analysis of symbiotic gut microbiota composition with 
the variation in metabolic phenotypes measured in human fecal and urinary samples 
of seven Chinese individuals suggested that there are profound host-microbiota 
symbiotic associations. These associations have an important influence on the global 
metabolism, regardless of the genetic background across a range of pathways or 
environmental conditions of the host (207). The effect of the gut microbiota on the 
host blood-metabolome was investigated in germ-free mice by means of untargeted 
MS, which revealed a direct impact of the microbiota on the drug metabolism 
capacity of the host (363). A metabonomic study using proton-NMR profiling of urine 
and plasma to characterize and compare the metabolic response of conventional and 
germ-free rats to hydrazine exemplified a reduced toxicity in conventional rats, 
indicating that the microbiota specifically alters the host hydrazine toxicity response 
(314). Notably, microbiota modulations by pro-, pre-, and synbiotic supplementation 
could be coupled to alterations in major mammalian metabolic processes and 
interorgan cross-talk, which were speculated to have long-term health consequences 
to the host (223). 
These studies illustrate the intimate relation between overall biochemistry of the host 
and its microbiota, which supports their mutualistic relationship and underlines the 
importance of host-microbe metabolic relations. Analogously, combined metabolome 
analyses of different biological fluid, such as fecal water, urine and plasma in animal 
models further evidenced microbe-host mutualism, and allowed the tracking of 
microbial metabolites from non-digestible food ingredients (155). Knowledge 
obtained from studies using animal models could further be tested in humans to aim 
for more comprehensive phenotyping, more accurate definition of health, including 
information of metabolic disorders, which may open avenues for manipulating human 
microbiomes to optimize their contribution to human health by disease prevention 
and/or treatment (328).  
 
Research aims and thesis outline 
The research described in this thesis aims to provide a better understanding of the 
composition and dynamics of the human small intestinal microbiota and to provide 
insight in the metabolic potential as well as immunomodulatory properties of its 
typical commensal inhabitants. To this end, ileostoma effluent samples were used to 
investigate the small intestinal microbial composition with classical cultivation 
methods combined with state of the art microbial profiling technologies and molecular 
typing methodologies. 
Considering the importance of molecular techniques in contemporary ecology 
investigations that study microbial communities, chapter 2 compares and contrasts 
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two technologies, barcoded pyrosequencing and phylogenetic microarray analysis, 
for the determination of the bacterial composition in fecal and small intestinal 
samples from human individuals. In addition, the use of different primer pairs in 
barcoded pyrosequencing is evaluated to address their impact on the outcome of 
PCR-based approaches in microbial profiling. The analyses presented in the chapter 
demonstrate that different primers and the two profiling technologies provide overall 
similar results for samples of fecal and the terminal ileum. In contrast, the profiles 
obtained by barcoded pyrosequencing and phylogenetic microarray analyses were 
substantially different for ileostoma effluent samples, which is most likely attributable 
to less complete coverage of the small intestinal microbiota by the probes present on 
the phylogenetic microarray that were designed on basis of known large intestinal 
16S rRNA gene sequences. As pyrosequencing offers de novo community profiling, 
subsequent work employed this technologies as the method of choice for profiling of 
small intestinal communities. The 16S ribosomal RNA gene (rDNA) and ribosomal 
RNA (rRNA) content of ileostoma effluent samples from four different subjects was 
determined, while Illumina sequencing of cDNA derived from enriched mRNA was 
used to obtain metatranscriptome profiles of the same sample set (Chapter 3). This 
revealed that the composition of the small intestinal bacterial communities as 
assessed from rDNA, rRNA, and mRNA patterns appeared to be similar, indicating 
that the dominant bacteria in the small intestine are also highly active in this 
ecosystem. Streptococcus spp. were among the few bacterial species that were 
detected in each ileostoma effluent sample, albeit that their intra- and inter- individual 
abundances varied greatly. Veillonella spp. were frequently co-occurring with 
Streptococcus, indicating that the Streptococcus and Veillonella populations play a 
prominent role in the human small intestine ecosystem and their co-occurrence 
suggests a metabolic relation between these genera. Therefore, cultivation and 
molecular typing methodologies were employed to zoom-in on these groups 
(Chapter 4), which revealed that the richness of the small intestinal streptococci 
strongly exceeded the diversity that could be estimated on basis of 16S rRNA 
analyses, and could be extended to the genomic lineage level (anticipated to 
resemble strain-level). From ileostoma samples 3 different Streptococcus species 
were recovered belonging to the S. mitis group, S. bovis group, and S. salivarius 
group, which could be further divided in 7 genomic lineages. Notably, the 
Streptococcus lineages that were isolated displayed distinct carbohydrate utilization 
capacities, which may imply that their growth and relative community composition 
may respond quite strongly to differences in the dietary intake of simple 
carbohydrates over time. This notion is in good agreement with the observation that 
the Streptococcus lineage populations fluctuated in time with only one Streptococcus 
lineage being cultivated from both ileostoma samples collected in a one-year time 
frame. Conversely, the cultivated Veillonella isolates from samples during that same 
time-interval consistently encompassed a single lineage. Furthermore, this Veillonella 
lineage could be isolated from both the oral cavity as well as the ileostoma effluent. 
Analogously, three Streptococcus lineages that belong to a single phylotype also 
appeared to be present in both oral and small intestinal microbiotas. These 
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observations establish a high-level phylogenetic relatedness between the 
representatives of the Veillonella and Streptococcus genera that are encountered in 
the oral and small intestinal microbial ecosystems.  
The metabolic capacity of 6 small intestinal Streptococcus lineages was further 
investigated through the determination of their genomic sequence (Chapter 5). The 
Streptococcus lineages were found to encode a different repertoire of carbohydrate 
transporters and the cognate enzymes to metabolize different sugars, which was in 
excellent agreement with the observed carbohydrate utilization capacity determined 
for these representative strains of the Streptococcus lineages (Chapter 4). 
Additionally, the Streptococcus genomes were mined for two component systems 
and genes encoding bacteriocins to gain further insights how these Streptococcus 
lineages perceive and respond to environmental stimuli. In Chapter 6 dendritic cells 
were stimulated with strains of the different Streptococcus lineages to study their 
immunomodulatory properties. The Streptococcus lineages differed significantly in 
their capacity to modulate cytokine responses of blood-monocyte derived immature 
dendritic cells. Intriguingly, co-stimulation of dendritic cells with Streptococcus and 
Veillonella resulted in considerably different cytokine responses as those that could 
be predicted from the stimulations with either Streptococcus or Veillonella, indicating 
that it is not trivial to predict gut mucosal associated immune responses based on 
results from in vitro assays. 
Chapter 7 completes this thesis with a summary and discussion of the results that 
are presented in the light of what they contribute to the current state of knowledge. In 
addition, it discusses and proposes several research directions that may be 
developed in the future to further our knowledge of the microbial ecosystem in the 
human small intestine and its role in health and disease. 
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Abstract 
 
Large-scale and in-depth characterization of the intestinal microbiota necessitates 
application of high-throughput 16S rRNA gene-based technologies, such as 
barcoded pyrosequencing and phylogenetic microarray analysis. In this study, both 
techniques were compared and contrasted for analysis of the bacterial composition in 
three fecal and three small intestinal samples from human individuals. As PCR 
remains a crucial step in sample preparation for both techniques, different forward 
primers were used for amplification to assess their impact on microbial profiling 
results.  
An average of 7,944 pyrosequences, spanning the V1 and V2 region of 16S rRNA 
genes, was obtained per sample. Although primer choice in barcoded 
pyrosequencing did not effect species richness and diversity estimates, detection of 
Actinobacteria strongly depended on the selected primer. Microbial profiles obtained 
by pyrosequencing and phylogenetic microarray analysis (HITChip) correlated 
strongly for fecal and ileal lumen samples, but were less concordant for ileostoma 
effluent. Quantitative PCR was employed to investigate the deviations in profiling 
between pyrosequencing and HITChip analysis. Since cloning and sequencing of 
random 16S rRNA genes from ileostoma effluent confirmed the presence of novel 
intestinal phylotypes detected by pyrosequencing, especially those belonging to the 
Veillonella group, the divergence between pyrosequencing and the HITChip is likely 
due to the relatively low number of available 16S rRNA gene sequences from small 
intestinal origin in the DNA databases that were used for HITChip probe design. 
Overall, this study demonstrated that equivalent biological conclusions are obtained 
by high throughput profiling of microbial communities, independent of technology or 
primer choice. 
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Introduction 
 
The human gastrointestinal (GI) tract is inhabited by a microbiota that predominantly 
consists of bacteria and is dominated by the phyla Firmicutes, Bacteroidetes, and 
Actinobacteria (268). This community increases in numbers as well as diversity along 
the longitudinal axes of the GI tract and ultimately reaches populations as high as 
1011 bacteria per gram of contents in the large intestine (32, 203, 341). The diversity 
and population dynamics of the lower GI tract microbiota has been well documented 
(203, 266, 382). In contrast, the microbiota of the upper GI tract has been poorly 
described, which is mainly due to sampling difficulties (31, 203). Recently the human 
small intestinal microbiota was characterized using samples obtained from ileostomy 
subjects (31, 125), and samples from the small intestine of healthy individuals 
obtained with an orally introduced catheter (381). 
Much emphasis has been placed on understanding the dynamics and activities of the 
intestinal bacterial communities (31, 266, 329). The means by which this research 
has been conducted, underwent a revolution from culture based approaches to 
molecular technologies during the last decades (see (341) and (378) for reviews). 
Molecular technologies based on 16S ribosomal RNA (rRNA) and its encoding gene, 
such as fluorescent in situ hybridization (FISH) (124), quantitative PCR (qPCR) (272), 
denaturing gradient gel electrophoresis (DGGE) (19), terminal-restriction fragment 
length polymorphism (T-RFLP) (83), as well as the classical 16S rRNA gene 
amplicon-cloning and sequencing approach (80) are commonly used for 
compositional studies of the intestinal microbial ecosystem (346, 378). However, 
these approaches are laborious, especially when one aims for in-depth microbial 
community profiling (378). Phylogenetic microarrays (252, 266) and pyrosequencing 
technology (220) have become popular methods since they principally allow high-
throughput and in-depth monitoring of microbial communities. While the former relies 
on 16S rRNA gene-targeted oligonucleotide probes for detection of bacteria in 
environmental samples (266), the latter allows de novo community profiling by 
sequencing and subsequent identification of partial 16S rRNA gene amplicons (9).  
Each of the above mentioned approaches for characterization of microbial 
communities is limited in its correct assessment of microbial abundances due to the 
unspecified partial phylogenetic coverage by primers or probes that are used during 
the initial stages of sample preparation (16, 98). This notion is exemplified by the 
underestimation of Bifidobacterium spp. abundances in fecal samples by the 
commonly used universal 27F primer (127). One constraint of phylogenetic arrays for 
microbial profiling is their limitation to detect phylogenetic groups for which probes 
are represented on the array, although higher taxonomic level probes can still 
provide information for those groups (252), whereas analysis of data from 
pyrosequencing is challenging due to the vast number of obtained sequences that 
may contain sequence errors that disturb appropriate data interpretation (120). 
The aim of this research was to assess the accordance of barcoded pyrosequencing 
and a phylogenetic microarray, the Human Intestinal Tract Chip (HITChip) (266), for 
profiling of human fecal and small intestinal microbial communities. In addition, the 
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use of different primer pairs in barcoded pyrosequencing was evaluated to answer 
whether their use in PCR based approaches influences the outcome of microbial 
diversity estimates and profiling (Figure 2.1). 
 
Figure 2.1. Schematic 
representation of the 
experimental set up for 
characterization of the microbial 
composition in fecal samples, 
ileal content and ileostoma 
effluent using molecular 
approaches. *: Forward primers 
and the reverse primer used for 
pyrosequencing were appended 
with adaptor A and adaptor B, 
respectively. 
 
 
 
Materials and methods 
 
Sample collection 
Fecal samples (F1-F3) used in this study were collected at home from three healthy 
individuals (2 female, 1 male; aged 30-32 years), frozen in dry-ice immediately, and 
transported to the laboratory where they were kept at -80°C until further analysis. 
Ileostoma effluent samples (S1 and S2) were previously collected (31) at least 3 h 
apart in the morning and afternoon, respectively, from a healthy 74 year old male 
ileostomist as part of a previous project, results of which are reported elsewhere (31). 
The volunteer collected the ileostoma effluent samples by emptying the ileostoma 
effluent in freezer baskets as soon as the bulk of ileostoma effluent was collected in a 
clean empty ileostoma bag. Samples were stored on dry-ice at approximately -80°C 
and were processed within three days after collection. 
An ileum lumen sample (S3) was obtained from a 24 year old healthy female 
individual by using an orally introduced catheter, which passed to the ileum (120 cm 
distal to the pylorus) by peristalsis. Sampling was done under gastroenterologist-
supervision, following flushing the ileum with 10 ml physiological salt solution through 
a port of the catheter, after which the sample was frozen and stored at -80°C. 
 
Bacterial reference strains and culture conditions 
Bifidobacterium longum (DSM 20219) was grown in ST medium as described in (293) 
with a substitution of proteose peptone for 1 g/l casitone (Becton Dickinson, Breda, 
the Netherlands) and meat extract for 3 g/l beef extract (Sigma, St. Louis, MO, USA). 
E. coli MC1061 was cultivated in Luria-Bertani (LB) broth at 37°C in a shaking 
incubator (135 RPM; Heidolph Instruments GmbH & Co, Schwabach, Germany). 
Streptococcus thermophilus (CNRZ 1066) was grown in M17 broth (Becton 
Dickinson) supplemented with 0.5% (w/v) glucose (Sigma) at 37°C. Veillonella 
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atypica (DSM 20739) was grown in Veillonella medium described in the DSMZ 
catalogue (Medium 136) under an N2 atmosphere. 
 
DNA extraction 
Genomic DNA (gDNA) extractions from reference strains were performed using the 
fDNA® SPIN Kit for Soil (MP Biomedicals, Solon, OH, USA) with pelleted cells from 2 
ml pure culture as starting material (data not shown). 
Total DNA was extracted from 0.25 gram fecal sample and 0.25 ml ileal content, 
using the Repeated Bead Beating method described in (283), and from 0.2 gram 
ileostoma effluent as previously described (379) by using the QIAamp DNA Stool 
Mini Kit (Qiagen GmbH, Hilden, Germany). A recent study by Salonen, et al. (283) 
concluded that the difference in microbial composition between DNA extraction 
methods is relatively small in relation to that between subjects. 
DNA was quantified using a NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA) and adjusted to 10-20 ng/µl as template for 
subsequent 16S rRNA gene PCR amplification. 
 
16S rRNA gene amplicon pyrosequencing 
Amplicons from the V1-V6 region of 16S rRNA genes were generated by PCR using 
two degenerated (27F-DegL and 27F-DegS) and two non-degenerated (27F-Nondeg 
and 35F-Nondeg) primers in combination with a single reverse primer (1061R-Deg; 
Table 2.1) for each fecal and small intestinal DNA extraction. 
To facilitate pyrosequencing using titanium chemistry, each forward primer was 
appended with the titanium sequencing adaptor A and a ‘NNNN’ barcode sequence 
(Table 2.1) at the 5’ end, where NNNN is a sequence of four nucleotides that was 
unique for each sample and did not start with G nor contained a triplicate of identical 
bases. The reverse primer carried the titanium adaptor B at the 5’ end.  
PCRs were performed using a thermocycler GS0001 (Gene Technologies, Braintree, 
U.K.) in a total volume of 50 l containing 1× PCR buffer, 1 l PCR Grade Nucleotide 
Mix, 2.4 units of Faststart Taq DNA polymerase (Roche, Diagnostics GmbH, 
Mannheim, Germany), 200 nM of a forward and the reverse primer (Biolegio BV, 
Nijmegen, The Netherlands), and 0.2-0.4 ng/l of template DNA. The amplification 
program consisted of an initial denaturation step at 95C for 5 min, 35 cycles of: 
denaturation at 95C for 30 s, annealing at 56C for 40 s and elongation at 72C for 
70 s, and a final extension step at 72C for 10 minutes. The size of the PCR products 
was confirmed by gel electrophoresis using 1 μl of the reaction mixture on a 1% (w/v) 
agarose gel containing 0.4 µg/ml ethidium bromide (Bio-rad, Hercules, CA, USA). 
Control PCR reactions were performed alongside each separate amplification without 
addition of template, and consistently yielded no product. The optimal annealing 
temperature for primers (56C) with attached adaptors and barcodes was determined 
by a 12-degree temperature gradient (49C-61C) PCR using DNA from fecal sample 
F2 (data not shown). 
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PCR products were purified with the ZR-96 DNA Clean and Concentrator kit (Zymo 
Research, Orange, USA) followed by DNA yield quantification using a NanoDrop ND-
1000 spectrophotometer. 
Purified PCR products were mixed in equimolar amounts with a final DNA 
concentration of 100 ng/l. The pooled amplicons were pyrosequenced using a 
Genome Sequencer FLX in combination with titanium chemistry (GATC-Biotech, 
Konstanz, Germany). Sequencing occurred on a picotiterplate of which a quarter 
space was available for samples included in this study. 
 
HITChip analysis 
Microbial community profiling was also performed using the HITChip (266), which is a 
phylogenetic microarray, produced by Agilent Technologies (Palo Alto, CA) in 8×15K 
format, with over 4800 tiling oligonucleotides targeting the V1 or the V6 region of the 
16S rRNA gene from 1,132 microbial phylotypes present in the human 
gastrointestinal tract (266). See the supplementary materials and methods section for 
the hybridization and analysis procedure.  
 
Pyrosequence analysis and comparison with HITChip analysis 
Pyrosequences were sorted per barcode. To the best of our knowledge, no 
recommendations for quality filtering of reads generated by pyrosequencing using 
titanium chemistry have been published to date, and therefore, we applied previously 
reported recommendations for quality filtering of pyrosequences generated by the GS 
20 platform (149). This filtering was performed using an in-house perl script that 
passed sequences with exact matches to the forward primer, no ambiguous bases 
(N), and read-lengths not longer or shorter than 1 SD from the average sequence 
length (>87-157 and <314-359 nucleotides; See table S2.2 for the actual upper and 
lower read-length limit per sample). Additionally, primer sequences were removed 
from the pyrosequencing reads, and remaining sequences were analyzed. The 
number of operational taxonomic units (OTUs), rarefaction curves, and total species 
richness estimations (Abundance-based Coverage Estimators (ACE) and Chao1) 
(143) for the quality filtered sequences per sample were calculated using ESPRIT 
(310) with default settings (without removing low quality reads) at 0.02 distance level. 
Taxonomic classification of sequencing reads employed a locally installed version of 
the Ribosomal Database Project (RDP) Classifier (355), which by default produces 
classifications into the new higher-order taxonomy as proposed in Bergey’s 
Taxonomic Outline of the Prokaryotes (102). The corresponding assignments differ 
from those that are produced by HITChip analysis, which has a standard output of 
the relative contributions of 1,132 microbial phylotypes at Level 1 (phylum-like with 
Firmicutes divided into classes or clusters), Level 2 (genus-like), and/or Level 3 
(phylotypes based on >98% sequence identity) (266) to the overall microbial 
community per sample in the phylogeny as proposed by Collins, et al. (54). The 16S 
rRNA gene sequences of these phylotypes are present in a non-redundant ARB 
(215) database that was used for HITChip probe design: the human unique OTU 
database (266, 268). The sequences with corresponding assignments present in this 
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database were exported and used to train the RDP-classifier. This yielded a classifier 
that (in combination with a trial multiclassifier provided by the RDP staff) could 
classify pyrosequencing reads originating from different samples on a large scale 
with the same assignments as are produced by HITChip analysis. The confidence 
threshold used for classification of the pyrosequences was kept at 80%. Moreover, 
the multiclassifier summarized the assignments per taxon, which facilitated 
calculation of relative contributions and subsequent construction of microbial profiles 
for comparison with those that were generated by HITChip analysis. 
Hierarchical cluster analysis of the microbial profiles was done in R version 2.9.2 by 
computing a distance matrix that was based on Pearson product-moment correlation 
coefficients (r) between pairs of profiles with level 2 community data. Visualization of 
hierarchical clustering was done by using the distance matrix in the hclust function in 
R with Ward’s minimum variance method as agglomeration method. The Shannon 
diversity index was calculated in R using the diversity function with the level 2 
community data from each sample. Screening sequences for exact matches with the 
HITChip probes or primers was performed using in-house perl scripts.  
 
Quantification of bacterial community members by qPCR 
All qPCR reactions were performed in 96 well PCR plates (Bio-rad) sealed with 
Microseal ‘B’ Film (Bio-rad) using a MyIQ Icycler with MyIQ software version 1.0.410 
(Bio-rad). Each reaction was carried out in a total volume of 25 µl using IQ SYBR 
Green Supermix (Bio-rad) according to manufacturer’s instructions with 200 nM of 
forward and reverse primer in combination with 5 µl template DNA.  
From a literature survey, group-specific primers were chosen (Table 2.1) that were 
deemed optimal in their phylogenetic specificity and coverage (based on results of 
the ‘probe match’ tool offered in the Ribosomal Database Project 
http://rdp.cme.msu.edu/ (53)) as well as the minimal tendency to form secondary 
structures, including hairpin loops, heterodimers, and homodimers (assessed using 
the IDTDNA Oligoanalyzer 3.1; http://eu.idtdna.com/) that may interfere with PCR 
efficiency (184). The optimal annealing temperature for each primer pair was 
determined by an 8-degree temperature (53C-64C) gradient PCR using gDNA from 
target bacterial reference strains as template (data not shown). The amplification 
program for most qPCR assays consisted of an initial denaturation step at 95C for 5 
min, 40 cycles of: denaturation at 95C for 15 s, annealing at the optimal temperature 
for 30 s (with data acquisition) and elongation at 72C for 30 s, and a final extension 
step at 72C for 10 minutes. The elongation time for the Streptococcus qPCR assay 
was set at 20 s, whereas the denaturation and the elongation time for the 
Bifidobacterium qPCR assay were set at 30 s and 40 s, respectively. This was done, 
for practical reasons, to reduce the time to complete the Streptococcus qPCR assay 
and to provide sufficient time for denaturation and elongation of the relatively large 
amplicon (550 bp) produced during the Bifidobacterium qPCR assay. Melting curve 
analysis was carried out by incrementally increasing the temperature from 55°C to 
95°C at 30 s per 0.5°C with continuous fluorescence collection. 
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Table 2.1. Adaptors and primers used in this study for 16S rRNA gene sequence PCR 
amplification for pyrosequencing, HITChip analysis, qPCR, and 16S rRNA gene cloning and 
sequencing 
Target bacteria 
or bacterium Primer
a Primer sequence (5’-3’)b 
Applicationc and 
PCR annealing 
temperature 
(C)d 
Reference 
 Adaptor A CCATCTCATCCCTGCGTGTCTC
CGACTCAG 
P Provided by 
GATC-Biotech
 Adaptor B BioTEG/CCTATCCCCTGTGTGC
CTTGGCAGTCTCAG 
P Provided by 
GATC-Biotech
Total Bacteria 
27F-DegL AGRGTTYGATYMTGGCTCAG P(56) (251) 
27F-DegS GTTYGATYMTGGCTCAG P(56) This studye 
27F-Nondeg GTTTGATCCTGGCTCAG  P(56)/H(52)f/C(5
2) 
(266) 
35F-Nondeg CCTGGCTCAGGATGAACG  P(56) (127) 
1061R-Deg CRRCACGAGCTGACGAC P(56) (9) 
Uni-1492-rev CGGCTACCTTGTTACGAC H(52)/C(52) (266) 
BACT1369F CGGTGAATACGTTCYCGG Q(56) (313) PROK1492R GGWTACCTTGTTACGACTT 
Bifidobacterium 
g-Bifid-F CTCCTGGAAACGGGTGG Q(55) (228) g-Bifid-R GGTGTTCTTCCCGATATCTACA
Veillonella 
Veil-F-Rinttilä AYCAACCTGCCCTTCAGA Q(57) (272) Veil-R-Rinttilä CGTCCCGATTAACAGAGCTT 
Streptococcus 
Strep-F-Rudney AGATGGACCTGCGTTGT Q(55) (279) Stherm 08 GTGAACTTTCCACTCTCACAC (100) 
Escherichia coli E.coli-F-Huijsdens CATGCCGCGTGTATGAAGAA Q(57) (144) E.coli-R-Huijsdens CGGGTAACGTCAATGAGCAAA
a Primer names may not correspond to original publication 
b M = A or C; R = A or G; W = A or T; Y = C or T 
c Pyrosequencing (P); HITChip analysis (H); qPCR (Q); 16S rRNA gene clone library construction and 
sequencing (C) 
d Annealing temperatures indicated in bold were determined as explained in Materials and methods  
e 5’ end 3 nt trimmed version of the 27F-DegL primer 
f With a T7 promotor sequences appended on the 5’ end 
 
For each qPCR assay, a standard curve comprising 8 serial 10-fold dilutions of full-
length 16S rRNA gene PCR products was generated from target gDNA preparations 
of the respective reference strains. For the total bacteria qPCR assay a standard 
curve was generated using E. coli MC1061 gDNA. The standard curves of each 
qPCR assay were used to determine the relative contribution of target bacterial 
groups to the total bacterial community in sample DNA preparations. 
 
16S rRNA gene library construction and analysis 
The 27F-Nondeg and Uni-1492-rev primers (Table 2.1) were used for PCR 
amplification of 16S rRNA gene sequences from the undiluted extracted DNA of 
sample S1 and S2. Each reaction was performed in quadruplicate in a total volume of 
50 µl containing 1× PCR buffer (Promega), 200 nM of each primer (Biolegio), 200 µM 
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of each deoxyribonucleotide triphosphate (Promega), 1.25 U GoTaq® DNA 
polymerase (Promega) and 1 µl of the extracted DNA. The amplification program was 
performed on a T1 thermocycler (Biometra, Gôttingen, Germany) and consisted of an 
initial denaturation step at 94C for 2 min, 35 cycles of: denaturation at 94C for 30 s, 
annealing at 52C for 40 s and elongation at 72C for 90 s, and a final extension step 
at 72C for 5 minutes. PCR products were verified by gel electrophoresis using 5 μl 
of the reaction mixture on a 1% (w/v) agarose gel containing 0.4 µg/ml ethidium 
bromide (Bio-rad). Quadruplicate PCR products from the same sample were pooled 
and subsequently purified with a High Pure Cleanup Micro Kit (Roche) using 10 µl 
Elution Buffer (Roche) for elution. The purified PCR products were diluted 10 times of 
which 1 µl was used for ligation into the pGEM-T easy vector (Promega) overnight at 
4C according to the manufacturer’s instructions. XL1-blue competent cells (75 µl; 
Stratagene, La Jolla, CA, USA) were transformed with 2 µl ligation mixture according 
to manufacturer’s instructions and subsequently plated on LB agar containing 
ampicillin (100 µg/ml; Sigma), isopropyl-β-D-thiogalactopyranoside (IPTG; 0.16 mM; 
Carl Roth GmbH, Karlsruhe, Germany), and 5-bromo-4-chloro-3-inodlyl-β-D-
galactopyranoside (X-Gal, 100 µg/ml; Invitrogen, Carlsbad, CA, USA) for blue-white 
color screening. White colonies were randomly selected and separately cultured 
overnight at 37C in LB medium containing ampicillin. Subsequently, 2×96 clones 
from each clone library were randomly selected and the cloned inserts were 
sequenced from both ends using the T7 and SP6 priming sites (GATC-Biotech, 
Konstanz, Germany). The obtained sequences per clone were assembled using 
Clone Manager 9 Professional Edition (Scientific & Educational Software, Cary, NC, 
USA) yielding near full-length 16S rRNA gene sequences, which were analyzed with 
DNA Baser v2.71.0 (HeracleSoftware, Lilienthal, Germany) to trim vector sequences. 
Subsequently, sequences were tested for chimeras using Mallard (13) following the 
instructions of the authors with the default settings to identify chimeric sequences. 
Putatively anomalous 16S rRNA gene sequences identified by Mallard were further 
analyzed following the anomaly confirmation protocol suggested by the authors and 
unambiguously anomalous sequences were excluded from further microbiome 
interpretations. Non-chimeric sequences were taxonomically classified using the in-
house customized RDP classifier described above. Sequences for which no 
classification could be obtained above the 80% confidence threshold were classified 
using the locally installed version of the RDP classifier version 2.2 (355) with a 
default confidence threshold of 80%. 
The non-chimeric 16S rRNA gene sequences from each clone library were aligned 
using the SILVA Webaligner (261) and subsequently imported into ARB. Each clone 
library was manually screened (using a neighbor joining distance matrix, employing 
no correction, generated in ARB) for sequences showing <98% identity to 16S rRNA 
gene sequences represented in the human unique OTU database that was used for 
HITChip probe design. 
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Nucleotide sequence accession numbers 
The cloned 16S rRNA gene sequences from ileostoma effluent were deposited in the 
Genbank database and are available under accession numbers HQ176022-
HQ176318. 
 
Results 
 
Analysis of pyrosequencing reads from 16S rRNA gene amplicons 
Pyrosequencing of the 16S rRNA gene PCR amplicons from fecal samples (F1-F3), 
ileostoma effluent (S1 and S2), and ileal lumen content (S3) yielded in total 190,652 
sequences with 7,944 ± 2201 sequences per sample. Quality filtering passed 
approximately 50% of the pyrosequencing reads, with an average length of 224 nt 
(Table 2.2; See Table S2.1 for a comprehensive overview of the characteristics of 
pyrosequencing reads before and after quality filtering). Detailed analysis revealed 
that the majority (74.80% ± 4.74%) of the sequences that failed to pass quality 
filtering were due to sizes that were outside the sequence length thresholds (Table 
S2.2).  
Microbial profiles, based on the level 1 (phylum-like; Figure 2.2) and level 2 (genus-
like; Figure S2.1) taxonomic assignments of the pyrosequences that passed quality 
filtering, were constructed for all samples. As anticipated, most pyrosequences were 
assigned to the Firmicutes (85.6%), Actinobacteria (7.6%), and Bacteroidetes (2.9%; 
predominantly encountered in fecal samples F1 and F2 as well as in the ileal lumen 
content S3). 
Notably, only 1.5% of all pyrosequences could not be classified using the confidence-
threshold of 80% and are represented as unclassified_Human unique OTU (Figure 
2.2). Furthermore, microbial profiles obtained using all pyrosequences (without 
quality filtering), revealed essentially the same profiles as those obtained with the 
quality-filtered sequences, albeit with a raised abundance of the unclassified_Human 
unique OTU (Figure S2.2), indicating that the quality filtering step does not drastically 
influence the reconstruction of the microbial community but predominantly eliminates 
noise. 
Hierarchical clustering of the microbial profiles revealed separate grouping of fecal 
samples and ileum-lumen content from ileostoma effluent samples (Figure S2.3A). 
The divergence between these clusters was most apparent for phylogenetic groups 
belonging to the Firmicutes with fecal samples and ileum-lumen content being 
abundant in Clostridium clusters IV (12.3% ± 7.3%), XIVa (58.6% ± 8.6%), XVI (4.4% 
± 3.8%), and XVIII (3.0% ± 1.8%), while Bacilli (9.2% ± 4.5%) and Clostridium 
clusters I (24.0% ± 11.5%), IX (13.3% ± 7.1%), XI (14.0% ± 14.1%), and XIVa (27.2% 
± 13.4%) were predominant in ileostoma effluent. Moreover, species richness, as 
reflected by Chao1 and ACE supported by the rarefaction curves, as well as the 
Shannon diversity index, was higher in fecal samples and ileum-lumen as compared 
to ileostoma effluent (Table 2.2; Figure S2.4). 
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Figure 2.2. Relative contribution of detected bacterial phyla with pyrosequencing using four 
different forward primers and HITChip analysis for community data at level 1. Pearson product-
moment correlation coefficients (r) between pairs of profiles are shown above the bars. The phyla 
Firmicutes was subdivided in Bacilli, Clostridium clusters, Uncultured Mollicutes, and Uncultured 
Clostridiales. Pyrosequences that could not be classified above the confidence threshold of 80% are 
grouped to Unclassified_Human unique OTU which is indicated in the microbial profiles with a 
shadow. Phylogenetic groups that contribute at least 1% to one of the profiles are indicated in the 
legend. 
 
The effect of different forward primers on microbial profiling by barcoded 
pyrosequencing 
To determine the effect of different primers on microbial profiling, 16S rRNA gene 
PCR amplicons were generated for each intestinal sample using four different 
forward primers (27F-DegL, 27F-DegS, 27F-Nondeg and 35F-Nondeg). Microbial 
profiles constructed on basis of pyrosequences per sample were highly correlated for 
the different primers (average r of 0.88 ± 0.14 at level 2 community data; data not 
shown). Furthermore, hierarchical clustering (Figure S2.3A) of the microbial profiles 
revealed distinct clusters of microbial profiles for each of the samples using the four 
forward primers, except for sample S3 as will be discussed below, indicating that the 
effect of primers on microbial profiling is smaller than the sample specific effect and 
supporting a high level of technical reproducibility of the pyrosequencing method. 
Analogously, comparison of rarefaction curves (Figure S2.4), species richness 
estimators Chao1 and ACE, as well as Shannon diversity indices (Table 2.2) did not 
reveal a particular primer giving consistently the highest or the lowest value for any of 
these ecological metrics. Nonetheless, qualitative comparison demonstrated that the 
microbial profiles deduced from pyrosequencing using amplicons generated with the 
27F-DegL, 27F-DegS and 35F-Nondeg primers were notably more abundant in 
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Actinobacteria relative to those using the 27F-Nondeg primer (Figure 2.2), confirming 
previous reports on the underestimation of the Actinobacteria using the 27F-Nondeg 
primer (127).  
Because the PCR annealing temperatures used for amplicon generation differed 
between pyrosequencing and HITChip analysis (56°C vs. 52°C, respectively) both 
annealing temperatures were employed for HITChip analysis of sample F3 to 
investigate the effect of different annealing temperatures on microbial profiling. 
Results demonstrated highly similar microbial profiles (r ≥ 0.99; data not shown) and, 
therefore, comparison of microbiota profiling by pyrosequencing and HITChip 
analysis was not biased by different PCR annealing temperatures. 
 
Comparison of barcoded pyrosequencing with HITChip analysis 
The concordance between microbial profiling by pyrosequencing and phylogenetic 
microarray analysis was evaluated. Although the principle for classification and 
abundance estimations of microbial community members differ between these 
technologies, hierarchical clustering of the microbial profiles from both methods 
matched (Figure S2.3)  
Microbial profiles as a result of HITChip analysis were compared to those from 
pyrosequencing using the 27F-Nondeg primer as this forward primer is used for 
amplicon generation in the HITChip analytic procedure. The resulting comparison of 
the community data at level 1 (phylum-like) showed a high correlation for the fecal 
samples (F1-F3; r = 0.99-1.00) and ileum-lumen content (S3; r = 0.99), while the 
correlation was lower for ileostoma effluent samples (S1-S2; r = 0.53-0.62; Figure 
2.2). Correlations for the community data at level 2 (genus-like), were significantly 
lower, but remained highest for the fecal samples (r = 0.63-0.78) and ileum-lumen 
content (r = 0.71) and lowest for the ileostoma effluent samples (r = 0.31-0.49; Figure 
S2.1). This difference between ileostoma effluent and other intestinal samples is also 
demonstrated in the community data scatter plots at level 1 and 2 (Figure S2.5). 
Remarkably, numerous phylogenetic groups at level 2 showed significant 
abundances with HITChip analysis but were absent from the pyrosequence dataset 
(Figure S2.5 inset), suggesting that HITChip analysis enables detection of low 
abundance bacterial groups by its broader dynamic range compared to 
pyrosequencing. 
To verify if suboptimal HITChip probe matches could potentially explain higher 
abundances per cluster with grouping of fecal samples and ileal lument content 
(Cluster I) apart from ileostoma effluent samples (Cluster II) of some phylogenetic 
targets in the pyrosequence data relative to HITChip analysis (Figure S2.6), 
pyrosequences were screened for exact matches with the HITChip probes designed 
for detection of these phylogenetic groups (Figure S2.7). In general, both clusters 
approximately showed the same fraction (~90%) of pyrosequences that had a perfect 
match with at least one of the HITChip probes. For cluster I, Eubacterium rectale et 
rel. and Ruminococcus obeum et rel. contained most pyrosequences that lack a 
HITChip probe perfect-match, while Veillonella showed the highest number of 
sequences (19.3%) without a perfect-match for the HITChip probes for cluster II.  
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Phylogenetic groups for which the abundance estimates were higher in the HITChip 
analyses included Streptococcus spp. (Bacilli) for which a deviation in relative 
abundance estimations between the two profiling technologies was as high as ~7% 
(Figure S2.6). The abundance of this phylogenetic group and others was further 
investigated by means of qPCR as well as 16S rRNA gene cloning and sequencing 
(see below).  
 
Quantification of bacterial groups by qPCR 
To evaluate the performance of pyrosequencing and HITChip analysis in estimating 
relative abundances of microbial community members, the results of both techniques 
were compared with those obtained by means of group-specific qPCR, focusing on 
Bifidobacterium, Veillonella, Streptococcus, and E. coli (Figure 2.3). The estimated 
community proportion of Streptococcus spp. was consistently highest with HITChip 
analysis relative to qPCR assays and pyrosequencing, while Bifidobacterium 
abundance levels were expectedly low when determined with the HITChip as a result 
of using the 27F-Nondeg primer for the initial sample preparation. Surprisingly, 
Bifidobacterium abundances assessed with the qPCR assay were relatively low as 
well, whereas estimations by pyrosequencing using the 27F-DegL, 27F-DegS, and 
35F-Nondeg primers showed relative abundances varying from 1.10% to 6.98% for 
samples F1, F2, F3 and S3 and from 4.04% to 16.37% for samples S1 and S2. For 
Veillonella and E. coli relative abundances were highest by pyrosequencing analysis, 
followed by intermediate values obtained from qPCR and lowest values assessed by 
HITChip analysis. Sample S3 was the only sample for which an E. coli abundance 
above 1.5% was detected and showed relative contributions as high as 31.8% and 
17.4% in microbial profiles from pyrosequencing using the 27F-DegL and 27F-DegS 
primers, respectively. 
 
 
Figure 2.3. Comparison of the relative contribution as determined by means of HITChip, qPCR 
assays, and pyrosequencing for 4 phylogenetic groups in fecal (F) and small (S) intestinal 
samples. Relative contribution as assessed by qPCR assays were not determined for sample F3 
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Although the proportion of E. coli as assessed by the HITChip was considerable 
lower with an abundance of 0.44%, the E. coli specific qPCR assay revealed a 
contribution of 5% and confirms the abundant presence of E. coli in sample S3. 
Additionally, this observation suggests that microbial profiling using primers 27F-
DegL and 27F-DegS results in a more accurate representation of the microbial 
composition in intestinal samples that contain higher proportions of E. coli.  
 
Screening ileostoma effluent for novel bacterial phylotypes 
Based on the prominent deviations between pyrosequencing and HITChip analysis 
for ileostoma effluent, these small intestinal samples are a potential source for a 
range of bacteria with 16S rRNA gene sequences that are absent from the human 
unique OTU database to date. To support this notion, 16S rRNA gene clone libraries 
for the two ileostoma effluent samples were constructed and analyzed (Figure 2.4). A 
total number of 139 and 158 cloned non-anomalous 16S rRNA gene sequences were 
obtained for the S1 and S2 16S rRNA gene clone libraries, respectively. Out of the 
total of 297 cloned sequences, 6 could not be classified at Level 2 assignments 
above the 80% confidence threshold using the RDP classifier trained with the human 
unique OTU database. Consequently, these sequences were grouped to 
“unclassified_” with the specific Level 1 assignment (Figure 2.4).  
 
 
Figure 2.4. Total number of cloned sequences detected per phylogenetic group (black) and 
number of sequences showing <98% identity to the 16S rRNA gene sequences represented in 
the human unique OTU database (grey) for ileostomy sample S1 and S2. The ratio of number of 
sequences showing <98% identity to the 16S rRNA gene sequences represented in the human unique 
OTU database vs. total number of cloned sequences is provided for each level 2 group. Sequences 
that could not be classified above the confidence threshold of 80% are grouped to ”unclassified_” at 
the specific rank per taxon. 
 
To determine if the resolution of the identifications could be improved, sequences 
were re-classified using the standard RDP classifier (see Materials and methods), 
which is based on a more exhaustive set of 16S rRNA gene sequences compared to 
that of the human unique OTU database. This showed that both unclassified_Bacilli 
sequences were assigned to the order Lactobacillales, though deviating in their 
genus level classifications as Granulicatella for one and Streptococcus for the other. 
The sequence classified as the latter also showed <98% identity to 16S rRNA gene 
sequences represented in the human unique OTU database. Sequences of the 
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unclassified_Clostridium cluster XIVa group could be classified no further than the 
family Lachnospiraceae, whereas the unclassified_Proteobacteria were assigned to 
the genus Variovorax belonging to Betaproteobacteria. 
Further analysis of the libraries revealed that 20 sequences, predominantly belonging 
to Veillonella, showed <98% identity to 16S rRNA gene sequences represented in 
the human unique OTU database and were therefore considered to be phylotypes 
not previously reported as associated with the human intestine (Figure 2.4). The 
finding of a relatively large proportion of these phylotypes among the Veillonella 16S 
rRNA gene sequences supports the suggestion that the HITChip probes display 
relatively poor sequence matches with these sequences (see above). Detailed 
analysis indeed showed that 5 out of 7 HITChip probes specific for Veillonella had 
more than 2 mismatches with sequences classified as Veillonella, whereas the 
remaining two probes at most had 1 mismatch (Figure S2.8).  
The same screening strategy was applied to determine if the cloned sequences 
classified as Veillonella had exact matches with the forward and the reverse primer 
used for the Veillonella qPCR assay. Out of the 72 cloned sequences classified as 
Veillonella, only one sequence did not show a perfect match with the reverse primer. 
In contrast, 16 sequences had a single mismatch with the forward primer (Figure 
S2.8). Interestingly, 13 of these sequences were also identified as novel intestinal 
phylotypes (see above). This shows that the forward primer for the Veillonella qPCR 
assay is not in agreement with the 16S rRNA gene sequences of Veillonella and 
could also explain the lower Veillonella abundances as determined by qPCR in 
comparison with those estimated by pyrosequencing (Figure 2.3). Taken together, 
these results suggest that the human small intestine is inhabited by novel Veillonella 
phylotypes that previously have not been reported to inhabit this niche. 
 
Discussion 
 
In this study, the performance of two culture-independent techniques, barcoded 
pyrosequencing and phylogenetic microarray analysis using the HITChip, was 
compared and contrasted for profiling of human fecal and small intestinal microbial 
communities. Both techniques generated similar microbial composition profiles for 
fecal and terminal ileum-lumen samples, whereas more distinct profiles were 
obtained for ileostoma effluent samples. Ileostoma effluent, in comparison to fecal 
samples, contained less rich and diverse microbial communities, which were 
abundant in Streptococcus spp., Veillonella spp., and members of several 
Clostridium clusters. These findings are consistent with results published by Booijink, 
et al. (31) as well as with the recent study by Zoetendal, et al. that concluded that the 
phylogenetic composition in ileostoma effluent is different from that of the ileum and 
resembles the microbiota in the proximal small intestine, i.e., the jejunum and 
proximal ileum (381). 
The high comparability of the pyrosequencing- and HITChip-derived microbial 
profiles obtained for fecal samples is in agreement with previously published results 
(49). Thereby, this study confirms that both profiling technologies facilitate robust 
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microbial profiling and essentially generate equivalent biological conclusions 
regarding compositions of microbial communities. Nonetheless, abundance 
estimates for several phylogenetic groups deviated between pyrosequencing and 
HITChip analysis. Determining the exact cause for the technical divergence is not 
trivial, but possible reasons for this are: i) probe based vs. sequence based 
quantification; ii) failure to detect species that were not represented in the reference 
sequences used for probe design and cognate overestimation of relative abundances 
of the detected phylogenetic groups; iii) sequencing errors; iv) incorrect taxonomic 
classification of sequences; and/or v) difference in dynamic range between 
technologies. The latter was also apparent from comparison of HITChip analyses 
with very deep pyrosequencing resulting in a level of depth that is comparable to 
close to 200,000 reads per sample (49). Sequencing depth could be improved by 
employing the Illumina sequencing platform with which microbial community diversity 
is analyzed with increased depth relative to pyrosequencing (40, 50). However, to 
date, this approach is still challenging due to the limited phylogenetic resolution 
obtained from such short sequence reads and the increasing sequence-error rates 
for reads extended beyond 60 bp. 
A challenging yet essential part of pyrosequencing analysis is quality control of the 
acquired dataset. Here, a strict quality filtering procedure was employed that 
eliminated approximately half of the pyrosequences, most of which were either 
deemed too short or too long. The proportion of sequences excluded from further 
analysis due to quality filtering was higher compared to other studies applying similar 
exclusion criteria. Those studies, however, employed the older GS 20 (9, 149) or 454 
GS FLX (49) sequencing platforms, while in this study the Titanium method was 
applied.  
HITChip probe design is based on a 16S rRNA gene database that predominantly 
contains sequences with a fecal or colonic origin. Since both profiling techniques 
correlated strongly for fecal samples and the HITChip offers a broader dynamic 
range of detection, HITChip analysis is preferred for profiling of the lower GI tract 
microbiota. However, HITChip coverage of the small intestinal microbiota appeared 
to be more incomplete (31) and, therefore, pyrosequencing would be the method of 
choice for de novo profiling of these microbial communities. Furthermore, this finding 
exemplifies the intrinsic constraint of microarray approaches that are limited to 
detection of phylogenetic groups for which sequences were included during array 
design. This may to a large extent explain the lower correlations between 
pyrosequencing and HITChip analysis that were obtained for the ileostoma effluent 
samples and suggests that ileostoma effluent harbors novel intestinal bacteria that 
have not been detected in feces or other large intestinal samples. To identify these 
phylotypes, pyrosequences were screened per phylogenetic group for perfect 
matches with the respective HITChip probes. All groups had multiple sequences 
without a probe match, which may indicate the presence of novel intestinal 
phylotypes, suggesting that HITChip probe-design may be improved by the addition 
of probes to detect this expanding community. The latter would require a flexible 
array design strategy as suggested by Rajillić-Stojanović, et al. (266). However, 
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despite quality filtering to improve overall pyrosequence dataset reliability, this 
technology still suffers from a relatively high sequence-error rate (~0.5% for the GS 
20 and GS FLX platform (245)), which erroneously may contribute to the number of 
sequences that mismatch with the HITChip probes. Analogously, the pyrosequencing 
technology was reported to overestimate microbial diversity as a consequence of 
these sequencing errors (269).  
Results from screening cloned 16S rRNA gene sequences from the ileostoma 
effluent samples showed that 7% of the cloned sequences represented novel 
intestinal phylotypes, which appears to be lower than might have been anticipated on 
basis of previous studies (31, 125) The novel phylotypes encountered here 
predominantly belonged to the Veillonella group, which is in agreement with the 
relatively large fraction of pyrosequences corresponding to this group that lacked a 
perfect-match HITChip probe. Other novel phylotypes from the clone libraries were 
identified as Variovorax, which have been cultured from soil (305) and have been 
detected in the rabbit cecum (235). However, to the best of our knowledge, 
Variovorax spp. have not been identified as inhabitants of the human GI tract to date. 
Therefore, the human small intestine contains a range of species that were not 
previously associated with this niche, and elucidating the role of these 
microorganisms, especially of the abundant Veillonella, in their environment is a task 
for the future.  
Quantification of bacterial groups by means of qPCR was chosen as a benchmark 
technology to investigate the deviations in profiling between pyrosequencing and 
HITChip analysis. Discrepancies were observed between relative abundances as 
determined by qPCR and the two profiling techniques. This can at least in part be 
attributable to the difference in abundance calculations, which is based on a separate 
total bacteria assessment for qPCR, whereas for the HITChip and pyrosequencing 
relative abundances are calculated based on, respectively, probe signals or number 
of pyrosequences per phylogenetic group as part of the total. Streptococcus spp. 
abundance levels were consistently highest with HITChip analysis relative to qPCR 
assays and pyrosequencing. This observation corroborates the results previously 
published by Rajilić-Stojanović and colleagues (266), who reported a significantly 
higher relative abundance estimate of Streptococcus spp. in fecal samples based on 
HITChip analysis as compared to group-specific FISH analysis.  
PCR amplification was performed using four different forward primers for each 
intestinal sample to assess the impact of PCR primer choice on microbial profiling by 
means of pyrosequencing. With the exception of sample S3, microbiota compositions 
per sample were highly similar for the different primers. This underpins the degree of 
reproducibility of microbial profiling by means of pyrosequencing and suggests that 
correlations between technical replicates can be expected to be even higher. 
Moreover, primer choice did not profoundly affect species richness and diversity 
estimates, which is in agreement with a recent study that showed consistent species 
evenness estimates when using different primer pairs targeting the same region of 
the 16S rRNA gene (88). Qualitative analysis of the microbial profiles, however, 
clearly revealed a lower abundance of Actinobacteria by the 27F-Nondeg primer, 
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which confirms the observations by Hayashi, et al. (127) showing that the 27F-
Nondeg primer is incomplete in its coverage of Bifidobacterium spp. 
In conclusion, this paper demonstrates that different primers and high-throughput 
16S rRNA profiling technologies like barcoded pyrosequencing and HITChip analysis 
provide overall similar results. However, this similarity is dependent on the origin of 
the samples, which relates to the sequences used during array design and may thus 
be influenced by updated microarray design to accommodate novel sequences. 
Nonetheless, based on the results described here, it is our recommendation to use 
either the 27F-DegL or the 27F-DegS primer, since both these multiple-degenerate 
primers appear to provide a more complete assessment of Actinobacteria and E. coli 
abundances. 
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Supplementary information 
 
Supplementary materials and methods - HITChip analysis 
Microbial community profiling was also performed using the HITChip (266), which is a 
phylogenetic microarray, produced by Agilent Technologies (Palo Alto, CA) in 8×15K 
format, with over 4800 tiling oligonucleotides targeting the V1 or the V6 region of the 
16S rRNA gene from 1,132 microbial phylotypes present in the human 
gastrointestinal tract (266). The HITChip has been validated by using FISH and 
qPCR on abundant species while it has been validated with artificial mixtures of 16S 
rRNA gene amplicons showing a linear dose-response in a large dynamic range of 
over 1000-fold (266). Moreover, the HITChip analyses are based on hybridization to 
oligonucleotides that are spotted at least twice on the arrays and all analyses 
are repeated in duplicate with a dye swap providing almost perfect reproducibility (r ≥ 
0.98).  
The procedure for HITChip analysis was performed as described previously (266). In 
short, near full-length 16S rRNA gene amplicons were generated by PCR using the 
T7promotor-27F-Nondeg primer in combination with the Uni-1492-Rev primer (Table 
2.1). PCR conditions were generally the same as for amplicon generation for 
pyrosequencing, except that PCRs were performed in duplicate for each sample, 
annealing was set at 52C, and elongation time was set at 90 s. PCR products were 
pooled and purified with a High Pure Cleanup Micro Kit (Roche) using 15 µl Elution 
Buffer (Roche) for elution. Subsequently, PCR products were in vitro transcribed 
using the Riboprobe System (Promega, Madison, WI, USA) including a mix 
containing aminoallyl-rUTP (Ambion, Austin, TX, USA). DNA was digested by 
treatment with RNAse free DNAse (Promega), followed by RNA purification using 
RNeasy MinElute Cleanup Kit (Qiagen) and labeling with Cy3 and Cy5 (Amersham 
Biosciences, Little Chalfont, UK). Labeled RNA was purified as described above and 
fragmented with 10× fragmentation reagent (Ambion) Hybridization of labeled RNA 
on the arrays, washing of the slides followed by microarray data extraction and 
analysis was performed as described previously (266). Microbial profiles of the 
microbiota of each sample generated in this fashion were used for comparison with 
those from pyrosequencing. 
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Supplementary figures 
 
Figure S2.1. Relative contribution of detected bacterial phyla with pyrosequencing using four 
different forward primers and HITChip analysis for community data at level 2. Pyrosequences 
that could not be classified above the confidence threshold of 80% are grouped to “unclassified_” at 
the specific rank per taxon and are indicated in the microbial profiles with a shadow. Phylogenetic 
groups that contribute at least 5% to one of the profiles are indicated in the legend. 
 
Figure S2.2. Relative contribution of detected bacterial phyla with pyrosequencing using four 
different forward primers for community data at level 2 after bypassing the quality filtering 
step. 
Pyrosequences that could not be classified above the confidence threshold of 80% are grouped to 
“unclassified_” at the specific rank per taxon and are indicated in the microbial profiles with a shadow. 
Phylogenetic groups that contribute at least 5% to one of the profiles are indicated in the legend. 
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Figure S2.3. Hierarchical clustering of the microbial profiles from (A) pyrosequencing using 
four different forward primers and (B) HITChip analysis. 
 
 
Figure S2.4. Rarefaction curves at 0.02 distance level generated for Fecal samples (F1-F3), 
ileostoma effluent (S1-S2), and ileal lumen content (S3). The forward primers used for the 
respective PCR are indicated with different colors. 
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Figure S2.5. Comparison of relative contributions estimated by pyrosequencing versus 
HITChip analysis for community data of level 1 and 2. Data points for groupings of pyrosequences 
that could not be classified above the confidence threshold of 80% (Unclassified_) were removed 
because these groups are not represented in the output of HITChip analysis. The inset shows relative 
contributions for community level 2 from 0 to 1%. 
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Figure S2.6. Difference in relative abundances of phylogenetic groups as estimated by 
pyrosequencing and HITChip analysis in cluster I and II. Blue circles represent the average 
difference per phylogenetic group with the highest and lowest observed difference values from each 
cluster indicated with vertical lines. Phylogenies highlighted in lightgrey and darkgrey represent groups 
for which relative abundances were estimated >2.5% higher by pyrosequencing and HITChip analysis, 
respectively. 
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Figure S2.6 (Continued). Difference in relative abundances of phylogenetic groups as 
estimated by pyrosequencing and HITChip analysis in cluster I and II. Blue circles represent the 
average difference per phylogenetic group with the highest and lowest observed difference values 
from each cluster indicated with vertical lines. Phylogenies highlighted in lightgrey and darkgrey 
represent groups for which relative abundances were estimated >2.5% higher by pyrosequencing and 
HITChip analysis, respectively. 
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Figure S2.7 Total number of pyrosequences with (black) or without (grey) exact matches with 
HITChip probes per phylogenetic group. The ratio of number of sequences without exact matches 
with HITChip probes vs. total number of pyrosequences is indicated for each specific level 2 group.  
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2 
HIT 1900 (Rev. compl.)                                           CTCTTCTTCGGAAGCCAGAAAACA 
HIT 1901 (Rev. compl.)                         CAGAACTAGAGATAGTTCCTCTTC 
HIT 1902 (Rev. compl.)     CAGGTCTTGACATTGATGGACAGA   
H2-plate9_D04       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_E04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_E12       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAGCAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_A09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_D12      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCCCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_G03      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_F03       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate4_B05       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate4_D01       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_B10       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_C04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_H04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_B01       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_E05      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_H09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate4_H11       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_G04      ACCTTACCAGGTCTTGACATTGATAGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate4_F05       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate3_E05       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_C01       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_D09       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate3_H06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_A01       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate3_D06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate3_G12       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate4_E04       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_E03      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_F06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_B06       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_B02      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCCTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_D05      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_E03       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAGCAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_H04       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_E08       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_C11       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_G02      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_D02      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_F01      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_D04      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_G05      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_E09      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_C01      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_F03      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_G07      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_A04       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_H01       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_H08       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_E09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_G01      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_A08      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_B04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGACAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_H09      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_C11      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_G08      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_E06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_F09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_B02       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate3_C07       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_H12      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate3_A04       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_A07       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_B09       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_D07       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_E12      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_E10      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_H03      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H1-plate3_D09       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACGGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_D02       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate9_D11       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGCGAGATGTTGGGTTAAGTCC 
H2-plate9_H05       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_D10      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCGGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
H2-plate10_F07      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGCCAGAAAACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCC 
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Figure S8b: Alignment of cloned 16S rRNA gene sequences classified as Veillonella from 
ileostomy sample S1 and S2 with binding sites of HITChip probe HIT 1900, HIT 1901, and HIT 
1902 (reverse complement). Nucleotides that differ from the probes/primers have been highlighted in 
grey. Sequences highlighted in grey represent sequences with <98% identity to the 16S rRNA gene 
sequences represented in the human unique OTU database.  
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HIT 737 (Rev. compl.)                          CAGAACAAGAGATGGTTCCTCTTC 
H2-plate9_D04       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_E04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_E12       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_A09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_D12      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCCCTTCTTCGGAAGC 
H2-plate10_G03      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_F03       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H1-plate4_B05       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H1-plate4_D01       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_B10       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_C04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_H04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_B01       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_E05      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_H09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H1-plate4_H11       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_G04      ACCTTACCAGGTCTTGACATTGATAGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H1-plate4_F05       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H1-plate3_E05       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate9_C01       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate9_D09       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H1-plate3_H06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_A01       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H1-plate3_D06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H1-plate3_G12       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H1-plate4_E04       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_E03      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_F06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_B06       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_B02      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCCTCGGAAGC 
H2-plate10_D05      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate9_E03       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_H04       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_E08       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_C11       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_G02      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_D02      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_F01      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_D04      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_G05      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_E09      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_C01      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_F03      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate10_G07      ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate9_A04       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate9_H01       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate9_H08       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_E09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_G01      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_A08      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_B04      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_H09      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_C11      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate10_G08      ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_E06       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_F09       ACCTTACCAGGTCTTGACATTGATGGACAGAACTAGAGATAGTTCCTCTTCTTCGGAAGC 
H2-plate9_B02       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H1-plate3_C07       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate10_H12      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H1-plate3_A04       ACCTTACCAGGTCTTGACATTGATGGACAGAACCAGAGATGGTTCCTCTTCTTCGGAAGC 
H2-plate9_A07       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate9_B09       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate9_D07       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate10_E12      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate10_E10      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate10_H03      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H1-plate3_D09       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate9_D02       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate9_D11       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate9_H05       ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate10_D10      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCGGAGATGGACTCTCTTCTTCGGAAGC 
H2-plate10_F07      ACCTTACCAGGTCTTGACATTGATGGACAGGTCCAGAGATGGACTCTCTTCTTCGGAAGC 
                    ************************ *****  *  ***** *   * **** ******** 
Figure S8c: Alignment of cloned 16S rRNA gene sequences classified as Veillonella from 
ileostomy sample S1 and S2 with binding sites of HITChip probe HIT 737 (reverse complement). 
Nucleotides that differ from the probes/primers have been highlighted in grey. Sequences highlighted 
in yellow represent sequences with <98% identity to the 16S rRNA gene sequences represented in the 
human unique OTU database. 
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Veil-R-Rinttilä (Rev. compl.)            AAGCTCTGTTAATCGGGACG                    
H2-plate9_D04       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H2-plate10_E04      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H2-plate9_E12       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H2-plate9_A09       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAGTGGTTCTTGTGCGAA-T 
H2-plate10_D12      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate10_G03      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H2-plate9_F03       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H1-plate4_B05       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H1-plate4_D01       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate9_B10       ATGACGGCCT-CGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate10_C04      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGGCGAATGGTTCTTGTGCAAA-T 
H2-plate10_H04      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate9_B01       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate10_E05      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate9_H09       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H1-plate4_H11       ATGACGGCCTTCGGATT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate10_G04      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H1-plate4_F05       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H1-plate3_E05       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H2-plate9_C01       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H2-plate9_D09       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H1-plate3_H06       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCGAA-T 
H2-plate9_A01       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGTTCTTGTGCAAA-T 
H1-plate3_D06       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H1-plate3_G12       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H1-plate4_E04       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_E03      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_F06       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_B06       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_B02      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_D05      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_E03       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_H04       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_E08       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_C11       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-C 
H2-plate10_G02      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-C 
H2-plate10_D02      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_F01      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_D04      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_G05      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_E09      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_C01      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_F03      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_G07      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_A04       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_H01       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_H08       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_E09       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_G01      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_A08      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_B04      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_H09      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_C11      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate10_G08      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCAAA-T 
H2-plate9_E06       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_F09       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAAAGGCCTTCTTGCGAA-T 
H2-plate9_B02       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H1-plate3_C07       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate10_H12      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H1-plate3_A04       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate9_A07       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate9_B09       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate9_D07       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate10_E12      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate10_E10      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate10_H03      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H1-plate3_D09       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate9_D02       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate9_D11       ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate9_H05       ATGACGGCCTTCGGGNTTGTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAAAT 
H2-plate10_D10      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
H2-plate10_F07      ATGACGGCCTTCGGGTT-GTAAAGCTCTGTTAATCGGGACGAATGGCTACCATGCGAA-T 
                    ********** ***  * ******************** ***  **      *** **   
Figure S8d: Alignment of cloned 16S rRNA gene sequences classified as Veillonella from 
ileostomy sample S1 and S2 with binding sites of and qPCR primer Veil-R-Rinttilä. Nucleotides 
that differ from the probes/primers have been highlighted in grey. Sequences highlighted in yellow 
represent sequences with <98% identity to the 16S rRNA gene sequences represented in the human 
unique OTU database. 
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Table S2.2. Percentage of sequences remaining after quality filtering applying all criteria or a 
single criterion 
 Percentage of pyrosequences remaining after quality filtering 
Sample and 
primer 
All criteria Exact matches 
to the forward 
primer 
No ambiguous 
basses (N) 
Read-lengths no longer or 
shorter than 1 SD from the 
average sequence length 
F1  
 27F-DegL 50.72 91.84 85.19 64.36 
 27F-DegS 49.87 91.20 83.45 65.45 
 27F-Nondeg 48.53 95.08 85.53 60.49 
 35F-Nondeg 47.38 96.28 85.91 57.98 
F2     
 27F-DegL 52.10 92.29 84.45 66.40 
 27F-DegS 50.06 89.01 83.45 65.86 
 27F-Nondeg 49.39 95.86 84.48 60.90 
 35F-Nondeg 51.32 95.78 86.14 61.88 
F3     
 27F-DegL 54.27 92.74 88.12 65.68 
 27F-DegS 52.05 92.52 86.82 63.45 
 27F-Nondeg 48.53 96.26 88.17 56.33 
 35F-Nondeg 47.80 93.52 87.61 56.98 
S1     
 27F-DegL 48.26 92.36 83.40 64.36 
 27F-DegS 49.77 92.59 84.56 65.27 
 27F-Nondeg 48.58 96.21 83.14 62.82 
 35F-Nondeg 51.17 95.63 87.24 62.50 
S2     
 27F-DegL 50.38 92.62 84.68 64.69 
 27F-DegS 49.04 92.13 84.55 63.87 
 27F-Nondeg 49.19 96.26 84.86 61.60 
 35F-Nondeg 43.80 88.20 85.79 60.23 
S3     
 27F-DegL 52.79 91.29 85.08 66.17 
 27F-DegS 53.16 92.39 86.53 64.22 
 27F-Nondeg 47.60 94.35 86.45 57.35 
 35F-Nondeg 48.85 95.80 85.38 59.21 
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Abstract 
 
The human small intestine is the main site for food absorption and digestion. Here, 
samples collected from four ileostomy subjects at four time points were used to study 
the phylogenetic dynamics of total and active fractions of the small intestinal 
microbiota through pyrosequencing of 16S ribosomal RNA gene (rDNA) and 
ribosomal RNA (rRNA) combined with elucidation of the specific activity patterns 
through metatranscriptomics. The community composition as assessed from rDNA, 
rRNA, and mRNA patterns appeared to be similar, indicating that the dominating 
microbial community is also highly active in this ecosystem. However, species 
richness and diversity metrics of the active ileostoma microbiota were reduced 
compared to the total microbiota, suggesting that some low abundance populations 
may represent less active members of the microbial community. Although each 
subject displayed a distinct microbial community, the genera Streptococcus, 
Veillonella as well as clostridial community members not only co-occurred in all 
ileostoma samples but also in most activity profiles, indicating that these are typical 
and active commensals of the human small intestine. While specific metabolic 
functions were assigned to distinct phylogenetic fractions in different samples, the 
overall activity patterns of the samples appeared relatively similar, demonstrating a 
high degree of functional redundancy within the ecosystem. This study integrates the 
complementary 16S rRNA and metatranscriptome based community reconstruction 
and provides insights into the functional biodiversity of the intestinal microbiota and 
enables the detection of metabolic interactions between its community members.
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Introduction 
 
The human gastrointestinal (GI) tract is populated with complex microbial 
communities, collectively referred to as microbiota, that predominantly consists of 
bacteria (341). During the last decades, 16S rRNA gene-based technologies have 
been extensively used to profile the human intestinal microbiota in health and 
disease (266, 322). More recently, metagenomics of this ecosystem has provided a 
wealth of knowledge, including a comprehensive gene catalogue of the human fecal 
microbiota (262), and clues about key microbiota members that could influence host 
health and disease (35, 147). 
Metatranscriptomics may complement DNA-based metagenome analysis by 
identifying the active microbial members and unravelling their response to certain 
environmental conditions (106, 236, 356). Using next generation sequencing (NGS), 
in-depth metatranscriptomics of mRNA- or rRNA-derived cDNA sequences were 
successfully performed to investigate the activities of different complex microbial 
communities in marine (99, 105), soil (17, 333), and human gastrointestinal tract 
(112, 331) environments. 
In general, fecal samples are often employed as representative samples to study the 
human gut microbiota. However, several studies have revealed that fecal microbial 
communities can differ considerably from the microbial community at other locations 
in the GI tract, notably the small intestine (31, 339, 381). Considering that the major 
part of nutrient digestion and absorption occurs in the small intestine (203) and that 
its mucosa is the main immune sampling mucosal surface of the human GI tract (see 
(75) for a review), this region of the GI tract can be anticipated to be of great 
importance to study interactions between the host and the intestinal microbiota (see 
(58) for a recent review). Investigations in our laboratory have used samples 
collected from ileostomy subjects to study the composition and the function of the 
human small intestine. Ileostomy subjects are characterized by surgical resection of 
their colon and hence, have their terminal ileum connected to an abdominal stoma. 
As a results, luminal content from the small intestine is excreted into an appliance, 
providing a unique opportunity for repetitive and non-invasive sampling of the luminal 
microbiota of the small intestine (31, 339, 381). Our studies have revealed that the 
ileostoma microbiota resembles that of the proximal small intestine in healthy 
individuals, which is characterized by a less diverse and highly fluctuating community 
with bacteria belonging to the genera Streptococcus and Veillonella being enriched 
(31, 339, 341, 381). These genera were previously reported to metabolically interact 
through lactate production and utilization by the Streptococcus and Veillonella 
species, respectively (84, 381). Therefore, it is not surprising that these genera also 
co-occur in the oral cavity (169), throat (9), stomach (23), and esophagus (256) and 
thus seem to be important commensals of the upper digestive tract. Characterization 
of cultured isolates of the Streptococcus and Veillonella genera from the small 
intestine community, revealed substantial richness within the Streptococcus lineages 
present in the ecosystem ((340), Chapter 4). The genomes of representative isolates 
belonging to these lineages contained a diverse genetic capacity to import and utilize 
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(simple) carbohydrate substrates for growth, which was in excellent agreement with 
their phenotypic characteristics (Chapter 5). Preliminary, low depth 
metatranscriptomic analysis of ileostoma effluent employing cDNA clone-libraries 
revealed high expression of streptococcal carbohydrate transport functions, 
supporting a major role for the Streptococcus population in uptake and fermentation 
of the available dietary carbohydrates in the human small intestine (381). However, 
the limited depth of analysis in these studies prevented a more complete and 
comprehensive reconstruction of the activity profile of the streptococcal population, 
let alone the less abundant Veillonella spp. 
In this study we applied an integrated approach that combined microbial profiling by 
pyrosequencing the 16S ribosomal RNA gene (rDNA) and ribosomal RNA (rRNA) 
content and direct illumina sequencing of cDNA derived from enriched mRNA of four 
ileostomy subjects at four time points to elucidate the small intestinal microbiota 
dynamics at the level of population composition as well as its specific activity pattern.  
 
Materials and methods 
 
Ethics statement 
The study was approved by the University Hospital Maastricht Ethical Committee, 
and was conducted in full accordance with the principles of the ‘Declaration of 
Helsinki’ (52nd WMA General Assembly, Edinburgh, Scotland, October 2000). 
Subjects were informed about the study orally and in writing and signed a written 
informed consent before participation. 
 
Collection of ileostoma effluent 
A total of 16 ileostoma effluent samples were collected from four ileostomy subjects 
(2 male and 2 female; 66 ± standard deviation of 9.0 years) who were colectomized 
at least 5 years prior to the sampling period, are clinically considered to be healthy, 
and have a normally functioning small intestine: subjects did not report any 
complaints related to GI functioning for at least three years prior to testing, and were 
not following any treatment for GI-related symptoms or specific dietary regime. The 
subjects donated four samples each, collected on two distinct time points during the 
day (morning and afternoon), two days apart. The subjects collected the ileostoma 
effluent in a clean, empty ileostoma appliance, which was emptied in centrifuge 
bottles (Nalgene, Rochester, NY, USA) containing 100 ml RNAlater® (Ambion, 
Austin, TX, USA), immediately after the bulk of the effluent flowed into the appliance. 
Samples were gently homogenized and stored for 4-10 hours at room temperature, 
after which the samples were frozen by transferring the tubes to dry ice. Frozen 
samples were transported to the laboratory, where they were kept at -80°C until 
further analysis. 
 
RNA and DNA extraction 
Cell pellets were obtained from the RNAlater-effluent samples by adding four 
volumes of PBS, followed by centrifugation at 4600g for 10 minutes using a Heraeus 
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Multifuge 3 S-R Centrifuge (DJB Labcare Ltd., England, UK). The cell pellet was re-
suspended in 500 µl ice-cold TE buffer (Tris-HCl pH 7.6, EDTA pH 8.0). Total RNA 
and DNA was extracted from the resuspended cell pellet according to the Macaloid-
based RNA isolation protocol (377) with the use of Phase Lock Gel heavy (5 Prime 
GmbH, Hamburg) (240) during phase separation. The aqueous phase was split in 
two aliquots up to 300 µl, one for RNA and one for DNA isolation. For the RNA 
extraction, the aqueous phase was purified using the RNAeasy mini kit (Qiagen, 
USA), including an on-column DNAseI (Roche, Germany) treatment as described 
previously (377). Total RNA was eluted in 30 µl ice-cold TE buffer and the RNA 
quantity and quality were assessed using NanoDrop ND-1000 spectrophotometer 
(Nanodrop Technologies, Wilmington, USA) and Experion RNA Stdsens (Biorad 
Laboratories Inc., USA), respectively.  
Total DNA extraction was preceded by treatment of the sample (300 µl aqueous 
phase) with 3 µl RNAse A (10 mg/ml; Qiagen GmbH, Hilden, Germany) at 37°C for 
15 minutes. Subsequent steps employed a modified version of the QIAamp DNA 
Stool Mini Kit (Qiagen GmbH, Hilden, Germany) protocol. Initially, 22.5 µl proteinase 
K (20 mg/ml; Ambion) and 300 µl buffer AL from QIAmp kit were added to the sample 
followed by incubation at 70°C for 10 minutes. After addition of 300 µl ethanol (VWR, 
Amsterdam, The Netherlands), the sample was transferred to a QIamp column and 
centrifuged (13,000g, 1 minute, at room temperature). DNA pellets were washed 
subsequently with the AW1 and AW2 buffers from QIAmp kit, according to 
manufacturer’s instructions. Finally, the DNA was eluted with 30 µl Nuclease Free 
Water (Promega). 
 
Profiling small intestinal populations 
For 16S rDNA based microbial composition profiling and 16S rRNA based microbial 
activity profiling, barcoded amplicons from the V1-V2 region of 16S rDNA and 16S 
rRNA genes were generated by PCR and reverse transcription PCR (RT-PCR), 
respectively, using the 27F-DegS primer ((339); Chapter 2) that was appended with 
the titanium sequencing adaptor A and a 8 nt sample specific barcode (121) at the 5’ 
end, and an equimolar mix of two reverse primers (338R I and II (117) based on 
three previously published probes EUB 338 I, II and III (60); Table 3.1), that were 5’-
extended with the titanium adaptor B.  
 
Table 3.1. Adaptors and primers used in this study  
Primera Primer sequence (5’-3’)b Reference 
Adaptor A CCATCTCATCCCTGCGTGTCTCCGACTCAG Provided by GATC-Biotech 
Adaptor B CCTATCCCCTGTGTGCCTTGGCAGTCTCAG Provided by GATC-Biotech 
27F-DegS GTTYGATYMTGGCTCAG (339); Chapter 2 
338R-I GCWGCCTCCCGTAGGAGT (60, 117) 338R-II GCWGCCACCCGTAGGTGT 
a Primer names may not correspond to original publication 
b M = A or C; R = A or G; W = A or T; Y = C or T 
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PCRs were performed in a total volume of 100 l containing 1× HF buffer 
(Finnzymes, Vantaa, Finland), 2 l PCR Grade Nucleotide Mix (Roche, Diagnostics 
GmbH, Mannheim, Germany), 2 U of Phusion® Hot Start II High-Fidelity DNA 
polymerase, 500 nM of a forward and the reverse primer mix (Biolegio BV, Nijmegen, 
The Netherlands), and 0.2-0.4 ng/l of template DNA. The PCRs were performed 
using a thermocycler GS0001 (Gene Technologies, Braintree, U.K.) using an 
amplification program that consisted of an initial denaturation at 98C for 30 s, 30 
cycles of: denaturation at 98C for 10 s, annealing at 56C for 20 s and elongation at 
72C for 20 s, and a final extension at 72C for 10 minutes. RT-PCRs of total RNA 
were performed using a one-step RT-PCR system (Access Quick, Promega, Leiden, 
The Netherlands) according to the manufacturer protocol, albeit with 30 amplification 
cycles instead of 40 and modified amplification steps, which consist of denaturation 
at 94˚C for 10s, annealing at 56˚C for 20s and elongation at 68˚C for 20s. 
The size of the PCR and RT-PCR products (~375 bp) was confirmed by gel 
electrophoresis using 5 μl of the amplification-reaction mixture on a 1% (w/v) agarose 
gel containing 1× SYBR® Safe (Invitrogen, Carlsbad, CA, USA). PCR products were 
purified with the High Pure Cleanup Micro Kit (Roche) using 10 µl Nuclease Free 
Water for elution, and quantified using a NanoDrop ND-1000 spectrophotometer 
(Nano-Drop Technologies, Wilmington, DE). To determine the variation introduced by 
PCR amplification on the reproducibility of the pyrosequencing technique the RNA 
and DNA from the morning ileostoma sample collected on day 1 of ileostomy subject 
2 was amplified twice. Purified (RT-)PCR products were mixed in equimolar amounts 
followed by running the amplicons on an agarose gel, band-excision, and purification 
by the DNA gel extraction kit (Millipore, Billerica, MA, USA). Purified amplicon pools 
were pyrosequenced using a Genome Sequencer FLX in combination with titanium 
chemistry (GATC-Biotech, Konstanz, Germany). 
The pyrosequencing data analysis was carried out with a workflow employing the 
Quantitative Insights Into Microbial Ecology (QIIME) pipeline (38) using settings as 
recommended in the QIIME 1.2 tutorial with the following exceptions: reads were 
filtered for chimeric sequences using Chimera Slayer (118); and OTU clustering was 
performed with an identity threshold of 97%, using parameters as recommended in 
the QIIME newsletter of December 17th 2010 (http://qiime.wordpress.com/ 
2010/12/17/new-default-parameters-for-uclust-otu-pickers/). Additional data handling 
was done using in-house developed Python and Perl scripts. The Ribosomal 
Database Project (RDP) classifier version 2.2 (355) was used for taxonomic 
classifications up to the genus level. 
Hierarchical clustering of samples was performed using UPGMA with weighted 
UniFrac as a distance measure. Robustness of the clustering was estimated using 
jackknifing analysis (20 replicates) as implemented in Qiime 1.2. 
Pyrosequencing reads were deposited in the NCBI sequencing read archive (SRA) 
and are available under accession number SRP023505. 
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Metatranscriptome analysis of the human small intestinal microbiota 
The metatranscriptome datasets were generated by Illumina sequencing of 16 cDNA 
libraries derived from mRNA enriched samples of the ileostoma effluent microbiota. 
The mRNA enrichment was performed by the removal of 16S and 23S rRNA using 
sequence-based capture probes attached to magnetic beads (MICROBExpressTM, 
Ambion, Applied Biosystem, Niewerkerk a/d Ijssel, The Netherlands) using the 
manufacturer’s protocols (356). The enriched mRNA was quantified 
spectrophotometrically (NanoDrop) and its quality was assessed by microfluidics-
based electrophoresis system (Experion RNA Stdsens; Biorad Laboratories Inc., 
USA).  
Double stranded cDNA was synthesized using the Invitrogen’s SuperScript® Double-
Stranded cDNA Synthesis kit (Invitrogen), with addition of SuperScript® III Reverse 
Transcriptase (Invitrogen) and random priming using random hexamers (Invitrogen) 
as described previously (198, 371) followed by RNAse A (Roche, Germany) 
treatment, phenol-chloroform extraction, and ethanol precipitation. Double stranded 
cDNA was quantified using the NanoDrop 1000 spectrophotometer and verified by 
the sequencing provider (GATC Biotech, Konstanz, Germany) using an Agilent 2100 
Bioanalyzer (Agilent technologies Inc., Waldbronn, Germany).  
Sixteen Illumina sequencing libraries were constructed from double-stranded cDNA 
(ds cDNA) according to the ChiP protocol (292) with insert size between 200-300bp. 
Each sequencing library was barcoded and four libraries belonging to the same 
subject were pooled and sequenced on a single flow cell. Sequencing of four flow 
cells was performed using Illumina Hiseq2000, which generate in average of ~50 
million reads for each sample. 
After removal of low quality reads, the 16 Illumina sequencing datasets were 
subjected to a metatranscriptome analysis pipeline as described in (Leimena and 
Ramiro-Garcia, et al. Submitted). The mRNA reads were assigned to the NCBI 
prokaryote genome database (October, 2012). The metatranscriptome analysis 
pipeline was performed in four steps, which includes removal of ribosomal RNA 
derived sequences (180), assignment of taxonomic origin of mRNA derived 
sequences, classification of mRNA derived sequences as coding (mapped within an 
annotated gene) and non-coding (mapped within intergenic regions), and assignment 
of function prediction to coding sequence reads. All reads that passed the rRNA 
removal step were defined as mRNA reads. 
Taxonomic classifications were performed by aligning the mRNA reads using 
MegaBLAST and BLASTN (7) to a prokaryotic genome database consisting of 
bacterial and archaeal full and draft genomes. Minimal bit scores thresholds of 148 
and 110 were used for phylogenetic and functional assignments at genus and family 
level, respectively (Leimena and Ramiro-Garcia, et al. Submitted). Predicted gene 
products of identified protein encoding genes were assigned to the Clusters of 
Orthologous Groups (COGs) by BLASTP searches against the COG database (320) 
using an e-value <10-6 for COG assignments and to the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) database (165) using KEGG Automatic Annotation 
Server (KAAS; http://www.genome.jp/tools/kaas/). Principal component analysis 
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(PCA) was performed employing Canoco 5 software (202) to assess correlations 
between COG identifiers (IDs) and subject using the relative abundance of COG IDs 
as response variables and subjects as explanatory variables. The identified genes 
that have KEGG annotation were subjected to metabolic pathway mapping using 
iPath v2 (http://pathways.embl.de/iPath2.cgi) (368). Gene expression level of the 
metabolic pathways was indicated by the line width, which was determined from the 
log 2 value of the read count of KEGG annotated gene. 
 
Multivariate statistical analysis for metatranscriptome and pyrosequencing 
datasets 
Redundancy analysis (RDA) was performed using Canoco 5 software (202) to 
assess correlations between 16S rDNA, 16S rRNA and mRNA datasets and sample 
characteristics. COG relative abundances obtained from metratranscriptome dataset 
and OTU relative abundance obtained from pyrosequencing were used as response 
variables and subject origins as explanatory variables. RDA analysis was also 
performed using phylogenetic assignments of 16S rDNA, 16S rRNA, and mRNA 
sequences at genus level as biological variables. Unrestricted Permutation Test was 
used to assess significance of the variables.  
 
Results 
 
Analysis of pyrosequencing reads from 16S rDNA and rRNA amplicons 
The composition of the whole microbial community and the active fraction in 
ileostoma effluent samples collected from four ileostomy subjects at four different 
time points was analysed through pyrosequencing of 16S rDNA and rRNA, 
respectively. A total 369,184 quality filtered sequences were obtained with an 
average of 10,255 (± standard deviation of 4,650) sequences per sample. Over 99% 
of retrieved sequenced reads were assigned above the 80% confidence threshold 
using the RDP classifier to order level, while lower fractions were assigned to family 
(91%) and genus (72%) level. The majority (>98%) of the total sequences were 
assigned to the phyla Firmicutes (77.6%) and Proteobacteria (20.7%; Figure S3.1). 
The former predominantly comprised of Streptococcus (30.2%) and members 
belonging to the order Clostridiales (33.2%), while the latter was dominated by the 
genus Escherichia/Shigella (17.6%).  
The similarity between the microbial composition in each sample was assessed using 
the unweighted (based on presence/absence) and weighted (based on relative 
abundances) UniFrac distance metrics (210, 211). Independent amplicon production 
from independent nucleic acid extractions of the morning ileostoma sample collected 
on day 1 from ileostomy subject 2, yielded highly similar microbial profiles (Figure 
S3.2) that tightly clustered together (Figure 3.1) and were generally more similar 
compared to the intra- and inter-subject similarity between microbial composition or 
activity profiles (Figure S3.3). Comparison of OTU numbers, Chao1 richness 
estimations, and Shannon diversity from different sample preparations showed less 
variation in these ecological metrics compared to that between samples collected 
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from the same subject (Figure S3.4). These results imply that PCR amplification and 
nucleic acid extraction dependent variation is strongly exceeded by the sample-
specific variation, and underpins the technical reproducibility of these analyses.  
Clustering of the weighted UniFrac distances showed that morning and afternoon 
ileostoma effluent samples collected over a period of three days from subject 3 
grouped first by morning or afternoon and then by day of sampling (Figure 3.1), 
which is in agreement with previous observations by Booijink, et al. (31). However, 
samples obtained from the other subjects did not exhibit similar clustering 
consistency (Figure 3.1), indicating that the degree of compositional fluctuation of the 
small intestinal microbiota over time differs between individuals. Furthermore, 
qualitative analysis of the microbial profiles revealed considerable changes in the 
abundances estimated for different phylogenetic groups within a 72 hour time-frame 
and even between morning and afternoon samples obtained during the same day 
(Figure 3.2A). The fluctuations of small intestine microbial community composition 
and activity profiles confirms that these ecosystem dynamics occur within a single 
day’s timeframe in the ileostoma microbiota (31), which possibly relates to variations 
in the composition of the subject’s diet intake that is expected to impact strongly on 
the microbiota of the small intestine. 
 
Figure 3.1. Hierarchical 
clustering of the microbial 
composition profiles derived 
from pyrosequencing of 16S 
rRNA amplicons representing 
the total microbial community 
(rDNA) and its active fraction 
(rRNA) in morning (Mrn) and 
afternoon (Aft) ileostoma 
samples. Leaves are colored 
according to subject. Closed 
circles represent total microbiota 
and open circles represent the 
active fraction of the small 
intestinal microbiota. Independent 
amplicon production (I and II) and 
nucleic acid extractions (I and 2nd 
extraction) were performed for 
DNA and RNA from the morning 
ileostoma sample collected on 
day 1 from ileostomy subject. 
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Figure 3.2. Relative contributions of detected bacterial taxa at genus level in afternoon (Mrn) 
and evening (Aft) ileostoma samples from four subjects with pyrosequencing (of the total 
(rDNA) and active fraction (rRNA) of the microbial community (A) and with sequencing of 
mRNA reads (B) as well as the first two principal components (PC 1 and PC 2) from RDA 
analysis based on genus level community data (C). Phylogenetic groups that contribute at least 
2.5% to one of the profiles are indicated in the color key. Pyrosequences that could not be classified 
above the confidence threshold of 80% are grouped to “Unclassified_” at the specific rank per taxon, 
which is indicated in the microbial profiles with shadowing grey bars for groups classified no further 
than family level and black bars for groups with classifications that did not reach family level. mRNA 
reads with bit scores above 148 were used for taxonomic classification at genus level, scores between 
110 and 148 are grouped to Family, while the scores lower than 110 were grouped as “Unclassified 
Bacteria”.  
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Weighted UniFrac-based hierarchical clustering (Figure 3.1) and principal coordinate 
analysis (PCoA) analysis (Figure 3.3) revealed a grouping by subject on basis of 
community composition, although the bacterial communities detected in samples 
from subject 1, 2, and 4 displayed considerable overlap. This is likely due to the 
relatively short phylogenetic distance between the microbial communities in samples 
from these subjects that were dominated by bacterial species belonging to 
Firmicutes, while Escherichia belonging to Proteobacteria predominated in the 
samples from subject 3. Unweighted UniFrac based PCoA analysis resulted in a 
more prominent separation of the microbial communities by subject (Figure 3.3), 
implying that the divergence in microbial composition between individuals is likely 
due to variations in the less abundant phylogenetic groups. These findings are in line 
with previous results (31), showing that each individual harbors a distinct small 
intestinal microbiota. This notion is clearly supported by the pyrosequencing based 
microbial profiles generated on basis of genus taxonomic assignments (Figure 3.2A) 
that indicate that samples from subject 1 were dominated by Turicibacter and 
members of the family Peptostreptococcacea, while samples from subject 3 were 
abundant in Escherichia/Shigella. Although, the microbial communities in samples 
from subject 2 and 4 were enriched with Streptococcus, the divergence between 
these subjects could predominantly be attributed to less abundant genera such as 
Bifidobacterium (Figure 3.2A). 
Despite the subject-specific phylogenetic composition of the ileostoma microbiota, 
the genera Streptococcus, Veillonella, and Actinomyces, were represented in the 
total microbial communities of all samples (Figure S3.5). Nevertheless, 
Streptococcus abundance estimates varied substantially between samples, ranging 
from 0.4% to 88.3% (Figure 3.2A). Veillonella and Actinomyces were generally 
present at lower relative abundances and ranged from <0.1% to 10.1% and <0.1% to 
1.3% of the microbial community, respectively (Figure 3.2A). Bacteria belonging to 
the genera Clostridium and Haemophilus were detected in the total microbial 
communities of all but one sample (afternoon samples of day 1 from subject 2 and 
day 3 from subject 4, respectively) with variable relative abundances ranging from 
<0.1% to 31.1% and <0.1% to 10.2%, respectively. Furthermore, the genus 
Escherichia was detected in most samples collected from subject 1, 2, and 4, with 
relative abundance estimates up to 4.4% of the total microbial community. Notably, 
Escherichia assigned relative abundance in samples from subject 3 were 
considerably higher and ranged from 52.3% to 76.8% of the total ileostoma 
microbiota (Figure 3.2A). Analogously, the relative abundance estimates for 
Turicibacter (genus) and Peptostreptococcacea (family) were generally low, although 
these bacterial groups were highly abundant in samples from subject 1 (25.2 – 61.5% 
and 16.6 – 48.7%, respectively; Figure 3.2A). 
Streptococcus spp. were detected in the active fraction of each sample with 
abundances varying from 0.7% to 96.8%, while Veillonella and Actinomyces were 
detected in the active fraction of most, but not all ileostoma samples with relative 
contributions as high as 4.4% and 0.9%, respectively (Figure 3.2A and figure S3.5). 
Clostridium abundance estimates in the active fraction of the ileostoma microbiota 
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varied between subjects and could account for 40.4% of the active microbial fraction 
within a single sample. Relative abundances of the genera Haemophilus and 
Escherichia in the active fraction commonly amounted up to 3.5% and 6.8%, 
respectively, although samples obtained from subject 3 had Escherichia abundance 
levels of up to 88.7%. (Figure 3.2A). The high relative abundance of Turicibacter 
observed in samples obtained from subject 1 (see above), was also reflected by the 
high activity of this genus in the same samples (Figure 3.2A). 
Considering the abundance and prevalence of specific genera, we conclude that 
Streptococcus, Veillonella, and Clostridium can be considered as (active) signature 
members of the small intestinal microbiota, while Actinomyces and Haemophilus 
represent groups that are also common but at a lower abundance. Notably, although 
the abundance estimates for the genera Escherichia, Turicibacter and the family of 
Peptostreptococcacea was commonly low, specific subjects may have large 
communities of these bacterial groups. 
 
Comparison of the total and active fraction of the small intestinal microbiota 
The congruency between the total and active ileostoma microbial communities was 
evaluated. Based on observations in faecal microbial communities where microbial 
presence was not very well reflected by microbial activity (257, 316, 376), differences 
between the total and active fractions of the ileostoma microbial composition might 
also be anticipated. However, weighted UniFrac-based hierarchical clustering and 
principal component analysis revealed that the ileostoma effluent microbiota 
composition and activity profiles displayed close pairing per sample (Figure 3.1 and 
3.3). This is illustrated by the highly similar composition of the total and active 
ileostoma communities (Figure 3.2A and S3.3) and suggests that the vast majority of 
the bacterial groups present in the small intestine are active players in shaping small 
intestinal physiology. Nonetheless, in-depth analysis revealed that species belonging 
to the genera Grunulicatella and Actinomyces were significantly less abundant in the 
active fraction of the ileostoma microbiota compared to the total (p < 0.01). This 
suggests that although bacterial groups (e.g. Actinomyces) may be present in all 
ileostoma samples (see above), their activity at the time of sampling may be limited. 
The number of different taxonomic families and genera identified in the active fraction 
of each sample was consistently lower than that in the microbiota composition 
analysis (Table S3.1). This is also reflected in the lower number of OTUs, Chao1 
richness estimations and Shannon diversity indices calculated for the active fraction 
relative to the corresponding values for the whole microbiota composition, suggesting 
that the active community is less rich and diverse compared to the total community 
residing in the ecosystem (Figure S3.6; Table S3.2). These metrics were not skewed 
due to differences in sequencing depth per sample between the active fraction and 
the total community (Table S3.2). The observations that the phylogenetic make-up of 
the active and total community profiles are highly similar (see above) and unweighted 
UniFrac distances calculated for total and active community pairs showed a high 
degree of variation (Figure S3.3), indicate that only low abundance phylogenetic 
groups of the total ileostoma microbiota were not detected in the active fraction of the 
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ileostoma microbial community. This notion was supported by the fact that out of the 
total of 163 genus-level assignments, 46 were not detected in the active fractions, 
representing an average relative abundance of maximally 0.065% of the total 
microbial community per sample (Data not shown). 
 
 
Figure 3.3. First two 
principal components (PC 
1 and PC 2) from weighted 
and unweighted UniFrac-
based PCoA analysis of 
the total microbial 
community (16S rDNA) 
and the active fraction 
(16S rRNA) in ileostoma 
effluent samples obtained 
from four subjects (S1-
S4).  
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mRNA based phylogenetic profiling of the small intestinal microbiota 
The active fraction of the human small intestinal microbiota was further investigated 
by metatranscriptome analysis through sequencing of Illumina cDNA libraries derived 
from enriched mRNA samples from all 16 samples used in this study. A total of 
519,198,745 quality filtered sequences with an average of 32,449,922 (± standard 
deviation of 14,704,832) sequences per sample was obtained (read-length of 101nt). 
Due to incomplete rRNA removal during the mRNA enrichment using 
MICROBExpress (Ambion) (104, 198), an average of 93% (± standard deviation of 
4%) metatranscriptome sequences were removed from the datasets, leaving an 
average of 2,364,118 (± standard deviation of 1,678,586) putative mRNA sequence 
reads that were subjected for further analysis (Table S3.3).  
Between 35% to 78% of the total mRNA reads were classified at genus level while 
between 7% to 30% could be assigned no further than family level (Figure 3.2B). 
Analogous to the 16S rRNA (gene) based community profiles, phylogenetic 
distribution of mRNA reads at genus level revealed that streptococci were detected in 
datasets from all samples with relative abundances ranging from 7% and 70%. 
Streptococcus derived mRNA sequences dominated the metatranscriptome datasets 
from subject 2 and most samples from subject 1 and 4, while datasets from subject 3 
were dominated by Escherichia with relative abundances ranging from 14% to 52%. 
Notably, datasets from subject 1 and the afternoon sample collected on day 1 from 
subject 4, were enriched with mRNA assigned to the genera Clostridium and 
Turicibacter, which were also abundant in the 16S rRNA (gene) based profiles 
(Figure 3.2A). Though mRNA based phylogenetic profiles contained a larger 
percentage of reads that could not be assigned at genus level compared to those 
from 16S rRNA (gene) based profiling, the same dominant genera were detected at 
all three levels of analysis performed here (rDNA, rRNA, and mRNA). Furthermore, 
RDA analysis of the genus level community data from pyrosequencing (16S rDNA 
and 16S rRNA) and from RNA-sequencing (mRNA) revealed a significant separation 
of microbial profiles (p-value <0.05) between different subjects (Figure 3.2C), 
implying that individual-specific variation of microbial composition consistently are the 
predominant discriminator between the datasets, irrespective of the level of analysis 
(rDNA, rRNA, or mRNA).  
  
Functional analysis of ileostoma microbial communities 
To obtain insight in the functional properties of the human small intestinal microbiota, 
genes in the prokaryote genome database that were significantly aligned with 
metatranscriptome mRNA sequence reads were assigned to COG (321) for 
functional analysis and KEGG (164) for metabolic mapping purposes. Of the number 
of mRNA sequence reads assigned to the prokaryote genome database, between 
55% to 87% were assigned to genes that have COG annotation, whereas between 
44% to 75% reads were assigned to genes that have KEGG annotation. In total, 
3220 expressed COGs were identified in the metatranscriptome datasets, of which 
1022 COGs were shared between all datasets. Notably, these shared COGs 
captured between 64% to 95% of the total COG-assigned mRNA reads, indicating 
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that the metatranscriptomes of all samples are dominated by common functions. 
These common functions were frequently assigned to different phylogenetic origins, 
implying prominent functional redundancy of the community members of the small 
intestine microbiota. Analogously, many of the shared COGs belonged to the 
functional category of “information storage and processing”, and were predominated 
by functions associated to translation, ribosomal structure, and biogenesis, which 
represent more or less universally conserved microbial functions. Another dominant 
COG category among the shared functions was associated with “metabolism” 
(between 32 to 48% of the total COG-assigned mRNA reads), encompassing 
functions related to carbohydrate transport and metabolism (between 22 to 48% of 
the metabolism category), which indicates that the shared metabolic activity profile is 
executed by variable members of the microbial ecosystem. Moreover, this finding 
underpins that fermentation of diet-derived carbohydrates is an important functional 
driver of the small intestinal microbiota (381). 
PCA analysis of the COG distribution derived from all metatranscriptome datasets 
revealed grouping by subject (Figure S3.7) with subjects 1, 2, and 4 clustering more 
closely together and clearly distinct from subject 3. This function-expression based 
clustering is remarkably similar to that from weighted UniFrac-based PCoA analysis 
using community data from 16S rDNA and rRNA pyrosequencing (Figure 3.3). In fact, 
RDA analysis on the COG distributions and OTU distributions (derived from 16S 
rDNA and 16S rRNA sequences) from all samples sustained the grouping by subject 
(Figure 3.4). However, COG distributions per sample displayed less variation 
between samples from different subjects (inter) and the same subject (intra), 
compared to the variation observed by composition (rDNA) and global-activity (rRNA) 
profiles. This observation is in good agreement with the observation that the COGs 
that were shared by all samples, captured the majority of the metatranscriptome 
mRNA reads (see above).  
Figure 3.4. First two principal components (PC 1 
and PC 2) from RDA analysis based on COG relative 
abundances obtained from metratranscriptome 
dataset and OTU relative abundance obtained from 
pyrosequencing from ileostoma effluent samples 
obtained from four subjects (S1-S4).  
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KEGG annotations were mapped onto metabolic pathways using the iPath mapping 
module (368). Exemplary metabolic pathway maps were generated for the datasets 
from the transcriptome of the morning sample of day 1 obtained from subject 2 and 4 
(Figure 3.5). A high degree of similarity was observed for the metatranscriptomic 
landscapes of those two datasets for pathways related to nucleotide, carbohydrate, 
amino acid, energy, and lipid metabolism, as well as cofactor and vitamin synthesis. 
Nevertheless, distinct patterns of expression were observed for pathways related to 
oxidative phosphorylation and propanoate metabolism which were more prominently 
expressed in the sample from subject 2, whereas pathways related to metabolism of 
specific amino acid appeared to be higher expressed in the sample from subject 4 
(Figure 3.5). These differences may reflect ecosystem adaptations to environmental 
differences such as variation in the dietary composition of subject 2 and 4. 
Further analysis of the transcripts assigned to the genes encoding metabolic 
functions was performed to decipher genus specific metabolic activity in the small 
intestine ecosystem. Metabolic pathway-mapping specific for the genera 
Streptococcus, Clostridium, and Veillonella for the metatranscriptome dataset derived 
from the morning sample on day one from subject 2, revealed a strong domination of 
Streptococcus in pathways related to the primary metabolism of carbohydrate 
substrates. In contrast, metabolic pathways related to butanoate and propanoate 
metabolism were exclusively observed for Clostridium and Veillonella, respectively 
(Figure 3.6). These findings support the hypothesis that members of the small 
intestine microbiota intensely interact at a metabolic level, and illustrate the metabolic 
focus of the streptococci on the conversion of simple carbohydrate substrates to 
lactate and acetate, where the former metabolite serves as a substrate for 
subsequent conversion to acetate and propionate by Veillonella (381), while the latter 
metabolite (and in some cases also lactate) may serve as a substrate for butyrate 
production by the Clostridium members of the ecosystem (209). In fact, 
phosphotransbutyrylase and butyrate kinase involved in the butyrate formation 
pathway were found to be expressed by members of Clostridium cluster I. 
The individual activities and proposed food-chain relationships between individual 
groups within the ecosystem are supported by high expression levels of sugar PTS 
transporters and glycolytic enzymes by Streptococcus, in combination with high level 
expression of the lactate import permease and membrane associated lactate 
conversion machinery of Veillonella as well as the butyrate formation pathway in 
Clostridium. 
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Discussion 
 
This study determines the phylogenetic composition (rDNA) of the small intestine 
microbiota obtained in ileostoma samples, in combination with the determination of 
the overall activity of each of the bacterial ecosystem members (rRNA), as well as 
the specific activity of the overall ecosystem and its microbial members 
(metatranscriptomics). Moreover, by performing this in multiple individuals, and at 
multiple timepoints, both inter- and intra-personal dynamics of each of these 
ecosystem characteristics could be assessed. Last but not least, lysis and 16S rRNA 
(gene) PCR procedures were harmonized allowing accurate one to one comparisons 
at the different profiling levels. 
Sequence analysis of the 16S rDNA and rRNA content, used as proxies for 
assessing total and active community composition, revealed a subject specific 
phylogenetic composition. Notably, relative abundances of specific bacterial groups 
of the ileostoma microbiota of a subject could fluctuate considerably over time, which 
is different from what was concluded with respect to the ‘stable’ microbiota in fecal 
samples (40, 46, 66). Moreover, temporal stability of the ileostoma ecosystem 
displayed substantial inter-individual variation, which was apparent from the distinct 
clustering of ileostoma microbial communities in morning and afternoon samples in 
some subjects but not in others.  
The genera Streptococcus, Veillonella, and Actinomyces, co-occurred in the total 
community fractions of all samples and were detected in the majority of the active 
ileostoma community, albeit that Actinomyces abundance estimates were 
significantly lower in the active fraction compared to the total microbial communities. 
These findings support the notion that Streptococcus and Veillonella are typical and 
active inhabitants of the human small intestine (31, 340, 381). This observation as 
well as the notion that these microbial groups are also abundant in the upper GI tract 
(1, 3, 7, 43) supports their ‘autochtonous’ status in the small intestine microbiota 
(353). Moreover, the high expression of genes involved in fermentation of 
carbohydrates and short chain fatty acid metabolism (381) observed for these 
bacterial groups supports their prominent role in the overall functioning of the 
ecosystem.  
The results described here are in good agreement with findings presented in a 
previous study by Booijink and colleagues (31), that employed a phylogenetic 
microarray (the human intestinal tract chip (HITChip)) to investigate the composition 
and dynamics of the ileostoma effluent microbiota. Despite the principal differences 
between the HITChip and pyrosequencing methodologies (49, 339), the biological 
conclusions they generate appear to be similar with respect to the subject-specific 
nature, the temporal stability, and the predominant bacterial members encountered 
within the small intestinal microbial communities. Furthermore, taxonomic 
assignments of mRNA sequences at genus level comprised of the same dominant 
genera as were detected by 16S rRNA (gene) targeted pyrosequencing, 
demonstrating that independent of technology and targeted biomolecules the 
dominant community members are identified. However, the mRNA derived 
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phylogenetic profiles contained a considerable raised abundance of sequences that 
could not be classified at genus level, compared to the 16S rRNA (gene) based 
profiles. This confirms the high resolution taxonomic information encompassed in the 
16S rRNA gene, especially when compared to sequences of protein coding genes 
that are much less discriminative. Furthermore, as the majority of the primary RNA 
sequence data contained rRNA reads, the depth of functional analysis can be 
improved by increasing the efficiency of rRNA removal. 
Previously it has been postulated that ileostomy enhances oxygen penetration into 
the small intestine lumen, leading to disruption of the normal anaerobic environment 
(125). However, our analyses detected substantial abundances of typically anaerobic 
genera Clostridium, Veillonella, Turicibacter, and members of the 
Peptostreptococcaceae family, demonstrating that the small intestine of ileostomy 
subjects supports the growth and activity of strict anaerobes.  
Although the phylogenetic composition of the total and active fraction of the small 
intestinal microbiota were highly similar, species richness and diversity were lower in 
the active population compared to the total microbiota. This finding implies that most 
phylogenetic groups represented in each ileostoma sample contribute to the overall 
function and that especially low abundance populations may not participate 
prominently in the active microbial community. However, this conclusion may be 
skewed by differences in ribosomes per cell that may differ between fast-growing and 
slow growing microorganisms (93, 113, 181), while also reduced amplification 
efficiency of lowly abundant template sequences may have contributed (109). Our 
observations contrasts with compositional differences between the active and total 
(257) as well as viable (active) and injured or dead (non-active) fractions (18) of fecal 
microbial communities, where the total microbiota did not represent the active players 
of the fecal ecosystems. Both microbial ecosystems in the small and the large 
intestine are subjected to environmental conditions (e.g. antimicrobial peptides, host 
immune responses, and pH (32, 75)) that influence bacterial survival and thus the 
outcome of compositional analysis of the total and active microbial fractions. 
Although these factors differ between the distinct regions of the intestinal tract, they 
do not explain the divergence between total and active fractions in the fecal 
microbiota versus the congruent total and active fraction composition in the ileostoma 
microbiota. Fast transit, high nutrient availability, and low bacterial load in the small 
intestine as compared to further down the GI tract, may be significant determinants in 
the observed differences. We anticipate that there is severe microbial competition for 
the remaining (complex) carbohydrates in the colon (351). Consequently, colonic and 
fecal bacteria may suffer more significant nutrient starvation stress, leading to cell 
death as compared to bacteria in the small intestine. 
The microbial composition in ileostoma samples from the different subjects did not 
cluster consistently by sampling day and/or by morning versus afternoon, which 
indicates that factors other than day-night rhythms may determine fluctuations in this 
microbial ecosystem. Factors that can be considered here include variation in diet 
intake (amount and/or composition), which could have profound effects on the 
physico-chemical properties of the small intestinal habitat and in turn may modulate 
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temporal microbiota composition and activity. These considerations imply substantial 
opportunities to modulate the small intestinal microbiota by dietary interventions. 
Eventually this may enable the rational design of diets that aim to predictably 
modulate the relative abundance of particular phylogenetic groups of the 
endogenous microbiota. In this respect, it is of particular interest that individual 
Streptococcus lineages isolated from the small intestine display variable 
carbohydrate utilization capacity and have distinct immunemodulatory characteristics 
(Chapter 4, 5, and 6; (340)), which suggests that nutritional modulation of 
streptococcal population densities in the small intestinal lumen may affect local 
immune functions in the mucosa.  
Subject-specific phylogenetic composition is also reflected in subject-specific activity 
patterns revealed by metatranscriptome analyses. However, activity profile variations 
were relatively small, which is in agreement with a high degree of functional 
redundancy among the microbiota members in different individuals. Metabolism was 
among the dominantly expressed functional domains, which corroborates earlier 
findings from our laboratory and underpins the role of the small intestinal microbiota 
plays in metabolic conversion (fermentation) of diet-derived carbohydrates (381). 
Though, these functional categories were also found to dominate the 
metatranscriptome of the fecal microbiota (30, 112), the metatranscriptome of the 
small intestinal microbiota is particularly enriched with PTS and other carbohydrate 
systems involved in metabolism of simple carbohydrates (381). Metatranscriptomics 
also enabled the (partial) assignment of specific metabolic functions to distinct 
phylogenetic groups (e.g. the genera Streptococcus, Clostridium, and Veillonella), 
illustrating that these data can enable the reconstruction of interactive metabolic 
relationships (e.g., syntrophy, cross-feeding, competition, etc.) between microbial 
groups that are residing in the ecosystem. This is clearly exemplified by the 
metatranscriptome support for the previously postulated food-chain relationship 
between Streptococcus and Veillonella (381) as well as members of the genus 
Clostridium that utilize acetate for formation of butyrate. Interestingly, small intestinal 
bacteria, mostly belonging to Clostridium cluster I, appeared to use 
phosphotransbutyrylase and butyrate kinase for the final step in butyrate formation, 
rather than butyryl-CoA transferase utilized by butyrate producers from the lower GI 
tract (77, 209).  
In conclusion, this study demonstrates that 16S rRNA (gene) and metatranscriptome 
community profiling are complementary, and in the small intestinal ecosystem reveal 
that the phylogenetic composition of the microbiota as such and its activity 
distribution are highly congruent. Functional and phylogenetic interpretation of the 
metatranscriptome also allows the reconstruction of ecosystem interactions 
especially for dominanting signature genera of the small intestine community, such 
as Streptococcus and Veillonella. The relatively low degree of temporal stability of 
the small intestine microbiota implies that external influences like dietary intake 
strongly impacts the composition and activity of the small intestinal microbiota. This 
notion, in combination with the prominent role of the small intestine in immunological 
perception of the environment, may offer opportunities to modulate local host-
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immune-microbe interactions by specific dietary regimes, thereby aiming to improve 
health of the host organism.  
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Supplementary information 
 
Supplementary figures 
 
 
Figure S3.1. Relative contributions of detected bacterial taxa from domain to genus level 
through pyrosequencing of 16S ribosomal RNA gene (rDNA) and ribosomal RNA (rRNA) 
content from ileostoma effluent sample collected from four subjects at four time points. Figure 
generated using software described in Sundquist, et al (311), also providing a more detailed 
description of the visualization. 
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Figure S3.2. Relative contributions of detected bacterial taxa at genus level with 
pyrosequencing of the whole microbial community (16S rDNA) and the active fraction (16S 
rRNA) in the morning ileostoma sample collected on day 1 of ileostomy subject 2 for which the 
nucleic acids were amplified twice in separate reactions (I and II) and were extracted twice (2nd 
extraction). Phylogenetic groups that contribute at least 2.5% to one of the profiles are indicated in 
the color key. Pyrosequences that could not be classified above the confidence threshold of 80% are 
grouped to “Unclassified_” at the specific rank per taxon. 
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Figure S3.3. Boxplots based on weighted (upper panel) and unweighted (lower panel) UniFrac 
distance calculated between subjects, within subjects, between different sample preparations 
(replicates), and within pair-distance between total and active ileostoma microbiota as 
assessed by pyrosequencing of 16S rDNA and 16S rRNA, respectively. Lower UniFrac 
distances represent more similar microbial communities.  
 
 
Figure S3.4. Number of OTUs, Chao1 richness estimations, and Shannon diversity from 
sequence analysis of the total and the active microbial fraction in the collected ileostoma 
samples from subject 2. Data analysis for sample preparations from the morning sample on day 1 for 
which the nucleic acids were amplified twice in separate reactions (I and II) and were extracted twice (I 
and 2nd extraction). Values in represented ecological metrics are based on random sub-samplings of 
2836 reads per sample, average of four trials. 
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Figure S3.5. Venn diagram with distribution of genus-level taxa detected through 
pyrosequencing of the total microbial community (16S rDNA) and the active fraction (16S 
rRNA) that contribute at least 1% to one of the profiles (Figure 2) from ileostoma effluent 
samples collected from four subjects (A; each sphere indicates that the specific phylogenetic 
group was detected in all four samples from one or more subjects) and samples per individual 
(B). Pyrosequences that could not be classified above the confidence threshold of 80% are grouped to 
“Unclassified_” at the specific rank per taxon 
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Figure S3.6. Number of OTUs, Chao1 richness estimations, and Shannon diversity from 
sequence analysis of the total and the active microbial fraction in afternoon (Mrn) and evening 
(Aft) ileostoma samples. Values in represented ecological metrics are based on random sub-
samplings of 2836 reads per sample, average of four trials. 
 
Figure S3.7. First two 
principal components (PC 1 
and PC 2) from PCA analysis 
based on the COG 
distribution derived from all 
metatranscriptome datasets 
obtained from effluent 
samples obtained from four 
subjects (S1-S4). 
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Supplementary tables 
 
Table S3.1. Number of detected taxa in the total and active fraction* of ileostoma effluent 
samples 
Sample 
D
om
ai
n 
Ph
yl
um
 
C
la
ss
 
O
rd
er
 
Fa
m
ily
 
G
en
us
 
16S 
rDNA/rRNA Subject Day Timepoint 
16
S
 rD
N
A
 (t
ot
al
)*
 
1 
1 
Mrn 1 4 6 10 21 21 
Aft 1 5 8 12 20 20 
2 
Mrn 1 5 7 11 21 25 
Aft 1 5 8 12 26 27 
2 
1 
Mrn I** 1 4 6 8 12 13 
Mrn II** 1 4 7 9 14 15 
Mrn (2nd extraction)** 1 5 6 9 14 17 
Aft 1 4 6 10 14 18 
2 
Mrn 1 4 6 10 17 22 
Aft 1 8 13 18 27 27 
3 
1 
Mrn 1 4 6 10 18 26 
Aft 1 4 6 9 16 21 
2 
Mrn 1 6 8 12 23 35 
Aft 1 4 6 10 20 26 
4 
1 
Mrn 1 6 9 12 19 20 
Aft 1 5 8 11 19 21 
2 
Mrn 1 5 9 13 24 27 
Aft 1 7 10 13 24 26 
16
S
 rR
N
A
 (a
ct
iv
e)
* 
1 
1 Mrn 1 4 6 8 11 10 Aft 1 4 6 9 15 15 
2 
Mrn 1 5 7 9 18 19 
Aft 1 5 7 10 19 19 
2 
1 
Mrn I** 1 4 6 9 11 11 
Mrn II** 1 4 6 7 10 12 
Mrn (2nd extraction)** 1 4 5 6 8 9 
Aft 1 3 4 7 9 9 
2 
Mrn 1 4 6 9 14 13 
Aft 1 3 5 6 10 9 
3 
1 
Mrn 1 3 5 8 9 12 
Aft 1 4 5 6 11 15 
2 
Mrn 1 4 5 8 15 17 
Aft 1 4 6 7 12 16 
4 
1 
Mrn 1 4 7 7 7 7 
Aft 1 4 7 10 13 14 
2 
Mrn 1 4 6 8 13 15 
Aft 1 4 7 9 17 21 
Mrn: Morning; Aft: Afternoon 
*: The composition of the whole microbial community and the active fraction was analysed through 
pyrosequencing of 16S rDNA and rRNA, respectively. 
**: DNA and RNA from the morning ileostoma sample collected on day 1 of ileostomy subject 2 were 
extracted twice (I and 2nd extraction) of which the nucleic acids from the first extraction were amplified 
twice in separate reactions (I and II).  
Total and active small intestinal microbiota 
83 
 
 3 
 
  
Ta
bl
e 
S3
.2
. D
iv
er
si
ty
 s
ta
tis
tic
s 
fo
r a
m
pl
ic
on
 s
eq
ue
nc
in
g 
an
al
ys
is
 in
 th
e 
to
ta
l a
nd
 a
ct
iv
e 
fr
ac
tio
n 
of
 il
eo
st
om
a 
ef
flu
en
t s
am
pl
es
 
S
in
gl
es
* 
13
7.
6 
17
2.
2 
17
4.
0 
15
1.
6 
15
7.
2 
13
6.
2 
14
5.
0 
22
5.
0 
18
6.
8 
13
3.
4 
11
1.
4 
13
5.
4 
12
9.
8 
13
9.
6 
11
8.
8 
14
8.
0 
88
.4
 
18
0.
2 
81
.2
 
12
3.
0 
11
3.
4 
11
5.
6 
11
4.
0 
10
0.
8 
10
9.
2 
16
9.
4 
12
3.
6 
10
0.
4 
89
.0
 
10
7.
2 
73
.2
 
11
5.
6 
77
.2
 
10
7.
6 
60
.8
 
15
0.
6 
M
rn
: M
or
ni
ng
; A
ft:
 A
fte
rn
oo
n 
*:
 V
al
ue
s 
in
 re
pr
es
en
te
d 
di
ve
rs
ity
 m
et
ric
s 
ar
e 
ba
se
d 
on
 ra
nd
om
 s
ub
-s
am
pl
in
gs
 o
f 2
83
6 
re
ad
s 
pe
r s
am
pl
e,
 a
ve
ra
ge
 o
f f
ou
r t
ria
ls
 
**
: D
N
A
 a
nd
 R
N
A
 fr
om
 th
e 
m
or
ni
ng
 il
eo
st
om
a 
sa
m
pl
e 
co
lle
ct
ed
 o
n 
da
y 
1 
of
 il
eo
st
om
y 
su
bj
ec
t 2
 w
er
e 
ex
tra
ct
ed
 tw
ic
e 
(I 
an
d 
2n
d  e
xt
ra
ct
io
n)
 o
f w
hi
ch
 th
e 
nu
cl
ei
c 
ac
id
s 
fro
m
 th
e 
fir
st
 
w
er
e 
am
pl
ifi
ed
 tw
ic
e 
in
 s
ep
ar
at
e 
re
ac
tio
ns
 (I
 a
nd
 II
). 
E
qu
ita
bi
lit
y*
 
0.
52
81
 
0.
55
62
 
0.
58
89
 
0.
43
92
 
0.
55
44
 
0.
51
84
 
0.
53
25
 
0.
67
96
 
0.
58
40
 
0.
51
13
 
0.
42
32
 
0.
49
97
 
0.
41
91
 
0.
46
85
 
0.
50
73
 
0.
49
92
 
0.
30
79
 
0.
57
12
 
0.
51
85
 
0.
53
28
 
0.
50
61
 
0.
51
14
 
0.
43
88
 
0.
41
15
 
0.
41
97
 
0.
57
76
 
0.
52
11
 
0.
42
46
 
0.
32
91
 
0.
46
50
 
0.
26
57
 
0.
45
90
 
0.
35
56
 
0.
51
67
 
0.
18
44
 
0.
48
87
 
Fi
sh
er
_a
lp
ha
* 
59
.3
32
2 
78
.2
28
0 
84
.9
29
0 
65
.4
96
1 
77
.8
59
0 
65
.7
51
9 
67
.5
74
4 
11
8.
57
60
 
91
.9
59
6 
59
.5
24
3 
53
.4
33
4 
64
.3
53
0 
58
.4
81
3 
60
.4
37
7 
61
.0
02
1 
70
.4
36
8 
36
.7
14
3 
87
.5
09
4 
34
.1
19
2 
51
.8
63
2 
46
.0
86
1 
47
.8
17
4 
45
.2
93
0 
39
.4
09
6 
40
.6
27
4 
72
.1
86
4 
54
.7
11
4 
41
.9
66
5 
34
.8
22
9 
43
.4
60
3 
27
.3
52
2 
48
.2
07
1 
29
.1
19
3 
48
.2
70
8 
18
.8
06
0 
64
.8
97
3 
P
D
_w
ho
le
_t
re
e*
 
10
.6
14
7 
12
.9
69
7 
13
.5
90
2 
11
.7
88
0 
11
.5
80
4 
10
.5
46
3 
10
.7
00
2 
14
.0
15
1 
12
.8
40
3 
13
.6
66
0 
10
.3
49
9 
12
.0
68
0 
12
.1
38
9 
11
.9
38
1 
10
.4
00
3 
11
.6
61
2 
8.
02
93
 
14
.0
23
4 
7.
03
18
 
8.
70
81
 
9.
20
17
 
8.
54
27
 
8.
40
35
 
7.
01
67
 
6.
97
87
 
10
.7
96
4 
9.
38
52
 
6.
81
89
 
7.
52
96
 
8.
70
49
 
7.
32
17
 
9.
23
43
 
7.
17
23
 
8.
65
38
 
5.
48
61
 
10
.6
32
0 
O
bs
er
ve
d*
 
23
0.
6 
28
3.
0 
30
0.
4 
24
8.
2 
28
2.
0 
24
9.
0 
25
4.
0 
38
1.
2 
31
8.
2 
23
1.
2 
21
3.
2 
24
5.
0 
22
7.
8 
23
3.
8 
23
5.
4 
26
2.
0 
16
0.
0 
30
7.
0 
15
1.
2 
20
8.
4 
19
0.
6 
19
6.
0 
18
8.
0 
16
9.
0 
17
3.
0 
26
6.
8 
21
7.
0 
17
7.
4 
15
3.
6 
18
2.
2 
12
7.
2 
19
7.
2 
13
3.
6 
19
7.
4 
94
.4
 
24
6.
6 
O
TU
s 
60
3 
55
2 
53
7 
60
1 
42
5 
41
7 
42
8 
51
1 
55
5 
34
6 
43
2 
40
3 
55
7 
55
3 
44
5 
59
7 
33
4 
46
6 
22
8 
54
1 
44
2 
59
9 
26
6 
35
3 
35
9 
27
1 
36
7 
32
2 
30
0 
40
3 
27
7 
46
4 
16
6 
56
0 
22
9 
40
8 
R
ea
ds
 
17
95
6 
94
91
 
81
18
 
14
39
7 
59
66
 
71
78
 
72
30
 
49
15
 
82
74
 
57
83
 
11
26
7 
70
09
 
13
36
1 
13
49
3 
11
62
5 
14
33
3 
10
99
5 
58
02
 
62
66
 
16
10
6 
12
45
2 
22
92
2 
51
28
 
93
78
 
10
22
7 
29
02
 
71
20
 
78
99
 
88
10
 
11
33
4 
11
05
7 
15
01
0 
41
92
 
21
04
0 
13
50
0 
66
49
 
S
am
pl
e 
Ti
m
ep
oi
nt
 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 I*
* 
M
rn
 II
**
 
M
rn
 (2
nd
 e
xt
ra
ct
io
n)
**
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 I*
* 
M
rn
 II
**
 
M
rn
 (2
nd
 e
xt
ra
ct
io
n)
**
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
D
ay
 
1 3 1 3 1 3 1 3 1 3 1 3 1 3 1 3 
S
ub
je
ct
 
1 2 3 4 1 2 3 4 
 
16
S
 
rD
N
A
/ 
rR
N
A 
16
S
 
rD
N
A
 
(T
ot
al
) 
16
S
 
rR
N
A
 
(A
ct
iv
e)
 
Chapter 3 
84 
 
3 
  
Ta
bl
e 
S3
.2
 (C
on
tin
ue
d)
. D
iv
er
si
ty
 s
ta
tis
tic
s 
fo
r a
m
pl
ic
on
 s
eq
ue
nc
in
g 
an
al
ys
is
 in
 th
e 
to
ta
l a
nd
 a
ct
iv
e 
fr
ac
tio
n 
of
 il
eo
st
om
a 
ef
flu
en
t s
am
pl
es
 
sh
an
no
n*
 
4.
14
47
 
4.
53
03
 
4.
84
64
 
3.
49
40
 
4.
51
26
 
4.
12
66
 
4.
25
36
 
5.
82
65
 
4.
85
53
 
4.
01
48
 
3.
27
40
 
3.
96
54
 
3.
28
02
 
3.
68
65
 
3.
99
60
 
4.
00
99
 
2.
25
45
 
4.
71
89
 
3.
75
35
 
4.
10
39
 
3.
83
33
 
3.
89
38
 
3.
31
39
 
3.
04
48
 
3.
11
95
 
4.
65
53
 
4.
04
43
 
3.
17
21
 
2.
38
99
 
3.
49
09
 
1.
85
75
 
3.
49
90
 
2.
51
06
 
3.
93
96
 
1.
20
97
 
3.
88
31
 
M
rn
: M
or
ni
ng
; A
ft:
 A
fte
rn
oo
n 
*:
 V
al
ue
s 
in
 re
pr
es
en
te
d 
di
ve
rs
ity
 m
et
ric
s 
ar
e 
ba
se
d 
on
 ra
nd
om
 s
ub
-s
am
pl
in
gs
 o
f 2
83
6 
re
ad
s 
pe
r s
am
pl
e,
 a
ve
ra
ge
 o
f f
ou
r t
ria
ls
 
**
: D
N
A
 a
nd
 R
N
A
 fr
om
 th
e 
m
or
ni
ng
 il
eo
st
om
a 
sa
m
pl
e 
co
lle
ct
ed
 o
n 
da
y 
1 
of
 il
eo
st
om
y 
su
bj
ec
t 2
 w
er
e 
ex
tra
ct
ed
 tw
ic
e 
(I 
an
d 
2n
d  e
xt
ra
ct
io
n)
 o
f w
hi
ch
 th
e 
nu
cl
ei
c 
ac
id
s 
fro
m
 th
e 
fir
st
 e
xt
ra
ct
io
n 
w
er
e 
am
pl
ifi
ed
 tw
ic
e 
in
 s
ep
ar
at
e 
re
ac
tio
ns
 (I
 a
nd
 II
). 
do
m
in
an
ce
* 
0.
16
12
 
0.
12
82
 
0.
10
74
 
0.
31
75
 
0.
16
10
 
0.
20
09
 
0.
18
50
 
0.
04
65
 
0.
11
48
 
0.
23
49
 
0.
39
58
 
0.
21
82
 
0.
40
29
 
0.
28
61
 
0.
20
22
 
0.
23
07
 
0.
55
11
 
0.
17
61
 
0.
16
88
 
0.
14
44
 
0.
17
00
 
0.
16
65
 
0.
29
88
 
0.
34
32
 
0.
33
14
 
0.
10
75
 
0.
15
24
 
0.
33
91
 
0.
49
77
 
0.
21
74
 
0.
60
68
 
0.
27
89
 
0.
34
04
 
0.
15
77
 
0.
75
34
 
0.
26
71
 
do
ub
le
s*
 
32
.8
 
41
.0
 
45
.6
 
33
.2
 
47
.2
 
40
.8
 
36
.4
 
54
.2
 
47
.6
 
30
.6
 
33
.8
 
37
.6
 
34
.0
 
32
.6
 
38
.6
 
36
.2
 
22
.0
 
37
.8
 
20
.8
 
26
.8
 
25
.8
 
25
.4
 
24
.2
 
22
.0
 
19
.0
 
30
.6
 
39
.0
 
26
.2
 
24
.4
 
23
.6
 
18
.2
 
30
.0
 
22
.4
 
26
.4
 
12
.0
 
27
.6
 
si
m
ps
on
* 
0.
83
88
 
0.
87
18
 
0.
89
26
 
0.
68
25
 
0.
83
90
 
0.
79
91
 
0.
81
50
 
0.
95
35
 
0.
88
52
 
0.
76
51
 
0.
60
42
 
0.
78
18
 
0.
59
71
 
0.
71
39
 
0.
79
78
 
0.
76
93
 
0.
44
89
 
0.
82
39
 
0.
83
12
 
0.
85
56
 
0.
83
00
 
0.
83
35
 
0.
70
12
 
0.
65
68
 
0.
66
86
 
0.
89
25
 
0.
84
76
 
0.
66
09
 
0.
50
23
 
0.
78
26
 
0.
39
32
 
0.
72
11
 
0.
65
96
 
0.
84
23
 
0.
24
66
 
0.
73
29
 
ob
se
rv
ed
_s
pe
ci
es
* 
23
0.
6 
28
3.
0 
30
0.
4 
24
8.
2 
28
2.
0 
24
9.
0 
25
4.
0 
38
1.
2 
31
8.
2 
23
1.
2 
21
3.
2 
24
5.
0 
22
7.
8 
23
3.
8 
23
5.
4 
26
2.
0 
16
0.
0 
30
7.
0 
15
1.
2 
20
8.
4 
19
0.
6 
19
6.
0 
18
8.
0 
16
9.
0 
17
3.
0 
26
6.
8 
21
7.
0 
17
7.
4 
15
3.
6 
18
2.
2 
12
7.
2 
19
7.
2 
13
3.
6 
19
7.
4 
94
.4
 
24
6.
6 
S
im
ps
on
_e
* 
0.
00
52
 
0.
00
41
 
0.
00
37
 
0.
00
59
 
0.
00
42
 
0.
00
50
 
0.
00
48
 
0.
00
28
 
0.
00
36
 
0.
00
57
 
0.
00
78
 
0.
00
52
 
0.
00
74
 
0.
00
60
 
0.
00
53
 
0.
00
50
 
0.
01
40
 
0.
00
40
 
0.
00
80
 
0.
00
56
 
0.
00
63
 
0.
00
61
 
0.
00
76
 
0.
00
90
 
0.
00
87
 
0.
00
42
 
0.
00
54
 
0.
00
85
 
0.
01
30
 
0.
00
70
 
0.
02
00
 
0.
00
70
 
0.
01
14
 
0.
00
60
 
0.
04
32
 
0.
00
55
 
C
ha
o1
* 
51
3.
72
68
 
63
4.
08
24
 
64
9.
74
62
 
58
5.
56
20
 
53
9.
07
34
 
47
5.
25
12
 
54
2.
94
20
 
83
9.
87
98
 
69
3.
00
98
 
51
1.
71
29
 
39
3.
80
63
 
48
6.
52
81
 
47
8.
73
22
 
52
8.
70
53
 
41
6.
01
37
 
56
4.
59
27
 
33
0.
99
00
 
72
3.
99
57
 
30
1.
43
91
 
48
4.
06
82
 
43
2.
22
59
 
45
5.
84
30
 
45
7.
99
45
 
39
4.
52
32
 
49
6.
17
79
 
71
8.
72
81
 
40
8.
24
33
 
36
5.
81
68
 
32
5.
60
55
 
43
2.
37
66
 
27
6.
65
18
 
41
3.
52
86
 
26
2.
82
25
 
41
6.
66
95
 
24
0.
79
13
 
64
2.
57
23
 
S
am
pl
e 
Ti
m
ep
oi
nt
 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 I*
* 
M
rn
 II
**
 
M
rn
 (2
nd
 e
xt
ra
ct
io
n)
**
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 I*
* 
M
rn
 II
**
 
M
rn
 (2
nd
 e
xt
ra
ct
io
n)
**
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
M
rn
 
A
ft 
D
ay
 
1 3 1 3 1 3 1 3 1 3 1 3 1 3 1 3 
S
ub
je
ct
 
1 2 3 4 1 2 3 4 
 
16
S
 
rD
N
A
/ 
rR
N
A 
16
S
 
rD
N
A
 
(T
ot
al
) 
16
S
 
rR
N
A
 
(A
ct
iv
e)
 
Total and active small intestinal microbiota 
85 
 
 3 
 
Table S3.3. Number of sequence reads before and after rRNA removal 
Sample 
Reads entering the pipeline rRNA reads Putative mRNA reads 
Subject Day Moment 
1 
1 
Mrn 30,550,945 30,214,438 336,507 
Aft 19,387,391 18,886,114 501,277 
3 
Mrn 25,470,937 25,163,975 306,962 
Aft 52,975,043 50,836,679 2,138,364 
2 
1 
Mrn 29,208,566 24,912,430 4,296,136 
Aft 36,593,420 34,322,727 2,270,693 
3 
Mrn 45,673,033 42,620,544 3,052,489 
Aft 23,663,706 22,015,045 1,648,661 
3 
1 
Mrn 20,982,982 19,478,754 1,504,228 
Aft 28,135,249 26,571,132 1,564,117 
3 
Mrn 71,783,677 66,981,885 4,801,792 
Aft 14,927,709 14,013,161 914,548 
4 
1 
Mrn 42,006,183 36,075,240 5,930,943 
Aft 18,635,381 16,570,840 2,064,541 
3 
Mrn 26,697,579 24,419,378 2,278,201 
Aft 32,506,944 28,290,511 4,216,433 
Mrn: Morning; Aft: Afternoon 
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Abstract 
 
Molecular and cultivation approaches were employed to study the phylogenetic 
richness and temporal dynamics of Streptococcus and Veillonella populations in the 
small intestine. Microbial profiling of human small intestinal samples collected from 
four ileostomy subjects at four time points displayed abundant populations of 
Streptococcus spp. most affiliated with S. salivarius, S. thermophilus and S. 
parasasanguinis, as well as Veillonella spp. affiliated with V. atypica, V. parvula, V. 
dispar, and V. rogosae. Relative abundances varied per subject and time of 
sampling. Streptococcus and Veillonella isolates were cultured using selective media 
from ileostoma effluent samples collected at two time points from a single subject. 
The richness of the Streptococcus and Veillonella isolates were assessed at species 
and strain level by 16S rRNA gene sequencing and genetic fingerprinting, 
respectively. A total of 160 Streptococcus and 37 Veillonella isolates were obtained. 
Genetic fingerprinting differentiated 7 Streptococcus lineages from ileostoma effluent, 
illustrating the strain richness within this ecosystem. The Veillonella isolates were 
represented by a single phylotype. Our study demonstrated that the small intestinal 
Streptococcus populations displayed considerable changes over time at the genetic 
lineage level since only representative strains of a single Streptococcus lineage could 
be cultivated from ileostoma effluent at both time points.   
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Introduction 
 
The human body is populated with complex microbial communities, which vary in 
composition between body sites (57). The microbiota in the human gastrointestinal 
(GI) tract, for example, has adapted to the different conditions in the specific GI 
habitats (for a recent review see (353)), and is impressive not only because of its 
very high population density, but also because of its high phylogenetic diversity (268, 
341), and its extensive functional capabilities that complement the human genetic 
potential (262). The composition and dynamics of the bacterial community in the 
lower GI tract have been well described (31, 266, 317, 322, 329), whereas the upper 
GI tract microbiota in healthy humans is less well characterized as a consequence of 
sampling difficulties (32, 58, 203). Nevertheless, the different sections of the upper GI 
tract encompass distinct bacterial groups that interact with the host (195). 
Furthermore, the small intestine represents the first region where food components 
and the intestinal bacteria encounter each other, and it is also the region of the 
intestine that is predominantly involved in primary nutrient digestion and absorption 
(32, 203). Therefore, the small intestinal microbiota are expected to be of great 
importance to the host by playing a prominent role in the primary carbohydrate 
metabolism (381) and have an important influence on host physiology and health 
status (for a recent review see (58)) by, for example, immune-system modulation 
through luminal sampling and handling of bacteria (see (75) for a review). 
Recently, high-throughput 16S ribosomal RNA (rRNA) gene profiling was employed 
to characterize the human small intestinal microbiota in samples obtained from 
healthy individuals using an orally introduced catheter as well as samples collected 
from ileostomy subjects (31, 125, 381). The latter group of individuals underwent 
surgical removal of their colon, and as a consequence luminal content of their 
terminal ileum is excreted from an abdominal stoma, and can repetitively be collected 
in a non-invasive manner. These studies revealed that the bacterial community in 
ileostoma effluent is also encountered in the small intestine of healthy subjects with 
Streptococcus and Veillonella spp. as predominant components. Interestingly, both 
bacterial populations are not only abundant in the small intestine but also in the 
microbiota of the stomach (23), esophagus (256), throat (9), and oral cavity (169).  
The fact that members of Streptococcus and Veillonella are frequently co-occurring 
at these body sites may be partially attributable to their potential for metabolic 
interaction that has been shown to occur in the oral cavity (84) and postulated for the 
small intestine (381). Streptococcus spp. are involved in the fermentation of sugars, 
yielding lactic acid as their predominant fermentation end-product. In turn, Veillonella 
are renowned for their capacity to use lactic acid as a carbon and energy source 
(243). 
Since no small intestinal Streptococcus and Veillonella isolates have to our 
knowledge been described, this study focuses on in-depth assessment of their 
phylogenetic richness and population dynamics as well as the streptococcal 
carbohydrate metabolic capacities through a combination of cultivation and molecular 
typing methodologies. 
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Materials and methods 
 
Ethics statement 
The study was approved by the University Hospital Maastricht Ethical Committee, 
and was conducted in full accordance with the principles of the ‘Declaration of 
Helsinki’ (52nd WMA General Assembly, Edinburgh, Scotland, October 2000). 
Volunteers were informed about the study orally and in writing. Moreover, the 
volunteers signed a written informed consent before participation. 
 
Profiling small intestinal populations 
In total, 16 ileostoma effluent samples were collected from four ileostomy subjects 
(Table 4.1) who were colectomized at least 5 years prior to testing, are clinically 
considered to be healthy, and have a normally functioning small intestine: patients 
did not report any complaints related to GI functioning for at least three years prior to 
testing and were not following any treatment for GI-related symptoms. The subjects 
donated four samples each, collected on two distinct time points of the day (morning 
and afternoon), on two separate days (at least two days apart). The subjects 
collected the ileostoma effluent in a clean, empty ileostoma bag, which was emptied 
in centrifuge bottles (Nalgene, Rochester, NY, USA) containing 100 ml RNAlater® 
(Ambion, Austin, TX, USA), immediately after the bulk of the effluent flowed into the 
bag. Samples were stored for 4-10 hours at room temperature, after which the 
samples were frozen by transferring the tubes to dry ice. Frozen samples were 
transported to the laboratory, where they were kept at -80°C until further analysis. 
 
Table 4.1. Characteristics of subjects included in this study 
Subject Gender Age 
S1 Male 79 
S2 Female 65 
S3 Male 60 
S4 Female 60 
 
DNA was extracted using a method as described previously (377), with minor 
modifications. In short, 1 ml ileostoma effluent suspension was mixed with 4 ml PBS 
followed by centrifugation at 4600g at 4°C for 10 minutes. The cell pellet was re-
suspended in 0.5 ml ice-cold TE buffer (Tris-HCl pH 7.6, EDTA pH 8.0), after which 
the mixture was transferred to a microfuge tube containing 0.18 gram macaloid 
suspension (377), 0.1 mm zirconium beads, and 50 µl 10% SDS (Invitrogen, 
Carlsbad, CA, USA). The solution was mixed with 500 µl acid phenol (Invitrogen), 
followed by three Fastprep (Bertin Technologies, Montigny le Bretonneux, France) 
treatments at 5.5 m/s for 45 s with cooling on ice for 90 s between treatments. The 
sample was centrifuged at 13,400g at 4°C for 15 minutes, after which the nucleic 
acids in the aqueous phase were purified by consecutive extraction with 
phenol:chloroform:isoamylalcohol (25:24:1) and chloroform:isoamylalcohol (24:1). 
Phases were separated by centrifugation (13,400g at 4°C, 5 minutes) using Phase 
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Lock Gel tubes (5 Prime, Hamburg, Germany). Subsequently, 300 µl of the aqueous 
phase was treated with 3 µl RNAse A (10 mg/ml; Qiagen GmbH, Hilden, Germany) 
and incubated at 37°C for 15 minutes. Subsequent steps employed a modified 
version of the QIAamp DNA Stool Mini Kit protocol: 22,5 µl proteinase K (20 mg/ml; 
Ambion) and 300 µl buffer AL were added to the sample followed by incubation at 
70°C for 10 minutes. After addition of 300 µl ethanol (VWR, Amsterdam, The 
Netherlands), the sample was transferred to a QIamp column and centrifuged 
(13,000g, 1 minute). DNA pellets were washed with AW1 and AW2 buffer according 
to manufacturer’s instructions. Finally, the DNA was eluted with 30 µl Nuclease Free 
Water (Promega, Leiden, Netherlands). 
For 16S rRNA gene based microbial composition profiling, barcoded amplicons from 
the V1-V2 region of 16S rRNA genes were generated by PCR using the 27F-DegS 
primer ((339); Chapter 2) that was appended with the titanium sequencing adaptor A 
and a 8 nt sample specific barcode (121) at the 5’-end, and an equimolar mix of two 
reverse primers (338R I and II (60); Table 4.2), that carried the titanium adaptor B at 
the 5’-end. 
 
Table 4.2. Adaptors and primers used in this study  
Primera Primer sequence (5’-3’)b Reference 
Adaptor A CCATCTCATCCCTGCGTGTCTCCGACTCAG 
Provided by GATC-Biotech 
Adaptor B CCTATCCCCTGTGTGCCTTGGCAGTCTCAG 
27F-DegS GTTYGATYMTGGCTCAG (339); Chapter 2 
338R-I GCWGCCTCCCGTAGGAGT (60) 338R-II GCWGCCACCCGTAGGTGT 
27F GTTTGATCCTGGCTCAG 
(192) 1492R-rev CGGCTACCTTGTTACGAC 
357F CTCCTACGGGAGGCAGCAG 
(GTG5) GTGGTGGTGGTGGTG  
a: Primer names may not correspond to original publication 
b: M = A or C; R = A or G; W = A or T; Y = C or T 
 
PCRs were performed using a thermocycler GS0001 (Gene Technologies, Braintree, 
U.K.) in a total volume of 100 l containing 1× HF buffer (Finnzymes, Vantaa, 
Finland), 2 l PCR Grade Nucleotide Mix (Roche, Diagnostics GmbH, Mannheim, 
Germany), 2 U of Phusion® Hot Start II High-Fidelity DNA polymerase, 500 nM of a 
forward and the reverse primer mix (Biolegio BV, Nijmegen, The Netherlands), and 
0.2-0.4 ng/l of template DNA. The amplification program consisted of an initial 
denaturation at 98C for 30 s, 30 cycles of: denaturation at 98C for 10 s, annealing 
at 56C for 20 s and elongation at 72C for 20 s, and a final extension at 72C for 10 
minutes. The size of the PCR products (~375 bp) was confirmed by gel 
electrophoresis using 5 μl of the amplification-reaction mixture on a 1% (w/v) agarose 
gel containing 1× SYBR® Safe (Invitrogen, Carlsbad, CA, USA). PCR products were 
purified with the High Pure Cleanup Micro Kit (Roche) using 10 µl Nuclease Free 
Water for elution, and quantified using a NanoDrop ND-1000 spectrophotometer 
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(Nano-Drop Technologies, Wilmington, DE). Purified PCR products were mixed in 
approximately equimolar amounts and electrophoresed on an agarose gel, followed 
by excision and purification using the DNA gel extraction kit (Millipore, Billerica, MA, 
USA). Purified amplicon pools were pyrosequenced using a Genome Sequencer FLX 
in combination with titanium chemistry (GATC-Biotech, Konstanz, Germany). 
The pyrosequencing data analysis was carried out with a workflow employing the 
Quantitative Insights Into Microbial Ecology (QIIME) pipeline (38) using settings as 
recommended in the QIIME 1.2 tutorial with the following exceptions: reads were 
filtered for chimeric sequences using Chimera Slayer (118); and OTU clustering was 
performed with an identity threshold of 97%, using parameters as recommended in 
the QIIME newsletter of December 17th 2010 (http://qiime.wordpress.com/ 
2010/12/17/new-default-parameters-for-uclust-otu-pickers/). Additional data handling 
was done using in-house developed Python and Perl scripts. The Ribosomal 
Database Project (RDP) classifier version 2.2 (355) was used for taxonomic 
classifications up to the genus level. The most-likely species was determined by 
comparing sequences against the RDP reference set using NCBI BLAST (7), 
tentatively classifying an OTU as a specific species when the BLAST score of the 
OTU-reference sequence pair was higher than the lowest-scoring reference 
sequence-reference sequence pair for that species in the RDP set. Results of the 
tentative assignments were evaluated by generating maximum likelihood 
phylogenetic trees containing a representative sequence from each OTU and 
reference sequences from the RDP database (53). Multiple sequence alignments 
were done with Muscle (81), the part of the alignment matching the amplicon was 
retrieved using JalView (357) and maximum-likelihood phylogenetic trees were 
generated using Phyml (116). 
 
Sample collection for cultivation 
An ileostoma effluent sample was obtained in the evening from subject 1 (Table 4.1; t 
= 0) by transferring approximately 20 ml ileostoma effluent from the ileostoma bag to 
a 50 ml tube containing 20 ml Phosphate Buffered Saline (PBS)-cysteine solution (8 
g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2HPO4, 0.24 g/l KH2PO4, [Sigma, St. Louis, MO, 
USA] and 1 g/l cysteine-HCl [Sigma], pH 6.8). The PBS-cysteine solution was flushed 
with N2 to enhance survival of anaerobic bacteria such as Veillonella. Since large 
fluctuations on phylotype and function level were observed over a time span of one 
year (381), a second ileostoma effluent sample was collected in the morning from the 
same ileostomy subject (t = 1) one year after the first sampling to determine the 
population dynamics at the genetic lineage level. 
All samples were placed in sealed plastic bags with an anoxic atmosphere, 
generated by an anaerocult® A mini sachet (Merck, Darmstadt, Germany) and stored 
at home in the refrigerator. Samples were transported to the laboratory and 
processed within 24 hours after collection. 
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Cultivation 
Of all samples serial dilutions were prepared in PBS-cysteine solution (101-105), and 
plated on Mitis Salivarius (MS) agar (Becton Dickinson, Breda, the Netherlands) 
supplemented with Tellurite solution 1% (Becton Dickinson) according to 
manufacturer’s instructions, and Veillonella selective agar (VSA) (274, 275) to 
facilitate selective isolation of Streptococcus and Veillonella, respectively. MS agar 
plates were incubated aerobically, whereas VSA plates were incubated in anaerobic 
jars with an anaerobic atmosphere generated by an anaerocult® A sachet (Merck). 
All plates were incubated at 37°C for 18-48 hours. Emerging colonies were randomly 
picked and grown in liquid media at 37°C for 18-48 hours.  
The MS isolates were grown in MS medium, based on the MS agar, but lacking 
trypan blue, chrystal violet, and agar. The VSA isolates were cultivated under anoxic 
atmosphere, generated by the anaerocult® A mini system in Veillonella medium 
described in the DSMZ catalogue (Medium 136), which contains lactate as its main 
carbon source for growth. Bacterial isolates were stored at -80°C in these same 
media to which 15% glycerol was added. 
 
16S rRNA gene sequencing and analysis 
Near-full length 16S rRNA gene fragments from the bacterial isolates were PCR 
amplified using a PCR protocol described previously ((339); Chapter 2) with the 27F 
and Uni-1492-rev primers (Table 4.2) and either a single colony or 2.5 µl of bacterial 
suspension/glycerol stock as a template source. Amplicon size was verified by 
electrophoresis on a 1% (w/v) agarose gel. PCR products were purified and 
subsequently sequenced from the 27F, 357F, and Uni-1492-rev (192) priming sites 
(GATC-Biotech, Konstanz, Germany; Table 4.2). The obtained sequence reads per 
amplicon were assembled using Clone Manager 9 Professional Edition (Scientific & 
Educational Software, Cary, NC, USA), yielding near full-length 16S rRNA gene 
sequences, which were taxonomically classified using a locally installed version of 
the RDP classifier version 2.2 (355) with a default confidence threshold of 80%. 
The 16S rRNA gene sequences were aligned using the SILVA Webaligner (261), 
subsequently imported into ARB (215), and merged with the SILVA reference 
database release 106. A neighbor joining distance matrix employing no correction 
was calculated using ARB to group sequences into distinct phylotypes based on a 
threshold of 97% sequence identity. 
The near full-length 16S rRNA gene sequences were deposited in the Genbank 
database and are available under accession numbers JQ680047 to JQ680145 and 
JQ680199 to JQ680348. 
 
Typing of bacterial isolates 
Bacterial isolates were classified into genetic lineages using amplified fragment 
length polymorphism (AFLP) and Rep-PCR genetic fingerprinting. AFLP was 
performed as described previously (189). Based on analysis of replicates with the 
AFLP protocol, 90% of similarity was used as threshold for the separation of 
individual genetic lineages (data not shown). 
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Rep-PCR fingerprinting analyses were performed using a thermocycler GS0001 with 
an amplification program described by Matsheka, et al. (227). Each reaction was 
performed in a total volume of 25 µl composed of 1× PCR buffer (Promega), 1 µM of 
the (GTG)5 primer (Biolegio BV, Nijmegen, The Netherlands; Table 4.2), 200 µM of 
each deoxyribonucleotide triphosphate (Roche, Diagnostics GmbH, Mannheim, 
Germany), 1.25 U GoTaq® DNA polymerase (Promega) and 2.5 µl of glycerol stock. 
Rep-PCR products were separated by electrophoresis on a 1.5% (w/v) agarose gel 
and stained by in gel 1× SYBR® Safe DNA-stain. After standardized electrophoresis 
(75 minutes, 100 V, 1× TAE), banding patterns were visualized under UV light and 
digitally captured using the Gel Doc XR System (Biorad) with Quantity One software 
version 4.6.6 build 102. Comparative analysis of the resulting fingerprints was 
performed using the BioNumerics suite (version 4.6.1; Applied Maths, St Martens 
Latem, Belgium). Similarities among profiles were calculated using the Pearson 
correlation coefficient, and cluster analyses were performed applying the 
unweighted-pair group method with arithmetic averages algorithm (UPGMA) with an 
optimization of 0.69%. Based on analysis of replicates with the Rep-PCR protocol, 
84% of similarity was used as threshold for the separation of individual genetic 
lineages (data not shown). Rep-PCR based groupings for which no near full-length 
16S rRNA gene sequences were obtained, or that were inconsistent with 16S rRNA 
gene classification results (see above), were excluded from further analysis. 
The validity of using glycerol stocks as template source for Rep-PCRs was verified by 
comparing the resulting profiles with those obtained from Rep-PCRs using isolated 
genomic DNA of 3 randomly selected Streptococcus isolates, yielding identical 
profiles (data not shown). 
Substrate conversion capacity of individual Streptococcus isolates was evaluated 
using API 50 CH strips in combination with API CHL medium (Biomerieux, Marcy 
l'Etoile, France). To this end, isolates were grown overnight in MS medium and 
washed twice with 0.9% NaCl prior to inoculation of the strips, incubation at 37°C, 
and assessment of the reactions after 24 and 48 hours according to manufacturer’s 
instructions. To determine if fermentation patterns were consistent for isolates 
belonging to the same genetic lineage, two isolates from each genetic lineage (if 
available) were tested and compared. 
Growth of the isolates on different carbon sources was assessed using carbohydrate-
free MS-medium (MSBasal), supplemented with L-arabinose, D-(+)-glucose 
monohydrate, D-mannitol, N-acetylglucosamine, sucrose, D-trehalose, D-raffinose, 
soluble starch, or glycogen [Sigma] at a standard concentration of 1% (w/v). Bacteria 
suspended in 0.9% NaCl (see above) were diluted to an OD600 of 0.002 in the 
different MS-derived media, and incubated at 37°C for 18 hours. Growth was 
assessed by OD600 determination. 
MALDI-TOF MS analysis was performed with a Microflex mass spectrometer (Bruker 
Daltonics, Bremen, Germany) using FlexControl software (version 3.0). Spectra were 
recorded in the positive linear mode (laser frequency, 20 Hz; ion source 1, voltage at 
20 kV; ion source 2, voltage at 18.4 kV; lens voltage, 9.1 kV; mass range, 2000–
20 000 Da). Spectra were internally calibrated using Escherichia coli ribosomal 
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proteins. The spectra were imported into the integrated Biotyper software (version 
2.0) and analyzed by standard pattern matching with default settings. The spectrum 
of each isolate was compared with those in the database containing 9 Veillonella and 
61 Streptococcus spp. (see supplementary Materials and methods). Identification 
was provided with an accompanying score (log score 0–3) of reliability. This score is 
based on (i) matching of the spectrum in general, (ii) matching of the locus of the 
peaks and (iii) matching of the height of the peaks. Scores <1.7 represent no reliable 
identification. A score ≥1.7 and <2.0 is considered identification at the genus level, 
scores ≥2.0 identification at the species level (347). 
Colonies of each isolate were directly spotted on the MALDI-plate and were overlaid 
with 1 μl of matrix solution (α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile and 
2.5% trifluoroacetic acid) and air-dried. Measurements were performed as described 
previously (345). If an identification score was below a 1.7 cutoff, the isolate was 
again spotted on a MALDI-plate and pre-treated with 1 μl of 70% formic acid before 
being overlaid with the matrix solution. The highest of all the scores per isolate was 
considered the final result. 
 
Results 
 
Multiple Streptococcus and Veillonella spp. consistently co-occur in ileostoma 
effluent 
To establish the Streptococcus and Veillonella spp. relative abundances in ileostoma 
effluent, we characterized the microbial communities collected from four ileostomy 
subjects at four different time points through 16S rRNA gene pyrosequencing. In total 
162,785 quality filtered sequences with 10,174 (± standard deviation of 3,855) 
sequences per sample were obtained. From all sequences, 39,812 and 1,986 were 
assigned to the genera Streptococcus and Veillonella, respectively. Both genera 
were detected in all samples, with Streptococcus relative abundances ranging from 
0.4% to 88.3% (Figure 4.1A). Veillonella was generally present at lower relative 
abundance with variable abundances per sample ranging from <0.1% to 10.1% 
(Figure 4.1A). Interestingly, out of the different Streptococcus phylotypes detected in 
the whole dataset, phylotypes most closely related to the species S. salivarius, S. 
thermophilus (S. salivarius species-group), and S. parasanguinis (S. mitis species-
group) were of high relative abundance in all samples (Figure 4.1B and S4.1A). The 
Veillonella population in ileostoma effluent was represented by phylotypes, that most 
closely resembled the species V. dispar, V. parvula, V. rogosae, and V. atypica. 
Since discrimination of these species is not possible based on partial 16S rRNA gene 
sequences generated by pyrosequencing (Figure S4.1B), relative abundances for all 
phylotypes were combined (Figure 4.1A). The clustering in Figure S4.1B does show 
that we can specify that most of the OTUs detected in the small intestine are closely 
related to these four species and not to other Veillonella spp. (e.g. V. ratti and V. 
criceti).These findings demonstrate that the same Streptococcus and Veillonella spp. 
are detected in ileostoma effluent samples collected at different time points as well as 
from different subjects, indicating that these species are typical small intestinal 
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commensals. To further characterize the small intestinal Streptococcus and 
Veillonella population richness as well as its temporal dynamics at the strain-level, 
we applied an integrated approach that combined cultivation and physiological 
characterization (substrate utilization assays) with molecular typing, including genetic 
fingerprinting and MALDI-TOF MS-typing of bacterial isolates of these bacterial 
genera from ileostoma effluent of one of the subjects. 
 
 
Figure 4.1. Relative contribution of Streptococcus (primary axis) and Veillonella (secondary 
axis; A) and Streptococcus spp. (B) as detected with pyrosequencing in morning (Mrn) and 
afternoon (Aft) ileostoma samples. Since discrimination of S. salivarius and S. thermophilus was not 
possible based on partial 16S rRNA pyrosequencing, relative abundances for phylotypes assigned to 
these species were combined to “S. salivarius/thermophilus like”. 
 
Phylotype diversity of ileostoma effluent-derived bacterial isolates 
A total of 272 bacterial isolates collected from two ileostoma effluent samples at 2 
time points (t = 0 and, one year later, at t = 1; Table 4.3) were classified on basis of a 
combination of 16S rRNA gene sequencing and genetic fingerprinting by AFLP and 
Rep-PCR. These isolates were classified as the genera Streptococcus (160), 
Enterococcus (66), Veillonella (37), Bacteroides (5), and Lactobacillus (4) (Table 
4.3). While Streptococcus was exclusively isolated using MS agar and Veillonella, 
Lactobacillus, and Bacteroides were only isolated from VSA, Enterococcus isolates 
were recovered from both media (Table 4.3). In the remainder of the paper we focus 
Small intestinal Streptococcus and Veillonella 
97 
 
 4 
on analysis of the Streptococcus and Veillonella isolates as typical commensal 
inhabitants of the small intestine (31, 381). Characteristics of the isolates are 
included in Table 4.3 and S4.2. 
 
Table 4.3. Number of isolates per phylotype, lineage, and sample origin based on identification 
employing 16S rRNA gene classification, AFLP analysis and (GTG)5-PCR fingerprintinga 
16S rRNA 
gene 
classification 
(genus) 
Phylotype Lineage Species group identification 
Total 
isolatesb 
Isolates per ileostoma 
effluent sample 
t = 0 t = 1 
Streptococcus 
1c 1 S. mitis 3 3  
2c 2 S. bovis 17 13 4 3 64  64 
3c 
4 S. salivarius 1f 1  
5 1 1  
6 8 8  
7 66 66  
Veillonella 4d N.D.e V. parvula 37 21 16 
Enterococcus 
5c 
8 E. avium 1 1  
9 E. faecium 1  1 
10 E. gallinarum 5 4 1 
11 E. avium 6  6 
12 E. avium 10 1 9 
13 E. faecium 11 2 9 
5d N.D.e E. gallinarum 11 11  
6c 14 E. faecalis 21 20 1 
Bacteroides 7d N.D.e B. fragilis 5  5 
Lactobacillus 8d N.D.e L. fermentum 4  4 
a: Characteristics of the isolates are included in table S2.; A graphic representation of the data 
included in this table and table S2 is added as figure S4.3 
b: All isolates were obtained from a 79 year old male ileostomist (subject 1; Table 1) 
c: Isolated obtained from MS agar 
d: Isolates obtained from VSA 
e: N.D. Not determined because AFLP analysis and/or Rep-PCR genomic fingerprinting did not reveal 
discriminative lineages 
f: AFLP analysis unlike Rep-PCR genomic fingerprinting identified a single Streptococcus isolate as a 
separate genetic lineage 
 
Based on the near full-length 16S rRNA gene sequences, isolates identified as 
Streptococcus were divided in 3 phylotypes and Veillonella was represented by a 
single phylotype at a sequence identity threshold of 97%. The 16S rRNA gene 
sequences within each Streptococcus phylotype showed >99% sequence identity. 
The least abundant phylotype, consisting of three isolates, showed highest similarity 
to species in the SILVA database belonging to S. parasanguinis (>99%; S. mitis 
species group), while the second phylotype, consisting of 81 isolates showed highest 
similarity to S. equinus (>98.5%) and S. lutetiensis (>99.7%; S. bovis species group). 
The last phylotype, represented by 76 isolates showed highest similarity to S. 
salivarius subsp. salivarius (>98.7%) and S. vestibularis (>99.3%; S. salivarius group; 
Figure 4.2). These identifications were confirmed by MALDI-TOF MS analysis of 
Chapter 4 
98 
 
4 
randomly picked isolates from each of the Streptococcus phylotypes (data not 
shown). Considering the high sequence similarity with multiple species for isolates 
from one phylotype, in the remainder of the paper the phylotypes are indicated with 
the Streptococcus species group names (see above) as they are also used in the 
Bergey’s Manual of Systematic Bacteriology (65). 
 
 
 
Figure 4.2. Relative contribution of Streptococcus and Veillonella isolates obtained from 
ileostoma effluent (t = 0 and 1) on genus, phylotype and lineage level. The bar plots next to the 
pie charts represent the division of the Streptococcus isolates in phylotypes and genetic lineages. The 
numbering of the Streptococcus phylotypes and lineages are based on the groupings in table 3. 
Characteristics of the isolates are included in table 3 and S2.; A graphic representation of the 
complete data is included as figure S4.3. 
a: Isolated obtained from MS agar 
b: Isolates obtained from VSA 
c: Veillonella lineage groupings are not determined because AFLP analysis and/or Rep-PCR genomic 
fingerprinting did not reveal discriminative lineages 
d: AFLP analysis unlike Rep-PCR genomic fingerprinting identified a single Streptococcus isolate as a 
separate genetic lineage. According to Rep-PCR genomic fingerprinting this isolate belongs to 
Streptococcus lineage 7. 
 
Strain diversity of ileostoma Streptococcus populations exceeds the phylotype 
level 
AFLP analysis and Rep-PCR genetic fingerprinting were employed to discriminate 
different bacterial lineages within a 16S rRNA phylotype group. Both techniques 
generated consistent results in terms of subtyping of the 152 bacterial isolates 
obtained from ileostoma effluent at t = 0 (Figure S4.2, Table S4.2). It should be 
noted, however, that AFLP fingerprinting discriminated isolates within the S. 
salivarius species group into two distinct lineages (lineage 4 and 7), while these 
isolates were grouped together by Rep-PCR genetic fingerprinting (Figure S4.2), 
illustrating the higher resolution of AFLP as a fingerprinting technique. Because of its 
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higher throughput, Rep-PCR fingerprinting was used to classify the 120 isolates from 
ileostoma effluent at t = 1, identifying 7 genetic lineages within the 3 Streptococcus 
phylotypes (Figure 4.2 and S4.3), whereas no separate genetic lineages were 
identified for the Veillonella phylotype as indicated above. Notably, 7 distinct genetic 
lineages could be identified among the 2 Enterococcus phylotypes (Table 4.3 and 
S4.2; Figure S4.3).  
These findings illustrate the high degree of bacterial richness for the small intestinal 
ecosystem and confirm that 16S rRNA based approaches underestimate the true 
diversity of microbial ecosystems that extends to sub-phylotype levels.  
 
Temporal dynamics of ileostoma Streptococcus populations 
To determine if the occurrence of identified groupings on phylotype and sub-
phylotype levels varies in time, the dynamics of the ileostoma effluent populations 
were assessed by comparing two samples collected one year apart from the same 
individual.  
Isolates from the same Veillonella phylotype were obtained from ileostoma effluent at 
both time points. Intriguingly, only one of the three Streptococcus phylotypes that 
were cultivated from ileostoma effluent at t = 0 was recovered from the second 
ileostoma effluent sample obtained a year later (Figure 4.2). Detailed analysis 
revealed that of the 7 Streptococcus lineages that were cultivated from ileostoma 
effluent, 5 Streptococcus lineages were exclusively cultivated from ileostoma effluent 
at t = 0, while 1 Streptococcus lineage was only recovered from ileostoma effluent at 
t = 1. Additionally, 1 Streptococcus lineage was cultivated from ileostoma effluent at 
both time points (Figure 4.2). These findings suggest that while the same species are 
detected the small intestinal Streptococcus populations display population dynamics 
at the level of the genetic lineages within the phylotypes.  
 
Carbohydrate fermentative capabilities differ between Streptococcus lineages 
To assess whether genetic differences among the Streptococcus lineages are also 
reflected in their phenotypic characteristics, the carbohydrate-fermentation 
capabilities of one or two (if available) randomly picked bacterial isolates 
representing each of the 6 Streptococcus genetic lineages from ileostoma effluent at 
t = 0 (Figure 4.2) were tested using the API 50 CH system (Table S4.1). 
Fermentation profiles between duplicate tests for the same isolate were concordant, 
albeit that in some cases a clear positive or negative result was obtained for one 
duplicate while the second duplicate showed a weak reaction. Furthermore, 
fermentation patterns for isolates from the same lineage only showed minor 
differences (Table S4.1). All of the tested Streptococcus isolates were able to 
ferment the monosaccharides galactose, glucose, and fructose as well as the 
disaccharides maltose, lactose, and saccharose (sucrose). The three different 
Streptococcus phylotypes and most of the Streptococcus lineages could be 
discriminated based on their disparate capacity to ferment arabinose, N-
acetylglucosamine, amygdalin, arbutin, esculin, salicin, cellobiose, melibiose, 
trehalose, raffinose, amidon (starch), glycogen, and gentiobiose (Table S4.1). 
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Members of Streptococcus lineage 4 and 7 
as well as lineage 5 and 6 could, however, 
not be distinguished based on their 
fermentation profiles (Table S4.1). For the 
isolates belonging to lineage 4 and 7 this 
appears to reflect their close relatedness as 
was also concluded from the failure to 
distinguish these lineages by Rep-PCR 
genetic fingerprinting. However, the 
fermentation capabilities of the strains 
tested here did differ from phenotypic 
characteristics for closely related 
streptococci, including: S. parasanguinis, S. 
equinus, S. lutetiensis, S. salivarius and S. 
vestibularis (65). This illustrates the 
difference in metabolic capabilities exhibited 
by individual strains of a species, as is also 
apparent from the distinct fermentation 
profiles obtained for the 4 S. salivarius 
strains in this study (Table S4.1). 
Isolates were further cultured in basal 
medium (MSBasal medium) supplemented 
with different sugars as sole carbohydrate 
and energy source to test exemplary if the 
isolates could also utilize the substrates as 
a carbon source for growth (Table 4.4). 
Growth was observed for the same 
substrates that were fermented in the API 
50 CH assay, except for isolates from 
Streptococcus lineages, which were able to 
ferment N-acetyl-glucosamine (lineage 4 
and 7), D-raffinose (lineage 5 and 6), and 
glycogen (lineage 2) according to the API50 
assay, but were not able to use this 
substrate as a carbon source for growth 
(Table 4.4). Overall, these results 
demonstrate that the phenotypic diversity of 
the Streptococcus isolates is in good 
agreement with the determined phylotype-
grouping and, to some extent is reflecting 
the grouping on the sub-phylotype level. 
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Discussion 
 
Culture (in)dependent analysis of small intestinal Streptococcus and 
Veillonella populations 
The current study employed cultivation and polyphasic molecular typing to provide 
increased insights into the richness and dynamics of the small intestinal 
Streptococcus and Veillonella populations. Ileostoma effluent samples were used as 
a representation of the luminal content of the human small intestinal ecosystem. A 
recent study, however, postulated that oxygen penetration disrupts the ileostoma 
microbiota and therefore do not represent that of the terminal ileum in healthy 
subjects (125). Although the influence of oxygen cannot be ruled out, investigations 
in our laboratory revealed that the ileostoma effluent microbiota contains a high 
relative abundance of strict anaerobes (31). Moreover, the ileostoma effluent 
microbiota resembles that encountered in the proximal part of the small intestine of 
individuals with a normal intestinal tract that includes a colon (339, 381). 
Streptococcus and Veillonella populations were detected in all ileostoma effluent 
samples and showed fluctuations in relative abundance in a 72 hour time frame, 
which are most likely due to the subject’s diet composition. These results are in good 
agreement with a previous study performed in our laboratory (31). Although the 
relative abundances of Streptococcus and Veillonella populations varied per subject 
and time of sampling, two groups of Streptococcus (S. salivarius and S. mitis group), 
Veillonella spp. (affiliated with V. atypica, V. rogosae, V. parvula, and/or V. dispar) 
were consistently dominant in all ileostoma effluent samples. Therefore, we decided 
to proceed with deciphering the diversity of the Streptococcus and Veillonella 
populations at the genetic lineage level. To facilitate in depth analysis of isolates from 
ileostoma effluent, we focused on samples collected from a single male ileostomist 
(subject 1), rather than samples collected from several subjects. Samples were 
collected with a long time-interval (one year apart) to expand the collection of distinct 
bacterial genetic lineages relative to the diversity that may be expected from 
ileostoma effluent collected over a relative short time frame (381). Selective 
cultivation conditions enabled the targeted isolation of these Streptococcus and 
Veillonella spp., although isolates within the genera Enterococcus, Lactobacillus and 
Bacteroides were also obtained. Though the latter genera were also detected in other 
ileostoma samples from subject 1, their relative abundance was generally low 
(<0.7%; Van den Bogert, et al. Unpublished results). The number of obtained 
Enterococcus isolates might be explained by a cultivation bias resulting from the use 
of selective media that preferentially allow growth of specific microbial groups, and 
are known to provide a distorted view of bacterial abundances in the original samples 
(76, 239). Of each of the streptococcal species groups identified by pyrosequencing, 
representative bacterial isolates, including streptococci affiliated with S. equinus and 
S. lutetiensis belonging to the S. bovis species group, were cultured from ileostoma 
effluent. Unambiguous affiliation of the Veillonella isolates to specific species, i.e. V. 
atypica, V. rogosae, V. parvula, and/or V. dispar, was not possible based on 16S 
rRNA gene sequences, which is in agreement with what has previously been 
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described for species within this genus (65). Nonetheless, MALDI-TOF MS analysis 
identified the Veillonella phylotype as V. parvula. The fact that isolates from 
Streptococcus, Veillonella and three other genera were obtained shows that these 
populations were alive at the time of sampling and may be part of the active small 
intestinal microbiota. 
The Streptococcus isolates obtained from ileostoma effluent collected at two time 
points could be clustered into multiple species-groups, which could be further 
subdivided into strains belonging to distinct genetic lineages on basis of genetic 
fingerprinting. Although not the prime subject of this study, also the Enterococcus 
isolates were found to display a substantial level of phylogenetic richness, indicating 
that these groups of small intestinal cocci encompass a high degree of genetic 
diversity. The two ileostoma samples that were taken one year apart from the same 
individual revealed distinct Streptococcus lineages, while only representative strains 
of one of the Streptococcus lineages were cultivated at both time points. This 
indicates that the fluctuations in relative abundance seen at the genus and species 
level are confirmed and expanded at the genetic lineage level. Moreover, while 
representative strains of the same species are frequently detected in multiple 
samples from one or several individuals, the occurrence of the corresponding genetic 
lineages may be quite different. Genetic fingerprinting methods have been widely 
applied to discriminate strains from Streptococcus spp. such as S. pneumoniae (79) 
and S. pyogenes (90), and were used to assess the oral Streptococcus diversity at 
the strain level, which showed that the oral cavity of most subjects harbored multiple 
genotypes of S. mutans (46, 375) and S. oralis (73). Similarly, Enterococcus faecium 
strains from different sources were differentiated (134). Furthermore, the temporal 
fluctuations of strain abundances of Lactobacillus and Bifidobacterium spp. in fecal 
samples were analyzed previously (230), revealing similar results as described here. 
However, to the best of our knowledge, the (small) intestinal Streptococcus richness 
has not yet been assessed to the sub-phylotype level. We hypothesize that this is 
important for the functioning of the ecosystem, since the substrate conversion 
capacities were different among the Streptococcus lineages. Furthermore, these 
observations underpin the limitation of species-level identifications of intestinal 
bacteria on basis of 16S rRNA gene sequences alone, when it comes to the 
prediction of function of the microbiota. This is especially true for the novel high 
throughput sequencing technologies that provide only partial 16S rRNA gene 
sequences.  
 
Possible interactions of small intestinal bacterial populations with the human 
host 
Notably, streptococci and Veillonella are also abundant in other sections of the upper 
GI tract (1, 9, 23, 256) and likely originate from their abundant populations in the oral 
cavity (353). Molecular typing of oral Streptococcus and Veillonella strains, isolated 
from the ileostomist studied here (subject 1), identified a Veillonella phylotype and 
three S. salivarius lineages that, remarkably, group together with those that were 
cultivated from ileostoma effluent (Van den Bogert, et al. Unpublished results; 
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Chapter 7). Although speculative, this first comparison between oral and small 
intestinal microbiotas suggests that the oral microbiota may serve as an inoculum for 
the upper GI tract. Though this suggest that these populations are allochthonous to 
the small intestine (353), the considerable common abundance of the streptococci 
and their high activity in efficient uptake and fermentation of the available (diet-
derived) carbohydrates (381), suggest that Streptococcus populations play a 
prominent role in the primary carbohydrate metabolism occurring in the small 
intestinal ecosystem.  
Since the number of isolates obtained from the ileostoma effluent samples is limited, 
it cannot be ruled out that lineages that were recovered only from one of the two 
ileostomy samples would in fact be shared lineages when larger numbers of isolates 
were to be analyzed. However, some of these lineages were represented by a 
relatively large number of isolates (e.g. Streptococcus lineage 3 and 7), indicating 
that even if these lineages were present at both time points, their relative abundance 
would have differed considerably. 
Preliminary investigations in our laboratory identified unique genetic markers for 
several of the different Streptococcus lineages. Remarkably, these genetic markers 
were detected in small intestinal samples of other human individuals, suggesting that 
these lineages are common commensals of the small intestinal microbiota (Chapter 
5). It is well-known that dietary changes lead to an alteration of intestinal microbial 
composition, which has a profound influence on responses of the host immune 
system (for a recent review see (226)). Furthermore, recent studies revealed that 
substantially different mucosal responses and immunoregulatory cascades can be 
modulated by closely related species (335), different bacterial strains (233), and even 
different preparations of the same strain (336). Based on these findings, in 
combination with the discriminating fermentation and growth patterns among the 
Streptococcus strains and lineages described here, it is tempting to speculate that 
there is a potential for directed modulation of mucosal immune responses by dietary 
modulation of the endogenous Streptococcus populations. To this end, elucidating 
the role of the small intestinal microbiota, especially of the abundant and diverse 
Streptococcus population, is a task for the future. 
 
General conclusion 
The work presented here demonstrates high intra-genus and intra-species genetic 
diversity of the small intestinal microbiota, focusing on populations of Streptococcus 
and Veillonella. It is of particular interest to assess whether the small intestinal 
Streptococcus and Veillonella isolates have the potential for metabolic interaction 
similar to what is observed in the oral cavity (84). In addition, our findings show that 
the Streptococcus population in the small intestine has a high phenotypic variability, 
which may be a dominant driver of the high population dynamics of the small 
intestinal streptococci in response to varying nutrient availability that is caused by 
variable food intake. These dynamic streptococcal populations may profoundly 
influence local host-microbe interactions, thereby modulating small intestinal 
physiology and immune system functions. 
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Supplementary information 
 
Supplementary material and methods – MALDITOF MS database 
 
Veillonella and Streptococcus spp. included in the MALDITOF MS database: 
 
Veillonella atypica  2 strains     
Veillonella caviae  1 strain     
Veillonella criceti  1 strain     
Veillonella denticariosi  2 strains     
Veillonella dispar  1 strain     
Veillonella montpellierensis 1 strain     
Veillonella parvula  2 strains     
Veillonella ratti   1 strain     
Veillonella rogosae  1 strain     
Veillonella sp.   1 strain     
Streptococcus acidominimus 1 strain     
Streptococcus agalactiae 9 strains     
Streptococcus alactolyticus 1 strain     
Streptococcus anginosus 2 strains     
Streptococcus australis  1 strain     
Streptococcus caballi  1 strain     
Streptococcus canis  2 strains     
Streptococcus constellatus 2 strains     
Streptococcus criceti  1 strain     
Streptococcus cristatus  2 strains     
Streptococcus dentirousetti 1 strain     
Streptococcus devriesei  2 strains     
Streptococcus didelphis  1 strain     
Streptococcus downei  1 strain     
Streptococcus dysgalactiae 6 strains     
Streptococcus entericus  1 strain     
Streptococcus equi  5 strains     
Streptococcus equinus  2 strains     
Streptococcus ferus  1 strain     
Streptococcus gallinaceus 1 strain     
Streptococcus gallolyticus 8 strains     
Streptococcus gordonii  3 strains     
Streptococcus halichoeri 1 strain     
Streptococcus hyointestinalis 1 strain     
Streptococcus hyovaginalis 2 strains     
Streptococcus infantarius 1 strain     
Streptococcus infantis 1 strain     
Streptococcus intermedius 1 strain     
Streptococcus lutetiensis 1 strain     
Streptococcus macacae 1 strain     
Streptococcus marimammalium 1 strain     
Streptococcus massiliensis 1 strain     
Streptococcus minor 3 strains     
Streptococcus mitis 1 strain     
Streptococcus mutans 1 strain     
Streptococcus oralis 4 strains     
Streptococcus orisratti 1 strain     
Streptococcus orisuis 1 strain     
Streptococcus ovis 1 strain     
Streptococcus parasanguinis 2 strains     
Streptococcus parauberis 2 strains     
Streptococcus peroris 1 strain     
Streptococcus phocae 2 strains     
Streptococcus pleomorphus 1 strain     
Streptococcus pluranimalium 1 strain     
Streptococcus pneumoniae 9 strains     
Streptococcus porcinus 1 strain     
Streptococcus pseudopneumoniae 1 strain     
Streptococcus pseudoporcinus 1 strain     
Streptococcus pyogenes 8 strains     
Streptococcus ratti 1 strain     
Streptococcus salivarius 4 strains     
Streptococcus sanguinis 4 strains     
Streptococcus sinensis 1 strain     
Streptococcus sobrinus 2 strains     
Streptococcus suis 3 strains     
Streptococcus thermophilus 6 strains     
Streptococcus thoraltensis 2 strains     
Streptococcus uberis 1 strain     
Streptococcus urinalis 1 strain     
Streptococcus vestibularis 1 strain   
Streptococcus sp. 2 strains 
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Supplementary figures 
 
Figure S4.1. Maximum likelihood phylogenetic trees containing the reference sequences from 
the RDP database and a representative sequence from each OTU from pyrosequencing for 
Streptococcus (A) and Veillonella (B). Tree leaves beginning with ‘OTU’ represent sequences that 
were obtained from pyrosequencing. Numbers between brackets indicated the number of sequences 
for that tree leaf. 
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Figure S4.1 (Continued). Maximum likelihood phylogenetic trees containing the reference 
sequences from the RDP database and a representative sequence from each OTU from 
pyrosequencing for Streptococcus (A) and Veillonella (B). Tree leaves beginning with ‘OTU’ 
represent sequences that were obtained from pyrosequencing. Numbers between brackets indicated 
the number of sequences for that tree leave. 
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Figure S4.3. Groupings of Streptococcus, Enterococcus, Veillonella, Lactobacillus, and 
Bacteroides spp. (inner circles) isolates obtained from ileostoma effluent into phylotypes 
(middle circles) and genetic lineages (outer circles). Faded colored groupings represent the 
number of bacterial isolates AFLP analysis and/or Rep-PCR genomic fingerprinting did not reveal 
discriminative lineages. I0/I1: isolates obtained from ileostoma effluent at time point 0 and/or 1. a: 
isolates obtained from MS agar; b: isolates obtained from VSA; c: AFLP analysis unlike Rep-PCR 
genomic fingerprinting identified a single Streptococcus isolate as a separate genetic lineage; d: S. 
mitis group; e; S. bovis group; f: S. salivarius group; g: E. faecium group; h: E. gallinarum group; i: E. 
avium group; j: E. faecalis; k: V. parvula; l: L. fermentum; m: B. fragilis.  
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Supplementary tables 
 
Table S4.1. API strip scores for MS bacterial isolates 
Black: positive reaction; Grey 
w: weak reaction, d: variable 
reaction between duplicate 
tests of the same isolate; 
White: negative reaction; 
a: The numbering of the 
phylotypes and lineages are 
based on the order of 
groupings in table 3 and 
(clockwise) groupings in figure 
S3; 
b: To determine if fermentation 
patterns were consisted for 
isolates belonging to the same 
genomic lineage, two isolates 
from most of genomic lineages 
were tested, if possible; c: 
Number 1 isolates were tested 
in duplicate; d: AFLP analysis 
unlike Rep-PCR genomic 
fingerprinting identified a single 
Streptococcus isolate as a 
separate genomic lineage. 
According to Rep-PCR 
genomic fingerprinting this 
isolate belongs to 
Streptococcus lineage 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S4.2. Characteristics of isolates from ileostoma effluent 
 
Available upon request or can be downloaded from the online version of this article 
(http://onlinelibrary.wiley.com/doi/10.1111/1574-6941.12127/suppinfo
Classification (genus) Streptococcus 
Phylotypea 1 2 3 
Lineagea 
(Total number of isolates) 
1 
(3) 
2 
(17) 
4d
(1) 
5 
(1) 
6 
(8) 
7 
(66) 
Isolateb,c 1 2 1 2 1 1 1 2 1 2 
CONTROL 0           
Glycerol 1           
Erythritol 2           
D-Arabinose 3           
L-Arabinose** 4   w w       
D-Ribose** 5           
D-Xylose** 6           
L-Xylose 7           
D-Adonitol 8           
Methyl-βD-Xylopyranoside 9           
D-Galactose** 10  w     w w  w 
D-Glucose** 11  w     w w   
D-Fructose** 12  w     w w   
D-Mannose** 13 d w   d d d w  w 
L-Sorbose 14           
L-Rhamnose 15           
Dulcitol 16           
Inositol 17           
D-Mannitol 18           
D-Sortbitol 19           
Methyl-αD-Mannopyranoside 20           
Methyl-αD-glucopyranoside 21           
N-AcetylGlucosamine 22 d    d    d  
Amygdalin 23           
Arbutin 24           
Esculin ferric citrate 25           
Salicin 26          w 
D-Cellobiose** 27     w    w  
D-Maltose** 28  w      w   
D-Lactose (bovine origin) 29  w      w  w 
D-Melibiose** 30 d     w     
D-Saccharose (sucrose) ** 31  w      w   
D-Trehalose** 32           
Inulin 33   d        
D-MeLeZitose 34           
D-Raffinose 35      w w    
AmiDon (starch) 36           
Glycogen 37           
Xylitol 38           
Gentiobiose 39           
D-Turanose 40           
D-Lyxose 41           
D-Tagatose** 42           
D-Fucose 43           
L-Fucose 44           
D-Arabitol 45           
L-arabitol 46           
Potassium GlucoNaTe 47           
Potassium 2-KetoGluconate 48           
Potassium 5-KetoGluconate 49           
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Abstract 
 
The human small-intestinal microbiota is characterised by relatively large and 
dynamic Streptococcus populations. In this study, genome sequences of small-
intestinal streptococci from S. mitis, S. bovis, and S. salivarius species groups were 
determined and compared with those from 58 Streptococcus strains in public 
databases. The Streptococcus pangenome consists of 12,403 orthologous groups of 
which 574 are shared among all sequenced streptococci and are defined as the 
Streptococcus core genome. Genome mining of the small-intestinal streptococci 
focused on functions playing an important role in the interaction of these streptococci 
in the small-intestinal ecosystem, including natural competence and nutrient-
transport and metabolism. Analysis of the small-intestinal Streptococcus genomes 
predicts a high capacity to synthesize amino acids and various vitamins as well as 
substantial divergence in their carbohydrate transport and metabolic capacities, 
which is in agreement with observed physiological differences between these 
Streptococcus strains. Gene-specific PCR-strategies enabled evaluation of 
conservation of Streptococcus populations in intestinal samples from different human 
individuals, revealing that the S. salivarius strains were ubiquitously detected in the 
small-intestine microbiota, supporting the representative value of the genomes 
provided in this study. Finally, the Streptococcus genomes allow prediction of the 
effect of dietary substances on Streptococcus population dynamics in the human 
small-intestine.  
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Introduction 
 
Streptococcus is a genus of Gram-positive, low GC-rich species belonging to the 
lactic acid bacteria (LAB) in the family Streptococcaceae (65). While several 
Streptococcus species, such as S. pyogenes (214) and S. pneumonia (162) are 
recognized as human pathogens, others like S. salivarius, S. mitis, S. parasanguinis 
are commonly detected as relatively dominant inhabitants in the upper respiratory 
tract (65), oral cavity (1, 169), throat (9), esophagus (256), stomach (23), and small 
intestine (31, 339, 381) of healthy individuals.  
Studies carried out by our laboratory focused on elucidating the composition and 
function of the microbial community in the small intestine, using ileostoma effluent 
samples as a representation of the luminal content of the small intestine (31, 339, 
340, 381). In ileostomy subjects the terminal ileum is connected to an abdominal 
stoma making this region of the intestinal tract accessible for non-invasive and 
repetitive sampling of the luminal fraction of the small-intestinal microbiota (31, 339, 
381). The microbial composition in ileostoma effluent resembled the microbiota that 
resides in the proximal part of the small intestine from individuals with an intact 
intestinal tract (341, 381). Although Streptococcus spp. were detected in each of 
collected ileostoma effluent samples, their relative abundance fluctuated greatly 
between individuals and even between samples obtained from the same individual 
(31, 340). Furthermore, metatranscriptomic analysis of ileostoma effluent identified 
carbohydrate transport systems, including several phosphotransferase systems 
(PTS) among the highly represented expressed functions in the small-intestinal 
streptococci, suggesting that the activity of these bacteria is focused on efficient 
uptake and fermentation of the available (diet-derived) carbohydrates in the human 
small intestine (381). 
Based on the above, the Streptococcus populations in the small intestine are 
predicted to play a prominent role in the metabolic conversion of primary 
carbohydrates that are present in this ecosystem, and may thereby effectively 
compete for dietary carbohydrate nutrients with the host mucosa. Therefore, a 
cultivation approach was employed to obtain representative Streptococcus isolates 
from the small-intestinal ecosystem ((340), Chapter 4). Classification of the isolates 
on the basis of molecular typing methodologies showed that from one ileostoma 
sample alone 3 different Streptococcus species were recovered belonging to the S. 
mitis group, S. bovis group, and S. salivarius group of which the latter could be 
further divided in four genetic lineages (strain level). Although considerable temporal 
fluctuations of distinguishable genetic lineages were observed when a second 
sample was collected and investigated one year later, isolates belonging to a single 
lineage were recovered from both ileostoma effluent samples. Moreover, the 
Streptococcus lineages displayed different carbohydrate conversion and growth 
patterns ((340); Chapter 4). However, the mechanisms underlying the dynamics at 
the genetic lineage level is unclear. Therefore, specific aspects of the environmental 
interaction-potential and the metabolic capacity of 6 small-intestinal Streptococcus 
strains were investigated through analysis of their genome sequences in this study. 
Chapter 5 
114 
 
5 
Furthermore, the genomes enabled the comparison with other streptococci from 
other niches, allowing the identification of genetic targets for strain-specific PCR-
based detection in intestinal samples from different individuals. 
 
Materials and methods 
 
Streptococcus isolates and chromosomal DNA extraction 
The isolation of the small-intestinal Streptococcus strains and their molecular typing 
was described previously ((340); Chapter 4). In short, isolates were obtained from 
ileostoma effluent plated on Mitis Salivarius (MS) agar (Becton Dickinson, Breda, the 
Netherlands) supplemented with Tellurite solution 1% (Becton Dickinson). The 
streptococcal isolates were classified by DNA fingerprinting into 6 genetic lineages 
that, in the remainder of the paper are indicated with their Streptococcus species 
group names: S. mitis (1 lineage), S. bovis (1 lineage) and S. salivarius (4 lineages). 
A randomly picked representative isolate of each lineage was selected for whole 
genome sequencing.  
Genomic DNA of the isolates was extracted from bacterial cells that were grown 
overnight in 10 ml MS medium at 37°C. Cells were pelleted by centrifugation at 
7250g at 4°C for 15 minutes and subsequently frozen at -20°C. Thawed cell-pellets 
were resuspended in 2 ml THMS (30 mM TRIS-HCl [Sigma, St. Louis, MO, USA; pH 
= 8.0], 25% (w/v) sucrose [Sigma], and 3 mM MgCl2 [Riedel-de Haën, Seelze, 
Germany]) supplemented with 10 mg/ml lysozyme (Sigma) and 40 µl mutanolysin 
(Sigma; 5000 U/ml), aliquoted in equal amount into 2 eppendorf tubes, and incubated 
at 37°C for 30 minutes. After centrifugation at 14.000g for 5 minutes and discarding 
the supernatant, cells were resuspended in 100 µl THMS and mixed with 400 µl TES 
(50 mM TRIS-HCl [Sigma; pH = 8.0], 20 mM EDTA [Sigma; pH = 8.0], 50 mM NaCl 
[Merck], containing 0.5% (v/v) SDS [Ambion, Austin, TX, USA]) and 20 µl Proteinase 
K (20 mg/ml) followed by incubation at 56°C for 15 minutes. Nucleic acids were 
subsequently purified by sequential extraction with acid-phenol (Phenol:Water 
(3.75:1 v/v); pH = 4.45-5.68; Invitrogen, Carlsbad, CA, USA), acid-phenol:chloroform 
(1:1), and chloroform (Sigma-Aldrich, Zwijndrecht, Netherlands) using standard 
procedures as described by Sambrook, et al. (285). DNA was precipitated from the 
water-phase by standard ethanol precipitation (285). After drying, the DNA pellets 
were dissolved in 50 µl nuclease free water (Promega, Leiden, Netherlands). One µl 
RNAse A (10 mg/ml; Qiagen GmbH, Hilden, Germany) was added to the solution 
followed by incubation at 37°C for 30 minutes. Samples were stored at 4°C. DNA 
quality and concentrations were determined by nanodrop and on a 1.0% (w/v) 
agarose gel containing 0.4 µg/ml ethidium bromide (Bio-rad). 
 
Genome sequencing and annotation 
DNA from bacterial isolates was sequenced using 454 GS FLX (Roche) technology 
in combination with titanium chemistry, producing 350-450 bp reads (234,320 ± 
86,626 reads per genome), and by using Illumina HiSeq 2000 technology, producing 
11,884,010 ± 1,026,060 paired reads of 50 bp per genome from 3 kb mate pair 
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libraries (Table S5.1; GATC-Biotech, Konstanz, Germany). Pyrosequence reads 
were assembled using the Celera Assembler v6.1 (http://sourceforge.net/ 
apps/mediawiki/wgs-assembler/index.php?title=Main_Page), and the resulting 
contigs were subsequently combined with paired-read Illumina sequencing data to 
generate scaffolds using the SSPACE software v1.1 (26). Genome pseudo-
assemblies were constructed by placing scaffolds in their likely order based on 
comparisons with the genomes from closely related bacteria: Streptococcus 
parasanguinis ATCC 15912 ([Genbank: NC_015678]; S. mitis species group), 
Streptococcus gallolyticus UCN34 ([Genbank: NC_013798], S. bovis species group), 
and Streptococcus salivarius CCHSS3 ([Genbank: NC_015760]; S. salivarius 
species group). These comparisons were manually screened for inconsistencies 
using the Artemis comparison tool (41). Genomes were annotated using the RAST 
server (14). The genes predicted in the genomes of the six small-intestinal isolates 
were assigned to Cluster of Orthologous groups (COG; (321)) categories, using 
blastp comparison with the COG database (NCBI, 
ftp://ftp.ncbi.nih.gov/pub/COG/COG) using an alignment E-value cut-off of 10-3. 
 
Strain identifiers and accession numbers 
The Whole Genome Shotgun projects of the human small intestinal Streptococcus 
strains have been deposited at DDBJ/EMBL/GenBank under the following strain 
identifiers (and accession number): S. mitis species group strain: HSISM1 
(ASKI00000000), S. bovis species group strain: HSISB1 (ASKA00000000), S. 
salivarius species group strain 1: HSISS1 (ASKB00000000), S. salivarius species 
group strain 2: HSISS2 (ASKC00000000), S. salivarius species group strain 3: 
HSISS3 (ASKH00000000), and S. salivarius species group strain 4: HSISS4 
(ASKD00000000). The version described in this paper is version XXXX01000000. 
 
Genome orthology 
Orthology relationships were identified by comparing all predicted gene products 
from all 6 small-intestinal Streptococcus genomes with the genes predicted to be 
encoded by the 58 other Streptococcus genomes (see Table S5.2 for accession 
numbers) that were available within the NCBI database on February 22nd, 2012 using 
OrthoMCL v2.0.2 with default parameters. Genome metadata (e.g. isolation site) from 
the Streptococcus genomes was retrieved from the Genome OnLine database 
(GOLD; http://genomesonline.org) on February 27th, 2012 (Table S5.2). 
 
Streptococcus phylogenetic tree reconstruction 
Multiple protein sequence alignments of the 450 orthologous groups with exactly one 
member in each Streptococcus genome were generated using MUSCLE (81). The 
variable positions were concatenated into a single alignment (length 5605 residues) 
and a maximum-likelihood phylogenetic tree was generated using PhyML (116). The 
phylogenetic tree was visualized using the TREEVIEW program (250). 
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Genome mining and metabolic mapping 
Bacterial genomes were mined for systems involved in responses to external stimuli, 
focusing on bacteriocins, identified using BAGEL2 employing no re-annotation (62), 
and two-component systems (TCS) consisting of sensor histidine kinase (HK) and 
response regulator (RR) pairs (307). 
Moreover, genomes were screened for gene clusters involved in regulation of natural 
competence: comCDE, present in the S. mitis group species, or comRS in S. bovis 
and S. salivarius streptococci (126).  
Genomes were further screened for sugar transport systems including constituents of 
the bacterial phosphotransferase system and ABC transporters. Metabolic and amino 
acid biosynthesis pathways were constructed for the newly sequenced genomes by 
mapping EC numbers from the genome annotations onto the Kyoto Encyclopedia of 
Genes and Genomes (KEGG) metabolic pathways (164). Pathways from individual 
KEGG maps that were represented in at least one of the Streptococcus genomes 
were included in combined metabolic visualizations for sugar metabolism and amino 
acid biosynthesis that were manually constructed. In cases where genes of key 
enzymes in specific pathways of interest were apparently absent from the genome-
based predictions, a further effort was made to identify homologous gene candidates 
by dedicated BLAST searches (7). 
 
Unique gene identification and PCR detection 
Each of the newly sequenced genomes was screened for ‘unique’ genes that were 
not present in other small-intestinal Streptococcus genomes or other genomes in the 
NCBI database. Single copy unique genes with a sequence length of at least 750 nt 
were used for primer design employing the Primer-BLAST tool 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/), which uses the Primer3 program 
(278). Default parameters were used, except for the following changes: PCR product 
size: 150 to 300 bp; maximum primer size: 23 nt; minimum GC content: 40%; 
maximum poly-X (mononucleotide repeats): 3; maximum self-complementarity: 3.  
Primer specificity was checked by submitting each primer to Primer-BLAST using 
genomes, “Genomes (chromosomes from all organisms)” from all Bacteria, as a 
reference database. An in-house perl script was used to determine if the primers 
designed had exact matches in small-intestinal Streptococcus genomes other than 
the intended Streptococcus strain target. This revealed that primers developed for S. 
salivarius lineage 4 were not exclusively specific for the intended target strain, but 
were predicted to be cross reactive with S. salivarius lineage 1. By decreasing the 
minimal gene sequence length to 500 nt, primers were developed that were specific 
for S. salivarius lineage 4.  
Primers that passed each screening step, were specific for their target strain, and 
had a minimal tendency to form secondary structures, including hairpin loops, 
heterodimers, and homodimers (analysed by the IDTDNA Oligoanalyzer 3.1; 
Integrated DNA Technologies) were ordered (Biolegio BV, Nijmegen, Netherlands) 
and tested for their application in strain specific PCR detection assays (see below; 
Table S5.3).  
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All PCRs were performed on a C1000TM Thermal Cycler (Bio-rad) with a CFX96 optic 
module (Bio-rad) employing CFX Manager 2.1 (Bio-rad) software for analysis. 
Reactions were carried out in Hard-Shell semi skirted clear 96 well plates (Bio Rad) 
sealed with Microseal B film (Bio Rad) in 25 μl volumes using IQ SYBR green 
supermix (Bio-Rad) according to the manufacturer’s instructions with 200 nM of 
forward and reverse primer and either 5 µl gDNA (10-20 ng/µl) or glycerol stock as a 
template source. 
The optimal annealing temperature (60°C) for each primer pair was determined by an 
8-degree temperature (53°C to 64°C) gradient PCR using gDNA from target strains 
as template (data not shown).  
The PCR program started with a denaturation step at 95°C for 5 minutes, followed by 
40 cycles consisting of denaturation at 95°C for 15 s, annealing for 60°C for 30 s and 
elongation at 72°C for 20 s with data collection, and a final elongation step at 72°C 
for 10 minutes. Ct values above 35 were considered negative. Melting curve analysis 
was carried out by incrementally increasing the temperature from 55°C to 95°C at 30 
s per 0.5°C with continuous fluorescence collection. Control PCRs were performed 
alongside each separate amplification without addition of template and consistently 
yielded no product. 
 
Small-intestinal and fecal sample collection 
In total, 30 ileostoma effluent samples were collected in the morning or afternoon (at 
least 3 h apart) on separate days (at least two days apart) from 6 ileostomy subjects 
(4 male and 2 female; aged 55 to 79; A-F), as part of previous projects, results of 
which are reported elsewhere ((31, 340); Chapter 3 and 4). Small-intestinal fluid 
samples were obtained from 3 healthy individuals (3 males; 24 ± 4.5 years; G-I) and 
included a jejunal sample and an ileum sample from subject H and a single ileum 
sample from subjects G and I.  
Fecal samples were collected from 10 individuals (4 male and 6 female; aged 19 to 
33; J-S) as part of a previous project (322). DNA was extracted using the Repeated 
Bead Beating method described in (283) or using a method adapted from Zoetendal, 
et al. (379), depending on the study they originated from, and was used to screen for 
the unique targets of the Streptococcus genetic lineages. 
 
Results 
 
General features of small-intestinal streptococcal genome sequences 
The entire genome set analysed in this study consisted of 64 genomes, 
encompassing 20 Streptococcus species. Six draft genome sequences were 
obtained from strains originating from the small intestine, which were determined in 
this study and ranged in genome size from 1.9 Mbp (S. bovis) to 2.4 Mbp (S. 
salivarius lineage 3; See table S5.1 for genome statistics). The full complement of 
genes (pangenome) of the Streptococcus genome set consisted of 12,403 
orthologous groups (OG), of which 4,232 OG were represented in the genomes of at 
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least one of the six small-intestinal Streptococcus strains. The size of the 
Streptococcus pangenome estimated here is somewhat larger as has been 
suggested in previous studies (197, 216). However, these studies based their 
pangenome estimates on a smaller genome set comprising fewer species. 
Furthermore, the Streptococcus pangenome defined here does not seem to be 
exceptionally high compared to, for example, the Lactobacillus pangenome estimated 
to consist of over 13,000 protein-encoding genes (166) or gene families (216). 
Further analysis revealed that all 64 Streptococcus genomes shared 574 OG, 
defining the core Streptococcus genome. All OG belonging to the core Streptococcus 
genome could be classified to a COG, although 26% of these OGs was assigned to 
poorly characterized COG categories (Figure 5.1). Most OG in the core 
Streptococcus genome were predicted to be involved in information storage and 
processing (29.2%), with most genes belonging to typically conserved functions such 
as ‘Translation, ribosomal structure and biogenesis’ and ‘Replication, recombination 
and repair’. Metabolic functions accounted for 28.4% of the core Streptococcus OG, 
followed by 15.7% of OG that were involved in cellular processes and signalling. 
Most OG belonging to ‘metabolism’ were assigned to functions in transport and 
metabolism of nucleotides and carbohydrates. 
Most streptococcal genome sequences from the public databases that were included 
in the analysis here, were derived from clinical bacterial isolates cultivated from 
different human body sites (Table S5.2). Due to frequent obscurity concerning the 
source of isolation it is far from trivial to identify niche-specific OG. Nonetheless, 197 
OG, mostly belonging to ‘metabolism’, were found to be present in at least two of the 
small-intestinal Streptococcus genomes, but not in any of the genomes from the 
public databases. Notably, a considerable fraction of these 197 small-intestine 
specific OG (65; 33.0%) could not be assigned to a COG, and were predominantly 
annotated as hypothetical proteins (44; Figure 5.2). This suggests that for a 
substantial amount of small-intestinal niche-specific streptococcal OG, the function 
needs to be further elucidated (Figure 5.2). 
 
Phylogenetic analysis of Streptococcus genomes 
The subset of genes of the core Streptococcus genome (450) that were present in 
single copy in each genome was used to construct a phylogenetic tree (Figure 5.3). 
This core-genome-based phylogeny revealed a division of 5 distinct clusters of 
Streptococcus strains that belong to the Streptococcus species groups: Pyogenic 
(e.g. S. pyogenes), S. bovis, S. mutans, S. salivarius, and S. mitis groups. S. suis 
genomes could not be assigned to one of these Streptococcus species-groups (65), 
but represented an additional and separate phylogenetic branch (Figure 5.3). 
Notably, 5-140 orthologous groups were exclusively present in all genomes 
belonging to one of the clusters (cluster-specific genes) and might be used as 
cluster-markers for molecular detection and quantification (Table S5.4). The small-
intestinal Streptococcus genomes clustered within the S. mitis, S. bovis, and S. 
salivarius groups, corroborating previous classifications based on 16S rRNA gene 
analysis ((340); Chapter 4).  
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Moreover, the distance between the strains from S. salivarius lineage 1 and 4 was 
relatively small (Figure 5.3), which is in agreement with similarity of fermentation and 
growth ((340); Chapter 4) as well as the immunostimulatory profiles (Chapter 6) that 
were determined for these strains. To further assess the similarity between S. 
salivarius lineage 1 and 4, the number of shared genes was determined. This 
revealed that both lineages shared 1730 OG, which is high compared to the number 
of shared genes between the two other S. salivarius lineages (Table S5.5). 
Nonetheless, S. salivarius lineage 1 and 4 were still predicted to have 128 and 237 
strain-specific OG, respectively. The set of 128 lineage 1 specific OGs were manually 
inspected for potential sequencing and / or gene-calling artifacts (see table S5.6). 
These genome sequence analyses confirmed that the representative isolates of S. 
salivarius lineages 1 and 4 are closely related, and confirmed and extended our 
previous observations based on AFLP and Rep-PCR fingerprinting ((340); Chapter 
4). 
 
Genomic mining to decipher environmental interaction potential 
To obtain an impression how the analysed Streptococcus strains may react to 
external stimuli, we mined their genomes for the canonical two-component system 
(TCS) regulatory modules, consisting of a HK and a RR, that are known to play a 
prominent role in bacterial interaction with their environment (307). The strains 
appeared to encode 12-18 HPK/RR) pairs, which are predicted to respond to a wide 
variety of environmental responses (Table S5.7). TCS annotated as CiaRH, ComDE, 
VraSR, and CsrSR were identified in all strains.  
The CiaRH system responds to environmental Ca2+ (103) and has been shown to be 
important for intracellular survival of group B Streptococcus (263). It has been shown 
that this system is involved in regulation of numerous functions in S. pneumoniae, 
including those associated with natural competence, which is a driver of evolution 
(126, 225). Analogously, the comCDE encoded TCS (ComDE), present in the S. mitis 
group species (126), has been shown to be the central regulatory module in the 
control of natural competence, involving a comC encoded extracellular competence 
stimulatory peptide (CSP) as its autoregulatory environmental cue (224). The small 
intestinal S. mitis strain appeared to encode two candidate comDE TCS, but a 
putative CSP encoding comC gene upstream of comDE could not be identified. The 
S. bovis and S. salivarius strains from the small-intestine were found to encode a 
distinct competence regulatory module consisting of a transcriptional regulator and a 
putative oligopeptide pheromone, that share similarity with ComR and ComS (97, 
126) and are genetically linked to conserved comX promoter structures (225). The 
oligopeptide predicted for the S. bovis strain (MKVFSILLTGWWLG) contains the 
conserved double-tryptophan (WW) motif, which is a conserved feature of ComS 
from bovis streptococci (225). 
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Figure 5.3. Streptococcus phylogenetic tree. Unrooted maximum-likelihood phylogenetic tree 
based on multiple protein sequence alignments (length 5605 residues) of the 450 orthologous groups 
with exactly one member in 64 Streptococcus genomes. Small-intestinal Streptococcus strains are 
highlighted and bulleted.  
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The oligopeptides predicted for the strains from S. salivarius lineage 1 and 4 are 
identical (MKKLKLFTLFSLLITILPYFAGCL) and resemble that of S. salivarius SK126 
(97, 225), albeit that the lineage 1 representing strain appears to contain a frameshift 
in the region encoding the N-terminal end of the oligopeptide. The oligopeptides 
predicted for the salivarius strains from lineage 2 and 3 are also identical, but are 
distinct (MKNLRKFLVLLIAAAPFFIIYY) from the sequence presented above. It is 
likely that competence could be induced in these strains via extracellular addition of 
the unmodified small peptides, especially since all genomes presented here appear 
to encode a complete competence regulon including genes encoding a competence 
specific sigma factor ComX, and late competence complexes (e.g. comEA/C, and 
comGA/B/C/D/E/F/G), which are involved in DNA uptake and DNA processing (see 
(126) for review).  
The genomes of all the small-intestinal Streptococcus strains described here, 
appeared to encode a TCS that resembles the NisK-NisR and/or SpaK-SpaR TCS 
modules involved in quorum-sensing controlled autoregulation of nisin and subtilin 
biosynthesis in Lactococcus lactis and Bacillus subtilis, respectively (for a review see 
(174)). Both nisin and subtilin are antimicrobial peptides (bacteriocins) that contain 
extensive post-translational modification and belong to the class of the lantibiotics 
(for a review see (342)) and their biosynthesis depends on multi-gene clusters 
encoding modification, export, immunity, and the mentioned TCS functions (174). To 
investigate whether the identified streptococcal homologues of these lantibiotic TCS 
may be involved in regulation of lantibiotic production by these strains, the genetic 
context of the TCS encoding genes was investigated. However, this analysis failed to 
identify additional genes that were predicted to be involved in lantibiotic biosynthesis 
in these organisms. To perform a genome wide analysis of the capacity to produce 
antimicrobial peptides, we employed the BAGEL2 software module (62) that 
identified at least one putative bacteriocin encoding gene in the genomes of the S. 
bovis and S. salivarius strains. All candidate genes belonged to the non-lanthionine-
containing bacteriocins of the pediocin-like (class IIA) and/or miscellaneous (class 
IID) class according to the scheme proposed by Cotter, et al. (59) (Table S5.8). This 
analysis indicates that despite their resemblance to NisRK-like TCS modules, these 
TCS systems are not involved in regulation of genetically linked or distantly located 
lantibiotic encoding gene clusters, and are thus most likely involved in regulation of 
other functions.  
All Streptococcus strains analysed here appeared to encode the CsrSR system, 
although S. mitis appeared to lack a HK paired to the RR similar to CsrR. The CsrSR 
TCS module is known to play a major role in regulating the virulence of group A and 
B streptococci (191, 325). Group A streptococcal CsrSR regulates the expression of 
virulence factors (e.g. pyrogenic exotoxin A, DNase, streptolysin O, streptokinase, 
and hyaluronic acid capsule synthesis) depending on environmental Mg2+, as well as 
human antimicrobial peptide LL-37 concentrations (325). The CsrSR TCS in group B 
streptococci is known to repress the expression of certain genes (e.g. coding for β-
haemolysin and secreted adhesins) while it stimulates expression of other genes 
(e.g. the cps operon coding for capsular polysaccharide (191)). All newly sequenced 
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Streptococcus genomes were predicted to encode genes with similarity to hemolysin 
III. However, only the S. mitis and S. bovis strains displayed partial (α) hemolysis and 
none displayed complete (β) hemolysis of blood cells when grown on blood agar 
(data not shown). Except for the S. bovis genome, the other streptococcal genomes 
were predicted to encode capsular polysaccharide biosynthesis. All S. salivarius 
strains appeared to encode a gene similar to exfoliative exotoxin B, and the strains 
representing S. salivarius lineage 1 and 4 also contained a gene with homology to 
the C5a peptidase precursor. The latter enzyme inactivates C5a, a chemotactic 
attractant of phagocytes to infection sites, and promotes streptococcal invasion (45, 
360). Although the strains described here are not known to be virulent, they appear 
to encode at least remnants of the virulence genes known in related streptococci, 
which may be regulated by the conserved CsrSR TCS module, analogous to what is 
observed for group A and B streptococci. Remnants of virulence related genes were 
also encountered in the genomes of strains of S. themophilus (28), suggesting that 
these benign streptococci share specific functions with their known pathogenic 
relatives. 
The VraSR TCS that appeared to be encoded by all streptococcal genomes reported 
here, has been extensively studied in Staphylococcus aureus where it belongs to the 
cell-wall-stress stimulon that is involved in maintenance of cell wall integrity under 
stress conditions (334). In S. aureus VraSR plays an important role in regulation of 
resistance to antibiotics that target the bacterial cell wall biosynthesis pathway. 
Whether the VraSR homologues in the small-intestinal streptococci play a similar role 
in cell-wall stress and possible antibiotic resistance control remains to be established. 
 
Amino acid and vitamin requirements 
The predicted enzyme functions of the newly sequenced Streptococcus genomes 
were mapped onto KEGG pathways to assess their predicted potential for amino acid 
biosynthesis. Each of the genomes was predicted to encode biosynthesis pathways 
for at least 18 amino acids (Table 5.1; Figure S5.1). However, none of the strains 
found to encode the enzymes required to synthesize lysine. Moreover, the 
biosynthesis of histidine from the pentose phosphate pathway intermediate 
phosphoribosyl pyrophosphate (PRPP) appears to be incomplete in the genomes of 
the S. salivarius strains representing lineage 2 and 3, as well as the S. mitis strain. 
Alanine biosynthesis appeared to depend on distinct enzymatic conversion of 
pyruvate to alanine, involving alanine transaminase dehydrogenase (EC 2.6.1.2) in 
the S. bovis strain and the S. salivarius strain representing lineage 3, while involving 
an alanine dehydrogenase (EC 1.4.1.1) in all other strains (Figure S5.1). 
Although the small-intestinal streptococci encode the capacity for synthesis of the 
majority of the amino acids, they also were predicted to encode the oligopeptide 
import system, oppABCDF (70), but lacked a gene resembling an extracellular 
protease function (e.g. PrtP; (187)). These findings may reflect the adaptation to the 
peptide and exogenous protease-rich environment that is probably encountered in 
the human small intestine.  
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Table 5.1. Predicted amino acid requirements for growth of newly sequenced Streptococcus 
strains 
Amino acid S. mitis S. bovis 
S. salivarius 
1 2 3 4 
Arginine + + + + + + 
Histidine - + + - - + 
Lysine - - - - - - 
Aspartate + + + + + + 
Glutamate + + + + + + 
Serine + + + + + + 
Threonine + + + + + + 
Asparagine + + + + + + 
Glutamine + + + + + + 
Cysteine + + + + + + 
Glycine + + + + + + 
Proline + + + + + + 
Alanine + + + + + + 
Valine + + + + + + 
Isoleucine + + + + + + 
Leucine + + + + + + 
Methionine + + + + + + 
Phenylalanine + + + + + + 
Tyrosine + + + + + + 
Tryptophan + + + + + + 
Black: required for growth; White: not required for growth 
 
Next we investigated the predicted capacity to produce B-vitamins, which is known to 
be variable among streptococci (273). Genome analyses indicate that all small-
intestine derived streptococci presented here encode the capacity to produce folate 
from phenylalanine. All strains, except S. mitis, also appeared to encode a complete 
pyridoxal-5-phosphate (B6) biosynthetic pathway. In addition, S. bovis was predicted 
to also encode the capacity to synthesize riboflavin (B2), nicotinate (B3), and 
pantothenate (B5), which appear to be lacking in S. mitis and S. salivarius. None of 
the strains is predicted to encode thiamine (B1), biotin (B8) and cobalamin (B12) 
biosynthesis pathways. 
 
Primary carbon metabolism and pyruvate dissipation 
As streptococci belong to the facultative heterofermentative LAB and generate 
energy through homolactic and mixed acid fermentation (163), we screened the 
genomes of the small-intestinal streptococci for genes involved in glycolysis and the 
pentose phosphate pathway. All strains encoded the required enzymes for glycolytic 
conversion of glucose to pyruvate (Table S5.9). Notably, only the S. mitis strain 
appeared to encode a complete and intact pentose phosphate pathway. However, 
the S. bovis and S. salivarius strains, appeared to code for a transketolase (EC 
2.2.1.1) that interconnects the glycolysis and the pentose phosphate pathway, 
enabling the synthesis of the precursor required in de novo purine and pyrimidine 
synthesis, phosphoribosyl pyrophosphate (PRPP; Figure S5.2). In addition, the S. 
bovis strain, codes for a putative xylulose-5-phosphate phosphoketolase (EC 4.1.2.9; 
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Table S5.9 and figure S5.2), suggesting that this strain can ferment pentoses (e.g. 
arabinose ((340); Chapter 4); see below) that enter the pentose phosphate pathway 
as xylulose-5-phosphate. As expected, genomic analyses showed that none of the 
small-intestinal streptococci code for a complete tricarboxylic acid (TCA) cycle, albeit 
that several enzymes (e.g. EC 1.3.99.1, Fumarate reductase) from this pathway are 
predicted in the genome annotations. The presence of fumarate reductase in the 
genomes may indicate that these streptococci possess a rudimentary electron 
transport chain, similar to what is observed for other LAB, including L. plantarum 
WCFS1 (175).  
As expected, all the small-intestinal Streptococcus genomes have the necessary 
enzymes to convert pyruvate to L-lactate (lactate dehydrogenase [EC 1.1.1.27]). 
Although the genomes appeared to lack the genes to produce a complete pyruvate 
dehydrogenase complex, they do encode the necessary enzymes for mixed acid 
fermentation via the formate lyase (EC 2.3.1.54), phosphate acetyltransferase (EC 
2.3.1.8), and acetate kinase (EC 2.7.2.1) pathway. In addition, the genomes also 
encompass acetaldehyde dehydrogenase (EC 1.2.1.10) and alcohol dehydrogenase 
(EC 1.1.1.1) encoding genes, implying their capacity to produce ethanol (Figure 
S5.2). Finally, all streptococci appeared to encode both acetolactate synthase (EC 
2.2.1.6) and acetolactate decarboxylase (EC 4.1.1.5) that could catalyze the 
conversion of pyruvate to acetoin. 
 
Sugar metabolism 
Streptococcus spp. have been proposed to contribute to microbial uptake and 
fermentation of the simple dietary carbohydrates in the small intestine (381). 
Therefore, we especially focused our genome annotation efforts on the strain-specific 
predictions of carbohydrate transport functions and metabolism that can be used as 
fuel for the downstream energy-generating pathways (e.g. glycolysis and pentose 
phosphate pathway). All small-intestinal strains encode the general cytoplasmic 
enzyme I (EI) and phosphor-carrier protein (HPr; Figure 5.4) involved in phospho-
donation to several PTS transport systems. In total, 11 distinct PTS transporter 
functions were found to be encoded by the small-intestinal Streptococcus genomes. 
Those with predicted specificities for glucose/maltose, mannose, fructose, sucrose, 
β-glucosides, and trehalose were redundantly present in some of the genomes 
(Figure 5.4). 
All sequenced genomes were predicted to encode complete enzyme II (EII) PTS 
complexes, consisting of IIa, IIb, and IIc (as well as IId in some cases) components, 
involved in import of glucose/maltose, mannose, fructose, and sucrose (Figure 5.4).  
Complete PTS with predicted specificity for cellobiose, β-glucosides, and trehalose 
appeared to be encoded in the S. bovis genome, while the PTS-mediated import 
capacity for the latter two substrates was also predicted for the lineage 1 and 4 
representing S. salivarius isolates. 
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Figure 5.4. Overview of PTS in six sequenced genomes from small-intestinal Streptococcus 
strains. Dots indicate for which genome the corresponding PTS (component) was encoded. Numbers 
in dots represent the number of times a complete PTS complex was encoded in the genome. Squared 
dots indicate which isolates were able to ferment the corresponding substrate, double squared dots 
indicate which isolates were able to ferment and grow on the corresponding substrate ((340); Chapter 
4). Components of PTS that are encoded by the same orthologous group are indicated with faded 
purple lines 
a: S. mitis and S. salivarius lineage 1 carried an additional phosphocarrier protein (Hpr), each 
belonging to different orthologous compared to the Hpr protein that belonged to the same OG that was 
shared between all Streptococcus 
b: complete PTS were encoded by genes belonging to different OG 
c: Component EIIa and EIIb from 2 complete cellobiose specific PTS were encoded by genes 
belonging to the same OG while component EIIc of the two systems belonged to different OG. 
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Next to these complete PTS EII complexes, all genomes also appeared to encode 
orphan PTS EIIc transport component(s), which lack the accompanying EIIb and EIIa 
encoding genes, and in all cases were predicted to have a cellobiose substrate-
specificity. This is a feature that has been recognized in many other bacterial 
genomes, and has been proposed to play a role in environmental signalling (107, 
175, 182, 297). The S. mitis and S. bovis genomes are predicted to encode β–
glucosidases (EC 3.2.1.21) that are required for the conversion of cellobiose to β–D–
glucose (figure S5.2). However, only S. bovis is able to ferment cellobiose ((340); 
Chapter 4), which appears to be in agreement with the presence of genes encoding a 
complete cellobiose PTS, which was exclusively encountered in the S. bovis genome 
(Figure 5.4). 
These genome-based predictions are in good agreement with the differential 
carbohydrate-fermentation and growth patterns that were previously determined 
((340); Chapter 4). However, all S. salivarius genomes lack the PTS for lactose, while 
all strains were able to ferment this substrate ((340); Chapter 4). It is known that S. 
salivarius, and its close relative S. thermophilus, can effectively ferment lactose and 
import this substrate by a dedicated lactose permease (LacS) that belongs to the 
galactoside-pentose-hexuronide translocator family (150, 204). Indeed, all S. 
salivarius, and S. bovis genomes presented here appeared to encode a lacS 
homologue. The S. mitis strain also encode a complete PTS EII complex predicted to 
be involved in import of galactose and galactosamine. To metabolize lactose and its 
galactose moiety, S. mitis and S. bovis encode the tagatose phosphate and/or Leloir 
pathways (350). The S. salivarius lineages, lacking the PTS for lactose, relied on the 
latter pathway for metabolism of these substrates (Figure S5.2). 
All sequenced genomes encode maltose/maltodextrin ABC transporters, while S. 
mitis and S. bovis also appear to encode ABC transporters for multiple sugars (the 
so-called MSM system). These transporters have been previously described for S. 
mutans and can import multiple sugars, including raffinose and melibiose (281).  
Notably, the S. mitis and S. bovis strains, also encode the downstream enzymes 
required for raffinose and melibiose metabolism. Finally, the S. bovis genome also 
contained genes encoding an “α-arabinosides ABC transport permease (araP)” as 
well as the necessary enzymes to metabolize this sugar. These findings are in 
excellent agreement with the observation that only S. bovis was able to grow on 
arabinose, while only S. mitis and S. bovis could ferment melibiose and grow on 
raffinose ((340); Chapter 4). 
Though all Streptococcus strains encoded at least one α-amylase, S. bovis could 
grow on media with starch as the sole carbohydrate source ((340); Chapter 4). 
However, this could be explained by the predicted subcellular location of the α-
amylase enzymes. The enzymes encoded by S. mitis and S. salivarius genomes 
were all predicted to be cytoplasmic, while only the S. bovis strain appeared to 
encode an excreted α-amylase (as well as a cytoplasmic one). Thereby, it seems 
likely that only S. bovis can access extracellular starch as a substrate for growth, 
whereas S. mitis and the S. salivarius strains may use intracellular polysaccharides 
(IPS) for energy-storage. The latter is supported by the fact the S. mitis and S. 
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salivarius strains encoded three key enzymes required for IPS synthesis, namely 
glycogen synthase (EC 2.4.1.21), glucose-1-phosphate adenylyltransferase (EC 
2.7.7.27), and branching enzyme (EC 2.4.1.18) (36). However, to the best of our 
knowledge there is no experimental evidence to support the capacity for IPS 
synthesis in any of the streptococcal species studied here, which may suggest that 
this only occurs under specific circumstances that were not studied to date.  
Since the observed physiological characteristics of the Streptococcus strains are in 
excellent agreement with genome predictions ((340); Chapter 4), the small-intestinal 
Streptococcus genomes are helpful to predict the effect of dietary changes on the 
Streptococcus populations in the small intestine. 
 
Detection of small-intestinal streptococcal strains and lineages 
To monitor the dynamics of the small-intestinal Streptococcus populations during 
dietary intervention studies, fast and high throughput, PCR-based detection assays 
were developed to target small-intestinal Streptococcus strain-specific or lineage-
specific genes. 
To evaluate the specificity and conservation of the genes selected for strain-specific 
detection among the representative isolates that belong to the different streptococcal 
lineages, they were amplified from 92 Streptococcus isolates and 28 Enterococcus 
isolates as negative control ((340); Chapter 4). The PCR amplicons robustly 
discriminated the 92 Streptococcus isolates into 3 S. mitis isolates, 13 S. bovis 
isolates, 1 S. salivarius lineage 2 isolate, and 8 S. salivarius lineage 3 isolates, 
thereby perfectly matching with their grouping according to AFLP and Rep-PCR 
(Table 5.2 and S5.10; (340); Chapter 4).  
 
Table 5.2. Number of positive PCR amplifications of bacterial isolates with Streptococcus 
lineage specific primers  
Grouping 
S. mitis S. bovis 
S. salivarius 
Enterococcus
1 2 3 4 
AFLP and Rep-PCR analysis* 3 13 1 1 8 66 28 
PC
R
 a
ss
ay
 S. mitis 3 - - - - - - 
S. bovis - 13 - - - - - 
S. salivarius 1 - - 1 - -  56 - 
S. salivarius 2 - - - 1 - - - 
S. salivarius 3 - - - - 8 - - 
S. salivarius 4 - - 1 - - 66 - 
*: Results from grouping according to AFLP and Rep-PCR ((340); Chapter 4) 
 
These results showed that among representative strains of the identified lineages, 
the selected gene is conserved and specific for the isolates of that lineage. In 
contrast, the primers designed to selectively amplify S. salivarius strain 1 and 4, 
failed to consistently discriminate between isolates of these two lineages, albeit that 
not every bacterial isolate belonging to S. salivarius lineage 4 revealed a PCR 
product with primers for S. salivarius lineage 1. Nonetheless, these results confirm 
the close relatedness of these lineages, which was already apparent from the 
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identical Rep-PCR profiles they generated (see above; (340); Chapter 4). The 
Streptococcus PCR assays developed here provide a simple and effective means to 
detect the small-intestinal S. mitis, S. bovis, and S. salivarius lineages 2, 3 and the 
group of S. salivarius lineage 1 and 4.  
All six Streptococcus strains from the small intestine were cultivated from a single 
ileostoma effluent sample. Therefore, the PCR assays were further evaluated with 
total DNA from 30 ileostoma effluent samples obtained from 6 ileostomists, 4 ileal 
fluid samples from 3 healthy individuals, and fecal samples from 10 healthy 
individuals to investigate the distribution of these genetic targets beyond the 
ileostomist they were derived from. As anticipated, the selected genes from all 
sequenced Streptococcus genomes were amplified in other ileostoma effluent 
samples collected from the ileostomist from which the strains were isolated (Subject 
A; Table 5.3). However, the S. bovis specific amplicon could only be detected in a 
single ileostoma effluent sample (Subject A) and in several fecal samples (Table 5.3). 
The S. mitis specific amplicon was exclusively detected in ileostoma samples, which 
were obtained from subject A and subject B. The latter samples were collected on 
two consecutive days, while additional samples that were collected from the same 
individual 5 years later did not allow the detection of this genetic marker. Considering 
that the mitis and, to a lesser extent, bovis group streptococci belong to the 
predominant streptococci in the small intestine in these samples ((340); Chapter 4), 
these findings imply that the small-intestinal microbiota in other individuals is 
encompassing other S. mitis and S. bovis lineages as compared to the strain 
targeted here. In contrast, the unique genes from at least 2 S. salivarius lineages 
(mostly lineage 2 and 4) were detected in all but one ileostoma effluent sample, all 
ileal fluid samples as well as several fecal samples obtained from other individuals 
(Table 5.3). These findings suggest that the S. salivarius lineages are highly 
conserved in the small intestine and, to a lesser extent in the terminal part of the 
gastrointestinal tract, among the different subjects. 
 
Discussion 
 
In this study, the genomes of six small-intestinal Streptococcus isolates were 
determined by next generation sequencing technologies and were compared with 
Streptococcus genomes from the public databases.  
Phylogenetic analysis of the small-intestinal Streptococcus genomes placed one 
strain into the S. mitis species group, one strain into the S. bovis species group, and 
four into the S. salivarius species group, matching species identifications that were 
previously based on the 16S rRNA gene sequence alone ((340); Chapter 4). The 
genomes of two of the S. salivarius strains (lineage 1 and 4) were highly similar, 
which was expected based on their highly similar genetic typing profiles and their 
conserved physiological characteristics ((340); Chapter 4). 
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Table 5.3. Detection of S. mitis, S. bovis and S. salivarius genetic targets in intestinal samples 
Subject Year Day Time of 
sampling S. mitis S. bovis 
S. salivarius 
1 2 3 4 
Ileostoma 
effluent 
A* 
1 
1 
Mrn       
Aft       
4 
Mrn       
Aft       
7 
Mrn       
Aft       
9 
Mrn       
Aft       
6 
1 Aft       
3 
Mrn       
Aft       
B 
1 
1 Aft       
2 Aft       
6 
1 Mrn       
3 
Mrn       
Aft       
C 
1 
1 Aft       
2 Aft       
6 
1 
Mrn       
Aft       
3 
Mrn       
Aft       
D 1 
1 Aft       
2 Aft       
E 
1 
 
1 Aft       
2 Aft       
F 6 
1 
Mrn       
Aft       
3 
Mrn       
Aft       
Small intestinal 
 fluid 
G (ileum) - - -       
H (jejunum) - - -       
H (ileum) - - -       
I (ileum) - - -      
Fecal 
sample 
J - - -   ND    
K - - -   ND    
L - - -   ND    
M - - -   ND    
N - - -   ND    
O - - -   ND    
P - - -   ND    
Q - - -   ND    
R - - -   ND    
S - - -   ND    
*: Ileostomist from which sequenced Streptococcus strains were obtained 
Mrn: Morning; Aft: Afternoon 
ND: Not determined 
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The Streptococcus pangenome consisted of 12,403 orthologous DNA sequences, 
which is double the size predicted by Lefébure and Stanhope based on 26 
Streptococcus finished and whole genome shotgun genomes (197). However, this 
genome set was represented by 6 species while the current study included as many 
as 20 different species. The core Streptococcus genome was defined here as a set 
of 574 OG shared by all Streptococcus genomes, which is in line with earlier 
predictions (197). Analysis of the core Streptococcus OG revealed that the function 
of most genes was well defined and belonged to typically conserved cellular 
processes like transcription, translation and replication. Nonetheless, a significant 
portion of core orthologous groups were involved in metabolism, especially transport 
and metabolism of nucleotides and carbohydrates. Likewise, a group of 197 OG only 
common among the streptococci analysed here was mostly involved in metabolism 
and may contain streptococcal genes that contribute specifically to the lifestyle of 
these bacteria in the (human small) intestine. 
Mining of the genomes revealed that the small-intestinal streptococci coded for two-
component regulatory modules, such as those involved in natural competence. Since 
natural competence is a mediator for evolution and genomic plasticity (126), we 
focused on functions that play an important role in this system. We found gene 
repertoires that imply that the competence regulon in each of the streptococcal 
genomes analysed here is complete, which implies that these small-intestinal 
streptococci may become naturally transformable under specific conditions, which 
could contribute to the high genetic diversity of the streptococcal community in the 
small intestine ecosystem ((340); Chapter 4). 
The small-intestinal Streptococcus strains had a predicted capacity to synthesize a 
large number of amino acids, and were expected to have capabilities to produce B-
vitamins. As expected, all streptococci analysed here coded for a complete glycolytic 
pathway and an intact or part of the pentose phosphate pathway for energy 
generation, yielding lactate, acetate, formate, and possibly acetoin as fermentation 
products. However, the strains differed considerably in their predicted capacity to 
transport and metabolize specific sugars. The Streptococcus genomes encoded for a 
complement of 11 different complete PTS, which in some cases were present in 
multiple copies in a single strain. This indicates that some substrates may be more 
important for certain strains. The S. bovis genome encoded for 9 different PTS, which 
was higher compared to the number of PTS encoded by S. mitis (8) and the S. 
salivarius strains (4-6). In addition, this strain was also the only sequenced small-
intestinal strain that appeared to encode transporters for arabinose and extracellular 
amylases for the degradation of starch. Nevertheless, the number of PTS was 
relatively low compared to a closely related strain S. gallolyticus UCN34, which 
encodes 25 PTS (280).  
While the S. bovis strain encoded for extra- and intracellular α-amylases, the S. mitis 
and S. salivarius strain were found to only code for those that remain intracellular, 
which have been postulated to play a role in breakdown of IPS (361). However, 
investigations into α-amylase of S. mutans revealed that intracellular α-amylase was 
not essential for breakdown of IPS and dextrins from starch digested by exogenous 
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α-amylase (299). Therefore, the role of intracellular α-amylases remains to be 
elucidated.  
The encoded carbohydrate transporters, and the reconstructions of the metabolic 
pathways based on genome analysis were in excellent agreement with physiological 
characteristics that were determined previously ((340); Chapter 4). The variation 
between their metabolic capacities may explain why they coexist in a harsh and 
fluctuating environment such as the small intestine. It also suggests that the small-
intestinal genomes can accurately predict the carbohydrate utilization capacities of 
these bacterial strains. This may be of value in studies determining the effect of food 
components on the small-intestinal microbiota in situ with a special focus on these 
Streptococcus populations. 
One prerequisite to this concept is to detect the Streptococcus lineages, using for 
example unique genes as genetic markers, in intestinal samples. To this end, PCR-
based screening assays were designed for each of the small-intestinal streptococci 
and tested with 92 Streptococcus isolates. These assays correctly amplified isolates 
belonging to the same lineage as their target Streptococcus strain, based on strain-
level groupings as was done with AFLP and Rep-PCR analysis ((340); Chapter 4). 
Although primer assays for S. salivarius lineage 1 and 4 isolates were developed 
using strain specific genes and employing strict primer design parameters to ensure 
primer specificity, both primer sets showed cross-reaction with isolates belonging to 
the non-target S. salivarius lineage. Determining the exact causes for this is not trivial 
and are likely related to the causes that potentially account for the inaccurate 
estimation of strain-specific genes (Table S5.6). Nonetheless, the Streptococcus 
PCR assays developed here provide a simple and rapid method for the screening of 
large numbers of samples from, for example, dietary intervention studies, for the 
unique genes of the small-intestinal S. mitis, S. bovis, and S. salivarius strains or 
lineages. 
Application of the assays on 34 intestinal and 10 fecal samples collected from 19 
human individuals revealed that at least two S. salivarius lineages were present in 
almost all small-intestinal samples and several fecal samples, indicating that these 
strains are ubiquitously present and represent an important population of, in 
particular, the small-intestinal microbiota. Only one ileostoma effluent sample showed 
no amplification within any of the assays. However, the Streptococcus population in 
this sample is most likely represented by one or more Streptococcus strains that do 
not carry the unique genes targeted by PCR-based detection assays. 
In conclusion, the work presented here describes a comparative genomics study of 
Streptococcus spp. that focused on strains from the human small intestine. 
Comparative genomic analysis revealed that the small-intestinal strains differed in 
their predicted transport and metabolism of sugars, which was in agreement with 
physiological data. Therefore, the small-intestinal Streptococcus genomes are useful 
to construct metabolic models to predict the effect of different dietary substances on 
Streptococcus populations dynamics in the human small intestine. Furthermore, 
assays designed for detection of two S. salivarius strains were positive for most of 
the small-intestinal samples from different individuals, suggesting that strains, 
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carrying the target functional gene, represent an important population of the small-
intestinal ecosystem. 
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Table S5.2. Characteristics of finished Streptococcus genomes* 
Accession Organism Goldcard Isolation site Host Comments 
NC_002737 Streptococcus pyogenes 
M1 GAS 
Gc00049 Patient with a wound infection Homo 
sapiens 
 
NC_003028 Streptococcus 
pneumoniae TIGR4 
Gc00058 Blood of a 30 year old male patient 
in Kongsvinger Norway 
Homo 
sapiens 
 
NC_003098 Streptococcus 
pneumoniae R6 
Gc00065 - Homo 
sapiens 
 
NC_003485 Streptococcus pyogenes 
MGAS8232 
Gc00081 throat swab from patient with acute 
rheumatic fever 
Homo 
sapiens 
 
NC_004070 Streptococcus pyogenes 
MGAS315 
Gc00094 patient with streptococcal toxic 
shock syndrome 
Homo 
sapiens 
 
NC_004116 Streptococcus agalactiae 
2603V/R 
GC00098 clinical isolate Homo 
sapiens 
 
NC_004350 Streptococcus mutans 
UA159 
GC00109 Child with active dental caries in 
1982 
Homo 
sapiens 
 
NC_004368 Streptococcus agalactiae 
NEM316 
Gc00100 Case of fatal septicemia Homo 
sapiens 
 
NC_004606 Streptococcus pyogenes 
SSI-1 
Gc00137 Toxic-shock patient in Japan Homo 
sapiens 
 
NC_006086 Streptococcus pyogenes 
MGAS10394 
Gc00205 pharyngeal swab from child, during 
a study of the epidemiology of 
pharyngitis in a private elementary 
school 
Homo 
sapiens 
 
NC_006448 Streptococcus 
thermophilus LMG 18311 
Gc00234 Commercial yogurt in 1974 in the 
United Kingdom 
-  
NC_006449 Streptococcus 
thermophilus CNRZ1066 
Gc00233 Isolated from yogurt in France -  
NC_007296 Streptococcus pyogenes 
MGAS6180 
Gc00284 Invasive disease in Texas in 1998 Homo 
sapiens 
 
NC_007297 Streptococcus pyogenes 
MGAS5005 
Gc00285 Invasive case in Ontario Homo 
sapiens 
 
NC_007432 Streptococcus agalactiae 
A909 
Gc00302 septic human neonate Homo 
sapiens 
 
NC_008021 Streptococcus pyogenes 
MGAS9429 
Gc00379 pharyngeal swab from animal Homo 
sapiens 
swab from 
animal but 
host name 
was still 
homo 
sapiens 
NC_008022 Streptococcus pyogenes 
MGAS10270 
GC00378 pharyngeal swab from child Homo 
sapiens 
 
NC_008023 Streptococcus pyogenes 
MGAS2096 
Gc00377 patient with acute poststreptococcal 
glomerulonephritis 
Homo 
sapiens 
 
NC_008024 Streptococcus pyogenes 
MGAS10750 
Gc00376 human pharyngeal swab from 
patient with pharyngitis 
Homo 
sapiens 
 
NC_008532 Streptococcus 
thermophilus LMD-9 
Gc00451 - -  
NC_008533 Streptococcus 
pneumoniae D39 
Gc00437 - Homo 
sapiens 
 
NC_009009 Streptococcus sanguinis 
SK36 
Gc00509 isolated from human dental plaque Homo 
sapiens 
 
NC_009332 Streptococcus pyogenes 
str. Manfredo 
Gc00455 Patient in the 1950's in Chicago Homo 
sapiens 
 
NC_009442 Streptococcus suis 
05ZYH33 
Gc00546 Chinese virulent strain isolated from 
fatal cases of STSS in 2005 
Homo 
sapiens 
 
NC_009443 Streptococcus suis 
98HAH33 
Gc00547 Chinese virulent strain isolated from 
fatal cases of STSS in 1998 
Homo 
sapiens 
 
NC_009785 Streptococcus gordonii str. 
Challis substr. CH1 
Gc00643 - Homo 
sapiens 
 
NC_010380 Streptococcus 
pneumoniae Hungary19A-
6 
Gc00735 Human ear, Hungary Homo 
sapiens 
 
NC_010582 Streptococcus 
pneumoniae CGSP14 
Gc00765 clinical isolate derived from a child 
with necrotizing pneumonia, 
simultaneously complicated with 
HUS, at Chang Gung Memorial 
Hospital and Children's Hospital, 
Taoyuan, Taiwan. 
Homo 
sapiens 
 
NC_011072 Streptococcus 
pneumoniae G54 
Gc00837 Genova Italy by G. Schito from a 
respiratory sample in 1997 
Homo 
sapiens 
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Table S5.2 (Continued). Characteristics of finished Streptococcus genomes* 
Accession Organism Goldcard Isolation site Host Comments 
NC_011134 Streptococcus equi subsp. 
zooepidemicus 
MGCS10565 
Gc00845 throat of a patient with nephritis 
diagnosed during an epidemic in 
the state of Minas Gerais, Brazil 
Homo 
sapiens 
 
NC_011375 Streptococcus pyogenes 
NZ131 
Gc00871 Patient with acute 
glomerulonephritis and was 
provided by Diana Martin, New 
Zealand Communicable Diseases 
Center, Porirua, New Zealand 
Homo 
sapiens 
 
NC_011900 Streptococcus 
pneumoniae ATCC 
700669 
Gc00940 hospital, Barcelona, Spain Homo 
sapiens 
 
NC_012004 Streptococcus uberis 
0140J 
Gc00948 clinical bovine mastitis case Bovine  
NC_012466 Streptococcus 
pneumoniae JJA 
Gc00973 - Homo 
sapiens 
 
NC_012467 Streptococcus 
pneumoniae P1031 
Gc00972 - Homo 
sapiens 
 
NC_012468 Streptococcus 
pneumoniae 70585 
Gc00969 - Homo 
sapiens 
 
NC_012469 Streptococcus 
pneumoniae Taiwan19F-
14 
Gc00974 cerebrospinal fluid, Taiwan Homo 
sapiens 
 
NC_012470 Streptococcus equi subsp. 
zooepidemicus 
   No 
GOLDCARD 
available, 
genbank 
entry: nasal 
swab taken 
from a healthy 
Thoroughbred 
racehorse 
NC_012471 Streptococcus equi subsp. 
equi 4047 
Gc00971 horse with strangles from New 
Forest, UK 
Horse  
NC_012891 Streptococcus 
dysgalactiae subsp. 
equisimilis GGS_124 
Gc01051 patients with STSS Homo 
sapiens 
 
NC_012924 Streptococcus suis SC84 Gc01063 case of streptococcal toxic shock-
like syndrome in Sichuan Province, 
China in 2005 
Homo 
sapiens 
 
NC_012925 Streptococcus suis P1/7 Gc01061 ante-mortem blood culture from a 
pig dying with meningitis 
Sus 
scrofa, 
Homo 
sapiens 
 
NC_012926 Streptococcus suis BM407 Gc01062 CSF from a human case of 
meningitis in Ho Chi Minh City, 
Vietnam in 2004 
Homo 
sapiens 
 
NC_013798 Streptococcus gallolyticus 
UCN34 
   No 
GOLDCARD 
available 
NC_013853 Streptococcus mitis B6 Gc01214 hospital in Bochum, Germany Homo 
sapiens 
 
NC_013928 Streptococcus mutans 
NN2025 
Gc01074 clinical serotype c strain isolated in 
Japan in 2002 from a patient with 
dental caries 
Homo 
sapiens 
 
NC_014251 Streptococcus 
pneumoniae 
TCH8431/19A 
Gc01351 respiratory tract Homo 
sapiens 
 
NC_014494 Streptococcus 
pneumoniae AP200 
Gc01425 clinical isolate from the 
cerebrospinal fluid of a patient with 
meningitis in Italy in 2003 
Homo 
sapiens 
 
NC_014498 Streptococcus 
pneumoniae 670-6B 
Gc01424 - Homo 
sapiens 
 
NC_015215 Streptococcus gallolyticus 
subsp. gallolyticus ATCC 
BAA-2069 
Gc01837 human blood culture; infective 
endocarditis 
Homo 
sapiens 
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Table S5.2 (Continued). Characteristics of finished Streptococcus genomes* 
Accession Organism Goldcard Isolation site Host Comments 
NC_015291 Streptococcus oralis Uo5 Gc01712 human mouth Homo 
sapiens 
 
NC_015433 Streptococcus suis ST3 Gc01735 - Homo 
sapiens, 
Sus 
scrofa 
 
NC_015558 Streptococcus parauberis 
KCTC 11537 
Gc01743 - -  
NC_015600 Streptococcus 
pasteurianus ATCC 43144 
Gc01797 human blood Homo 
sapiens 
 
NC_015678 Streptococcus 
parasanguinis ATCC 
15912 
Gc01842 human throat Homo 
sapiens 
 
NC_015760 Streptococcus salivarius 
CCHSS3 
Gc01887 Human blood Homo 
sapiens 
 
NC_015875 Streptococcus 
pseudopneumoniae 
IS7493 
Gc01960 sputum of a patient with human 
immunodeficiency virus (HIV) who 
had documented pneumonia 
Homo 
sapiens 
 
NC_016749 Streptococcus 
macedonicus ACA-DC 198 
Gc02096 traditional greek kasseri cheese -  
*: Retrieved from the Genome OnLine database (GOLD; http://genomesonline.org) on February 27th, 
2012 
 
Table S5.3. Primers used is this study 
Primer name* Primer sequence (5'-3') Annotation of target gene 
Expected 
PCR 
product 
HSISM1_486_fwd CGCTGCTTTAGAGGCATCAACCG 
Hypothetical protein 225 
HSISM1_486_rev ACCTGGCGATCAAGCACAGAGT 
HSISB1_163_fwd ACTTTGGTGCGTTATCCTGGTGG Alpha-N- 
arabinofuranosidase 
(EC 3.2.1.55) 
230 
HSISB1_163_rev TCAACTAAATGGCGGGCTTCGTC 
HSISS1_1164_fwd ACTGGTTGTTCTGGCTCCTCTGG 
Hypothetical protein 223 
HSISS1_1164_rev CGGTCGTACCAGATGTACCAGGC
HSISS2_1351_fwd GGTTGGCTTGGTTCTTTACGGGT 
Hypothetical protein 230 
HSISS2_1351_rev GGCTCCAAAGCTCGAATGGTTGC 
HSISS3_521_fwd GCTGAACCAACAAACCTCGCAGA Hypothetical protein; 
possible cell wallprotein, 
WapE 
286 
HSISS3_521_rev TGGCAACCTCTTGGTCGAGTGCT 
HSISS4_733_fwd  GGCTGAACCTGATCCTCCATTCG 
Hypothetical protein 170 
HSISS4_733_rev AACGAGACGAGTCAAAGGGCTTG
*: Target strain_locus tag_fwd/rev 
Fwd: forward primer, rev: reverse primer, HSISM1 represents the small-intestinal Streptococcus 
genome for the S. mitis species group, HSISB1 represents the small-intestinal Streptococcus genome 
for the S. bovis species group, and HSISS1, HSISS2, HSISS3, and HSISS4represents the small-
intestinal Streptococcus genome from lineage 1, 2, 3, and 4, respectively, from the S. salivarius 
species group. 
 
Table S5.4. Cluster specific orthologous groups 
Data file with cluster-specific locus tags for Streptococcus clusters is available upon request. 
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Table S5.5. Number of shared (lower left panel) and unshared (upper right) orthologous genes 
between S. salivarius genomic lineages 1-4 
 Lineage 1 Lineage 2 Lineage 3 Lineage 4 
Lineage 1 1858b 570 311 
433 
263 
237 
128 
Lineage 2 1547
a 
(76) 2117
b 398 487 
397 
547 
Lineage 3 1595
a 
(124) 
1630a 
(159) 2028
b 415 476 
Lineage 4 1730
a 
(259) 
1570a 
(99) 
1552a 
(81) 1967
b 
a: Numbers in brackets indicate number of shared orthologous genes between two strains without 
number of shared genes among all S. salivarius strains (1471) 
b: Total number of orthologous groups per lineage 
 
Table S5.6. Potential causes for inaccurate estimation of strain specific orthologous genes 
between S. salivarius lineage 1 and 4a 
Number of 
genes from 
lineage 1 
Description 
61 
Genes did not have an ortholog, but did contain one or more conserved regions 
potentially encoded by the lineage 4 genome (either as part of non-orthologous 
genes, or in a genomic region not predicted to encode protein, including gene 
fragments introduced by single nucleotide insertion or deletion in linage 4) 
  
42 Genes were N or C-terminal fragments of frameshifts in orthologous 4 lineage genes introduced by single-nucleotide insertions or deletions in lineage 1 
  
12 Genes were very small (<60 amino acid residues) and had not been recognized as ORFs in lineage 4 
  
8 Genes did not have a significantly similar sequence  
  
5 Genes were encoded in genomic regions for which only partial or no sequence data was available in lineage 4b  
a: Causes that may have led to an overestimation of the strain-specific OG prediction were determined 
by manual analyses of strain-specific ortholgous genes of the strain from S. salivarius lineage 1, 
employing OG-protein sequence detection by tblastn (7) in the genome that was predicted to lack the 
orthologous genes (lineage 4).  
b: Prediction based on analysis of conserved gene context of neighboring genes  
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Table S5.7. Number and description of two component systems predicted for small intestinal 
Streptococcus strains. 
 S. mitis S. bovis S. salivarius Comment 1 2 3 4 
Total number 
of two 
component 
systems 
14 13 14 12 18 14 
 
Number of 
orphan two 
component 
systema 
4 0 3 3 1 3 
 
CiaRH x x x x x x See main text 
ComDE x x x x x x See main text 
VraSR x x x x x x See main text 
CsrSR xb x x x x x See main text 
SA14-24 x x x x x x To the best of our knowledge, no function for this TCS has been proposed 
DltR  x x x x x involved in regulating incorporation of D-alanine in lipoteichoic acid (260). 
BlpH x      
Proposed sensor histidine kinase involved in 
regulation of genes with potential bacteriocin-like 
functions (64).  
FasB      x Sensor histidine kinase involved in control of Group A streptococcal virulence factors (183). 
KdpD    x   Sensor histidine kinase that promotes resistance to osmotic, oxidative, and antimicrobial stress (6).  
LevQRST x x     
Four component system that consists of the 
histidine kinase LevS, the response regulator 
LevR, and two putative extracellular sugarbinding 
proteins (LevQ and LevT), controlling 
transcriptional regulation of fruA (373). 
NisKR x x  x   
The chromosomes of S. mitis, S. bovis, and S. 
salivarius lineage 2 were predicted to code HK 
and RR controlling regulation of nisin biosynthesis 
by L. lactis (NisKR; (89, 213)). In addition, the S. 
salivarius strains also coded for TCS that was 
similar to SpaKR, which regulates subtilin 
biosynthesis by Bacillus subtilis (177). Both nisin 
and subtilin are lantibiotics and their gene clusters 
not only code for the nisin and subtilin precursors 
and proteins involved in their post-translational 
modification, but also contain genes involved in 
secretion of the modified precursors and immunity 
(174). However, the chromosomes of the newly 
sequenced Streptococcus strains did not appear 
to code for the complete nisin and subtilin 
biosynthetic gene clusters. These genes may 
have been deleted during evolution, indicating that 
the newly sequenced streptococci do not 
synthesize nisin and/or subtilin, or that the TCSs 
are involved in regulation of different systems. 
SpaKR   x x x x 
VncRS x  x   x 
Two component system playing a role in induction 
of multiple pathways leading to cell death in S. 
pneumonia (246). However, this finding was 
challenged by a study by Haas, et al. showing that 
this TCS was not essential for cell death, so its 
function remains to be further elucidated (119). 
YesMN x      To the best of our knowledge, no function for this TCS has been proposed 
a: TCS component coding for either a sensor histidine kinase or response regulator 
b: orphan response regulator 
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Table S5.8. Candidate bacteriocins identified by BAGEL2 
Strain belonging to 
Streptococcus species 
group 
Locus tag 
Peptide 
size 
(amino 
acids) 
Product Class Score* 
S. mitis 
HSISM1_1402 111 Alkylphosphonate utilization operon proteinPhn A  1150 
HSISM1_2084 105 hypothetical protein  1125 
HSISM1_1626 51 hypothetical protein IA 1100 
S. bovis 
HSISB1_1269 101 Endonuclease III (EC 4.2.99.18)  1150 
HSISB1_1297 116 Phenylalanyl-tRNA synthetase beta chain (EC6.1.1.20)  1125 
HSISB1_1598 53 hypothetical protein IID 6900 
HSISB1_1599 50 hypothetical protein  1125 
S. salivarius 
1 
HSISS1_1504 76 hypothetical protein IIA or IID 6500 
HSISS1_1495 76 Bacteriocin BlpU IIA or IID 6175 
HSISS1_1572 66 hypothetical protein IID 1175 
2 HSISS2_2019  84 pore-forming peptide, putative bacteriocin IIA 10100 HSISS2_2023 76 Bacteriocin BlpU IIA 5100 
3 
HSISS3_415 84 pore-forming peptide, putative bacteriocin IIA or IID 11150 
HSISS3_402 59 hypothetical protein IIA or IID 6175 
HSISS3_920 73 hypothetical protein IID 6125 
HSISS3_416 79 hypothetical protein IIA or IID 6100 
HSISS3_766 73 hypothetical protein IID 5925 
HSISS3_769 53 hypothetical protein  1475 
HSISS3_767 75 hypothetical protein IID 1275 
HSISS3_921 75 hypothetical protein IID 1125 
HSISS3_410 51 hypothetical protein  1100 
HSISS3_923 53 hypothetical protein  1050 
HSISS3_45 183 hypothetical protein  1025 
4 
HSISS4_689 105 Cytidine deaminase (EC 3.5.4.5)  1100 
HSISS4_1985 98 Acetyltransferase (EC 2.3.1.-)  1100 
HSISS4_1831 76 Bacteriocin BlpU IIA 5100 
HSISS4_1840 76 hypothetical protein IIA 5100 
*: Candidates with ≥1800 points are highlighted in grey and are considered ‘putative bacteriocins’ by 
BAGEL2 (62) while a score below this threshold value but with a score of 1000 are considered 
‘interesting candidates’. 
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Table S5.9. Locus tags of enzymes involved in glycolysis and pentose phosphate pathway 
Product EC number 
S. mitis 
(HSISM1) 
S. bovis 
(HSISB1) 
S. salivarius group 
1 
(HSISS1) 
2 
(HSISS2) 
3 
(HSISS3) 
4 
(HSISS4) 
Glucokinasea 2.7.1.2 1367 1465 1788 726 2176 887 
Glucose-6-phosphate 
isomerasea,b 
5.3.1.9 281 1539 311 516 1145 187 
6-phosphofructokinase 1a 2.7.1.11 1443 971 1897 1468 1331 762 
Fructose-bisphosphate 
aldolase class IIa 4.1.2.13 392 443 140 1041 94 331 
glucose-6-phosphate 1-
dehydrogenaseb 1.1.1.49 
1750 
      
6-phosphogluconolactonaseb 3.1.1.31 1690       
6-phosphogluconate 
dehydrogenaseb 1.1.1.44 
1918 
      
ribulose-phosphate 3-
epimeraseb 5.1.3.1 47 
1612 
1613 1603 2154 241 1953 
Xylulose-5-phosphate 
phosphoketolaseb 4.1.2.9 2010 
150 
151     
glyceraldehyde 3-phosphate 
dehydrogenasea,b 1.2.1.12 37 1622 1595 2144 292 1945 
phosphoglycerate kinasea,b 2.7.2.3 35 1623 1624 
1593 
 
2143 
 
293 
 
1943 
 
glyceraldehyde-3-phosphate 
dehydrogenase (NADP) a,b 1.2.1.9  
1346 
 
1810 
 
696 
697 
2201 
2202 
861 
862 
2,3-bisphosphoglycerate-
dependent phosphoglycerate 
mutasea,b 
5.4.2.1 797 1415 1891 1477 1323 769 
enolasea,b 4.2.1.11 1692 2143 1650 428 2044 1033 
pyruvate kinasea,b 2.7.1.40 1444 970 1898 1467 1332 761 
Phosphate acetyltransferaseb 2.3.1.8 1190 943 1241 1771 656 1592 
Acetaldehyde dehydrogenaseb 1.2.1.10 707 
260 
261 
262 
130 1031 1032 
86 
87 323 
Alcohol dehydrogenaseb 1.1.1.1 
2035 
592 
593 
707 
1673 
260 
261 
262 
130 
756 
819 
820 
1031 
1032 
1122 
1123 
848 
1570 
1621 
86 
87 
1123 
323 
478 
a: Enzyme involved in glycolysis 
b: Enzyme involved in pentose phosphate pathway  
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Table S5.10. Comparison of isolate groupings from genetic fingerprinting and results from 
lineage-specific PCRs 
Isolate Genus identification 
Grouping according to AFLP and Rep-
PCR analysis 
Grouping according to strain-specific 
PCR assays 
S. mitis S. bovis S. salivarius S. mitis S. bovis S. salivarius 1 2 3 4 1 2 3 4 
2010_Ileo_MS_Ia Streptococcus     
2010_Ileo_MS_Ib Streptococcus     
2010_Ileo_MS_Ic Streptococcus      
2010_Ileo_MS_Id Streptococcus      
2010_Ileo_MS_Ie Streptococcus     
2010_Ileo_MS_If Streptococcus     
2010_Ileo_MS_IIa Streptococcus     
2010_Ileo_MS_IIb Streptococcus      
2010_Ileo_MS_IIc Streptococcus     
2010_Ileo_MS_IId Streptococcus     
2010_Ileo_MS_IIe Streptococcus     
2010_Ileo_MS_IIf Streptococcus      
2010_Ileo_MS_IIIa Streptococcus      
2010_Ileo_MS_IIIb Streptococcus     
2010_Ileo_MS_IIIc Streptococcus     
2010_Ileo_MS_IIId Streptococcus     
2010_Ileo_MS_IIIe Streptococcus     
2010_Ileo_MS_IIIf Streptococcus     
2010_Ileo_MS_IVa Enterococcus             
2010_Ileo_MS_IVb Enterococcus             
2010_Ileo_MS_IVc Enterococcus             
2010_Ileo_MS_IVd Enterococcus             
2010_Ileo_MS_IVe Enterococcus             
2010_Ileo_MS_IVf Enterococcus             
2010_Ileo_MS_Va Streptococcus            
2010_Ileo_MS_Vb Enterococcus             
2010_Ileo_MS_Vc Streptococcus            
2010_Ileo_MS_Vd Streptococcus            
2010_Ileo_MS_Ve Streptococcus      
2010_Ileo_MS_Vf Streptococcus            
2010_Ileo_MS_VIa Enterococcus             
2010_Ileo_MS_VIb Streptococcus      
2010_Ileo_MS_VIc Streptococcus      
2010_Ileo_MS_VId Streptococcus      
2010_Ileo_MS_VIe Streptococcus            
2010_Ileo_MS_VIf Streptococcus            
2010_Ileo_MS_VIIa Streptococcus            
2010_Ileo_MS_VIIb Streptococcus      
2010_Ileo_MS_VIIc Streptococcus            
2010_Ileo_MS_VIId Enterococcus            
2010_Ileo_MS_VIIe Streptococcus            
2010_Ileo_MS_VIIf Streptococcus      
2010_Ileo_MS_VIIIa Streptococcus     
2010_Ileo_MS_VIIIb Streptococcus     
2010_Ileo_MS_VIIIc Streptococcus     
2010_Ileo_MS_VIIId Streptococcus     
2010_Ileo_MS_VIIIe Streptococcus     
2010_Ileo_MS_VIIIf Streptococcus     
2010_Ileo_MS_IXa Streptococcus     
2010_Ileo_MS_IXb Streptococcus     
2010_Ileo_MS_IXc Streptococcus     
2010_Ileo_MS_IXd Streptococcus     
2010_Ileo_MS_IXe Streptococcus      
2010_Ileo_MS_IXf Streptococcus     
2010_Ileo_MS_Xa Enterococcus             
2010_Ileo_MS_Xb Enterococcus             
2010_Ileo_MS_Xc Enterococcus             
2010_Ileo_MS_Xd Enterococcus             
2010_Ileo_MS_Xe Enterococcus            
2010_Ileo_MS_Xf Streptococcus     
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Table S5.10 (Continued). Comparison of isolate groupings from genetic fingerprinting and 
results from lineage-specific PCRs 
Isolate Genus identification 
Grouping according to AFLP and Rep-
PCR analysis 
Grouping according to strain-specific 
PCR assays 
S. mitis S. bovis S. salivarius S. mitis S. bovis S. salivarius 1 2 3 4 1 2 3 4 
2010_Ileo_MS_XIa Streptococcus     
2010_Ileo_MS_XIb Streptococcus     
2010_Ileo_MS_XIc Streptococcus     
2010_Ileo_MS_XId Streptococcus     
2010_Ileo_MS_XIe Streptococcus      
2010_Ileo_MS_XIf Streptococcus     
2010_Ileo_MS_XIIa Enterococcus             
2010_Ileo_MS_XIIb Enterococcus             
2010_Ileo_MS_XIIc Streptococcus      
2010_Ileo_MS_XIId Streptococcus      
2010_Ileo_MS_XIIe Enterococcus             
2010_Ileo_MS_XIIf Enterococcus             
2010_Ileo_MS_XIIIa Streptococcus     
2010_Ileo_MS_XIIIb Streptococcus     
2010_Ileo_MS_XIIIc Streptococcus     
2010_Ileo_MS_XIIId Streptococcus     
2010_Ileo_MS_XIIIe Streptococcus     
2010_Ileo_MS_XIIIf Streptococcus     
2010_Ileo_MS_XIVa Enterococcus             
2010_Ileo_MS_XIVb Streptococcus      
2010_Ileo_MS_XIVc Enterococcus             
2010_Ileo_MS_XIVd Enterococcus             
2010_Ileo_MS_XIVe Enterococcus             
2010_Ileo_MS_XIVf Streptococcus      
2010_Ileo_MS_XVa Streptococcus      
2010_Ileo_MS_XVb Streptococcus            
2010_Ileo_MS_XVc Streptococcus       
2010_Ileo_MS_XVd Enterococcus             
2010_Ileo_MS_XVe Streptococcus            
2010_Ileo_MS_XVf Streptococcus            
2010_Ileo_MS_XVIa Streptococcus     
2010_Ileo_MS_XVIb Streptococcus     
2010_Ileo_MS_XVIc Streptococcus     
2010_Ileo_MS_XVId Streptococcus     
2010_Ileo_MS_XVIe Streptococcus     
2010_Ileo_MS_XVIf Streptococcus     
2010_Ileo_MS_XVIIa Streptococcus      
2010_Ileo_MS_XVIIb Streptococcus      
2010_Ileo_MS_XVIIc Streptococcus     
2010_Ileo_MS_XVIId Streptococcus     
2010_Ileo_MS_XVIIe Streptococcus      
2010_Ileo_MS_XVIIf Streptococcus     
2010_Ileo_MS_XVIIIa Streptococcus            
2010_Ileo_MS_XVIIIb Enterococcus             
2010_Ileo_MS_XVIIIc Enterococcus             
2010_Ileo_MS_XVIIId Enterococcus             
2010_Ileo_MS_XVIIIe Enterococcus             
2010_Ileo_MS_XVIIIf Enterococcus             
2010_Ileo_MS_XIXa Streptococcus     
2010_Ileo_MS_XIXb Streptococcus     
2010_Ileo_MS_XIXc Streptococcus     
2010_Ileo_MS_XIXd Streptococcus     
2010_Ileo_MS_XIXe Streptococcus     
2010_Ileo_MS_XIXf Streptococcus     
2010_Ileo_MS_XXa Streptococcus     
2010_Ileo_MS_XXb Streptococcus     
2010_Ileo_MS_XXc Streptococcus     
2010_Ileo_MS_XXd Streptococcus     
2010_Ileo_MS_XXe Streptococcus     
2010_Ileo_MS_XXf Streptococcus     
Total number of isolate per 
lineage  3 13 1 1 8 66 3 13 57 1 8 67 
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Abstract 
 
The human small intestine is a key site for interactions between the intestinal 
microbiota and the mucosal immune system. Here we investigated the 
immunomodulatory properties of representative species of commonly dominant 
small-intestinal microbial communities, including six streptococcal strains (four 
Streptococcus salivarius, one S. bovis, one S. mitis) one Veillonella parvula strain, 
one Enterococcus gallinarum strain, and Lactobacillus plantarum WCFS1 as a bench 
mark strain on human monocyte-derived dendritic cells. The different streptococci 
induced varying levels of the cytokines IL-8, TNF-α, and IL-12p70, while the V. 
parvula strain showed a strong capacity to induce IL-6. E. gallinarum strain was a 
potent inducer of cytokines and TLR2/6 signalling. As Streptococcus and Veillonella 
can potentially interact metabolically and frequently co-occur in ecosystems, 
immunomodulation by pair-wise combinations of strains were also tested for their 
combined immunomodulatory properties. Strain combinations induced cytokine 
responses in dendritic cells that differed from what might be expected on the basis of 
the results obtained with the individual strains. A combination of (some) streptococci 
with Veillonella appeared to negate IL-12p70 production, while augmenting IL-8, IL-6, 
IL-10, and TNF-α responses. This suggests that immunomodulation data obtained in 
vitro with individual strains are unlikely to adequately represent immune responses to 
mixtures of gut microbiota communities in vivo. Nevertheless, analysing the immune 
responses of strains representing the dominant species in the intestine may help to 
identify immunomodulatory mechanisms that influence immune homeostasis.  
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Introduction 
 
The human intestine is home to a myriad of different microbial organisms, most of 
which are bacteria (341) and collectively known as microbiota. The intestinal 
microbiota is of particular interest because it plays an essential role in the maturation 
and development of the mucosal immune system in early life (170, 217) and the 
preferential tolerance induction to harmless antigens at mucosal sites (172, 315). The 
contribution of individual microbes to the mechanisms that maintain immune 
homeostasis are just beginning to be understood (154, 241, 341), but their 
importance is highlighted by the disturbances in microbiota composition associated 
with several intestinal-related diseases including obesity, multiple sclerosis, 
inflammatory bowel diseases, and type 1 diabetes (170, 196, 322, 326, 352, 359). 
Research on this topic has been biased towards the analysis of fecal samples that 
only provide information about the microbiota at the end of gastrointestinal (GI) tract 
(159, 194, 329), meaning that, microbial communities in the upper intestinal tract 
have been largely overlooked or ignored (381). This is mainly attributable to the 
limited accessibility of the small intestine (31, 32). Nevertheless, the Peyer’s patches 
(PP) of the small intestine are major sites for sampling of luminal antigens, including 
bacteria, and the induction of adaptive immune responses. Antigen sampling by the 
follicle–associated epithelium (FAE) overlaying the lymphoid follicles of the PP is 
facilitated by the lack of mucin secreting goblet cells and the presence of specialized 
Microfold cells (M cells) (75, 217, 242). Bacteria sampled by M cells in the FAE are 
transported intact to the sub-epithelial dome of PP where dendritic cells (DCs) play a 
key role in bacterial handling and the induction of subsequent immune responses 
(see (55) for a review). Recently, PP dendritic cells were shown to sample bacteria 
and antigens through M cell-specific transcellular pores (199, 200). Additionally, DCs 
have been shown to sample luminal bacteria (and other luminal constituents) directly 
in the lumen by passing protrusions through the paracellular space of the epithelium 
without disrupting epithelial integrity (270). 
While both the human small and large intestinal microbiota encompasses anaerobes 
belonging to the Clostridium clusters, the marked difference between these intestinal 
niches is a microbial composition predominated by facultative anaerobes, including 
the streptococci and Veillonella bacteria in the small intestine ((31, 339, 381); 
Chapter 3). The co-occurrence of these genera may in part depend on their potential 
for metabolic interaction as shown in the oral cavity (84) and previously postulated for 
the small intestine (381). Support for this notion comes from the high expression of 
genes involved primary carbohydrate transport systems by the small intestinal 
streptococci (381), indicating a role for the Streptococcus populations as primary 
fermentors of diet-derived simple sugars in the human small intestine. 
Characterization of small-intestinal bacterial streptococci revealed that the small 
intestine is inhabited by a variety of Streptococcus lineages that belong to the S. 
mitis, S. bovis, and S. salivarius species groups. These lineages displayed 
considerable phenotype variability in terms of carbohydrate utilization capacities 
((340); Chapter 4), which was in excellent agreement with their capacities predicted 
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on basis of their genome sequences (Chapter 5). With the exception of streptococci, 
the lactic acid bacteria are generally present at low abundance in the small intestine 
microbiota (31) (Leimena and Van den Bogert, et al. Unpublished results; Chapter 3), 
but nevertheless display a substantial level of phylogenetic richness in individuals, as 
was the case for members of the genus Enterococcus ((340); Chapter 4). The 
enterococci are common colonizers of the GI tract, but have a less attractive 
reputation because of their pathogenic potential (10). 
Considering the prominent role of DCs in modulation of the small-intestinal immune 
system the aim of the current study was to investigate the immunomodulatory 
properties of different small-intestinal Enterococcus, Streptococcus, and Veillonella 
isolates ((340); Chapter 4), with a special focus on the latter two genera because of 
their predominance in the small-intestinal ecosystem.  
 
Materials and methods 
 
Bacterial strains 
Six Streptococcus strains (with known genome sequences; Chapter 5) and single 
Enterococcus gallinarum HSIEG1 and Veillonella parvula HSIVP1 strains (340), as 
well as the reference strain Lactobacillus plantarum WCFS1 (175) were used in the 
immunoassays (Table 6.1). The streptococcal strains were representative isolates of 
6 distinct phylogenetic lineages, as determined by DNA fingerprinting, and for the 
remainder of the paper will be referred to by their species-group names: S. mitis (1 
strain; HSISM1), S. bovis (1 strain; HSISB1) and S. salivarius (4 strains; HSISS1-4; 
Table 6.1; (340); Chapter 4). The streptococcal and Enterococcus strains were grown 
in Mitis Salivarius (MS) medium (340), while Veillonella was grown in medium 
described in the DSMZ catalogue (Medium 136) under anoxic N2 atmosphere. 
Lactobacillus plantarum WCFS1 was grown in Mann-Rogosa Sharpe (MRS) medium 
(Becton Dickinson, Breda, the Netherlands). Fresh culture media did not induce any 
cytokine responses (data not shown). All strains were twice subcultured overnight 
successively, after which the streptococci and the Enterococcus strains had an 
average OD600 of 1.3 (± standard deviation of 0.2), while the V. parvula strain and 
WCFS1 had OD600 of approximately 0.5 and 2.5, respectively. The bacteria 
suspsensions were diluted in PBS (GIBCO) to a final OD600 of 1. 
 
Table 6.1. Strains used in this study 
Species Strain identifier Origin Reference 
Streptococcus mitis HSISM1 
Ileostoma effluent (340); Chapter 4 
Streptococcus bovis HSISB1 
Streptococcus salivarius HSISS1 
Streptococcus salivarius HSISS2 
Streptococcus salivarius HSISS3 
Streptococcus salivarius HSISS4 
Veillonella parvula HSIVP1 
Enterococcus gallinarum HSIEG1 
Lactobacillus plantarum WCFS1 Human saliva (175) 
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Differentiation and maturation of dendritic cells 
The study was approved by the Wageningen University Ethical Committee and was 
performed according to the principles of the Declaration of Helsinki. Buffy coats were 
obtained from the Sanquin Blood bank Nijmegen, the Netherlands. A written informed 
consent was obtained before sample collection. Human monocytes were isolated 
from blood using a combination of Ficoll density centrifugation and cell separation 
using CD14-specific antibody coated magnetic microbeads (Miltenyi Biotec). The 
purity of isolated CD14+ cell fraction was greater than 90% and cell-viability was 
above 95% in all experiments. To generate immature DC (iDCs), the purified CD14+ 
cells were cultured for 6 days in RPMI 1640 medium (Invitrogen, Breda, the 
Netherlands), supplemented with 100 units/ml penicillin G (Invitrogen), 100 µg/ml 
streptomycin (Invitrogen), 50 ng/ml IL-4 (R&D systems, Abingdon, United Kingdom) 
and 50 ng/ml granulocyte-macrophage colony-stimulating-factor (GM-CSF) (R&D 
systems). GM-CSF and IL-4 were added to differentiate the monocytes into myeloid 
DCs. On day 6 approximately 1×106 iDCs were stimulated with LPS (1 µg/ml) or the 
different bacteria at a cell to bacteria ratio of approximately 1:1 and 1:10 for 48 hours. 
As anticipated and as a consequence of the supplementation of the cell-media with 
antibiotics, no bacterial growth was observed during this period. Non-stimulated iDCs 
were used as a negative control. 
 
Analyses of cell surface markers and measurement of cell death by flow 
cytometry 
During the culturing period (8 days) of the CD14+ cells, cells were stained on days 3, 
6 and 8 with fluorescence-conjugated monoclonal antibodies specific for CD83, 
CD86 or their isotype-matched controls (BD biosciences, San Diego, USA) and 
analysed by flow cytometry (FACSCanto II, BD, San Diego, USA) to check the 
maturation and activation status of the cells. CD83 and CD86 are highly expressed 
on DCs after stimulation with known maturation factors (e.g. LPS) compared to non-
stimulated immature dendritic cells. The expression of CD83 and CD86 from different 
human donors can vary considerably after stimulation with different stimuli so for 
comparison the data was normalized to the values (100%) obtained using a standard 
amount of LPS added to cells from each donor. 
On days 3, 6 and 8 the percentage of viable cells was measured by flow cytometry 
(FACSCanto II, BD, San Diego, USA). Live, apoptotic and necrotic cells were 
discriminated by staining with Annexin V and propidium iodide (PI) on days 3, 6 and 
8 according to the manufacturer's protocol. The cells were analysed using flow 
cytometry (FACSCanto II, BD, San Diego, USA) and the BD FACSDiva software. 
Cells that are negative for both Annexin V and PI are not apoptotic or necrotic as 
translocation of the membrane phospholipid phosphatidylserine has not occurred and 
the plasma membrane is still intact. Therefore, Annexin V and PI double negative 
cells were considered as viable cells, whereas both single and double positive cells 
were regarded as non-viable (349). On days 3 to 8 the viability of the cells was 
between 60 and 95%. There were no significant differences in cell death between the 
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bacteria-stimulated cells and the non-stimulated (negative control) or LPS-stimulated 
(positive control) cells. 
 
Cytokine assays 
Supernatants from the DC stimulation assays were collected after stimulation for 24 
hours, and analysed for the presence of cytokines (IL-1β, IL-6, IL-8, IL-10, IL-12p70 
and TNF-α) using a cytometric bead-based BD Human inflammation kit that enables 
multiplex measurements of soluble cytokines in the same sample (237), according to 
the manufacturer's protocol (BD biosciences, Breda, the Netherlands). The 
sensitivity-limits of detection were as follows: IL-1β 7.2 pg/ml, IL-6 2.5 pg/ml, IL-8 3.6 
pg/ml, IL-10 3.3 pg/ml, IL-12p70 1.9 pg/ml and TNF-α 0.7 pg/ml. The flow cytometry 
data were analysed using the BD FCAP software. Unless stated otherwise, cytokine 
secretion in the remainder of the paper are based on stimulation of iDCs with a DC to 
bacteria ratio of approximately 1:10.  
 
TLR2/6 assay 
TLR2/6 signalling capacities of the bacterial strains were determined using a reporter 
assay with Human Embryonic Kidney (HEK)293 (Invivogen, Toulouse, France) cells 
expressing human TLR2 and TLR6 heterodimers that recognize lipoteichoic acid 
(LTA) and lipoprotein lipid anchors of Gram-positive bacteria (4). The TLR2/6 
signalling assay was performed essentially as previously described (167). Briefly, 
HEK293 cells were transformed with human TLR2/6 and pNIFTY, a NF-κB luciferase 
reporter construct (Invivogen, Toulouse, France). HEK293 cells transformed with only 
the pNIFTY did not respond to Pam2CSK (synthetic agonist of TLR2/6) 
demonstrating the dependency of NF-κB activation on co-expression of hTLR2/6 
receptor (167). The cells were plated at a concentration of 6×104 cells per well in 
DMEM medium (Invitrogen). Cells were then stimulated with the different bacterial 
strains, or Pam2CSK as a positive control or with medium alone (negative control) 
followed by incubation at 37°C for 6 hours under a 5% CO2 atmosphere. Thereafter, 
the medium was replaced with Bright glow (Promega, Leiden, the Netherlands), and 
the plates shaken for 5 minutes before measuring the luminescence in a Spectramax 
M5 (Molecular Devices, Sunnyvale, United States). HEK293 cells not expressing TLR 
receptors that harbour pNIFTY were used as the negative control in the NF-κB 
assays. 
 
Statistical analysis 
Mixed general linear model using restricted maximum likelihood (REML) was used to 
determine the statistical differences within donors between cytokine produced by 
DCs stimulated with the different bacterial strains. A two-sided p-value of 0.05 or 
lower was considered to be significant. The statistical analysis was performed by 
using SAS software (version 9.1, SAS Institute Inc., Cary, NC, USA). 
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Results 
 
Small-intestinal bacteria differentially affect DC maturation and activation 
S. mitis HSISM1, S. bovis HSISB1, four different S. salivarius strains (HSISS1-4), E. 
gallinarum HSIEG1, and V. parvula HSIVP1 strains obtained from the human small 
intestine were investigated for their capacity to induce maturation and activation of 
immature monocyte-derived DCs from donors. The DCs were stimulated for 48 hours 
with different strains at DC to bacteria ratios of 1 and 10. The expression of the 
surface marker CD83 (maturation marker) and CD86 (maturation marker and co-
stimulatory molecule) were measured to determine maturation and activation status 
of the DCs. The mean fluorescence intensity (MFI) of dendritic cells was normalized 
to LPS stimulation (Figure 6.1). Stimulation of DCs with the high dose of bacterial 
strains (1 to 10) resulted in higher maturation and activation marker expression than 
with the low dose (1 to 1), except in the case of V. parvula stimulation. The induction 
of the expression of the surface markers CD86 and CD83 differed markedly among 
the different species used as DC stimulants, and with S. salivarius strain 1, 3, and 4 
as well as E. galinarum inducing highest expression. Moreover, the data obtained 
suggested that, S. bovis and S. salivarius strain 2 were the least effective at 
maturating DC. 
 
Figure 6.1. The MFI of stained cell surface markers CD83 (A) and CD86 (B) by monocyte derived 
dendritic cells, with immature DCs as the negative control and LPS as the positive control.  
 
DC cytokine responses to bacterial isolates from the small intestine 
The small-intestinal Streptococcus, Veillonella and Enterococcus strains were further 
investigated for their capacity to induce cytokine secretion by monocyte-derived 
iDCs. In addition, L. plantarum WCFS1 was tested and used as a benchmark strain 
that was analysed several times before (232, 233, 300, 336). Although cytokine 
responses upon stimulation with the different bacterial strains varied between the 
different donors, the induced immune profiles were consistent (Figure 6.2).  
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In agreement with what has previously been described for members of the S. bovis 
species group (27), the strain tested here induced relatively low levels of cytokines 
(Figure 6.2). The V. parvula strain elicited a moderate induction of the production of 
the cytokines IL-8, IL-1β, IL-10, and TNF-α. In contrast to the Streptococcus strains, 
V. parvula did not stimulate IL-12p70 secretion in DCs, whereas its capacity to 
induce IL-6 was substantially higher. 
 
 
Figure 6.2. Cytokine secretion by dendritic cells derived from 5 human donors after stimulation 
with bacterial strains. Cytokine levels are expressed as relative values of the highest inducing strain 
(100% cytokine levels (pg/ml): IL-8: 17598 ; IL-1β: 41; IL-6: 4775; IL-10: 206; TNF-α: 5151; IL-12p70: 
2397; Table S1). Lines represents the average secreted cytokine amounts and faded colours 
represent the interval between the upper and the lower SEM. SEM values higher than 100% are not 
visualized.  
*: Cytokine responses determined using DCs derived from 2 different human donors (Figure 5, Table 
S2) 
 
Although, the cytokine response between donors for the E. gallinarum strain varied, 
the induced cytokine amounts by E. gallinarum strain were the highest among the 
tested strains (Figure 6.2), indicating that the immune system response is more 
pronounced if triggered with this strain compared to the streptococci. Furthermore, 
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the IL-10 and TNF-α levels induced by L. plantarum WCFS1 were comparable to 
previous study (232). Noteworthy, L. plantarum WCFS1 induced considerably higher 
amounts of IL-8, IL-6, and IL-10, higher than the streptococci, albeit that this was 
based on DCs derived from 2 donors (Table S6.2). 
The Streptococcus strains induced relatively consistent levels of IL-1β (16-41 pg/ml), 
IL-6 (161-2221 pg/ml), and IL-10 (7-78 pg/ml), while showing substantial differences 
in their ability to induce the production of the chemokine IL-8 (5231-17147 pg/ml) and 
the pro-inflammatory cytokines TNF-α (86-4933 pg/ml) and IL-12p70 (81-1416 pg/ml) 
(Figure 6.2; Table S6.1). This illustrates that the strains tested here elicited distinct 
cytokine profiles, which is in agreement with earlier observations that revealed 
distinct DC responses to closely related species and strains (233, 335). Notably, the 
immune response profiles elicited by the S. salivarius strains 1 and 4, were similar, 
which corroborates earlier observations on the genetic and physiological similarity of 
these strains ((340); Chapter 4 and 5).  
 
S. bovis is not immunosuppressive 
As the S. bovis strain elicited a low immune response compared to the other strains 
tested (Figure 6.2), we hypothesized that this strain might possess an 
immunomodulatory component, which suppresses cytokine secretion. Therefore, we 
co-stimulated DCs with LPS (10 ng/ml) and S. bovis or S. salivarius strain 4. The S. 
bovis strain did not reduce the cytokine levels induced by LPS stimulation. In fact, the 
amount of IL-6 produced by DCs stimulated with S. bovis and LPS together, was 
greater than the sum of the individual IL-6 responses, indicating a synergistic effect 
of these stimuli on secretion of this cytokine by DCs. A synergistic effect on IL-6 
production was also observed when DCs were co-stimulated with S. salivarius and 
LPS (Figure 6.3). Furthermore, co-stimulation of DCs with LPS in combination with 
spent culture supernatant from either of the two bacterial strains also elevated 
cytokine production as compared to LPS alone (Figure 6.3), with the exception of 
TNF-α which was produced in lower amounts compared to the LPS alone. Although, 
spent bacterial culture supernatant elevated cytokine secretion in combination with 
LPS it was less than that measured when bacteria were combined with LPS as a 
stimulus. Together these results indicate that S. bovis is not actively 
immunosuppressing dendritic cell cytokine production and can in fact enhance 
cytokine production in response to LPS.  
  
Chapter 6 
156 
 
6 
 
Figure 6.3. Cytokine secretion by dendritic cells derived from 2 human donors after mono-
stimulation with tested strains, disrupted strains, medium strains with or without co-
stimulation with LPS.  
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Involvement of TLR2 and TLR6 in innate immune signalling by small-intestinal 
Streptococcus and Veillonella strains 
TLR2/6- mediated activation of NF-κB is potentially one of the major pathways for DC 
activation via LTA or lipoproteins in the cell envelope of bacteria. Therefore, we 
tested the TLR2/6 signalling capacities of the Streptococcus and Veillonella strains in 
a reporter assay using HEK293 cells expressing human TLR2 and TLR6 
heterodimers that recognize lipoteichoic acid (LTA) and lipoprotein lipid anchors of 
Gram-positive bacteria (4). The results demonstrated that most strains are capable of 
triggering NF-κB activation via TLR2/6 dependent signalling. However, the S. bovis 
strain did not activate significant TLR2/6 signalling in this reporter assay (Figure 6.4), 
which is analogous to its failure to induce high levels of cytokine production in DCs 
(see above). Similarly, the strong DC-response elicited by E. gallinarum stimulation 
was reflected in its TLR2/6 signalling capacity, where this strain classified as one of 
the strongest TLR2/6 stimulators among the strains tested. These results suggest 
that there is at least a certain degree of congruency between the capacity of 
individual strains to elicit TLR2/6 signalling in HEK293 NF-κB reporter cells, and their 
capacity to stimulate high levels of cytokine production in iDCs. However, S. 
salivarius strain 2 hardly induced responses in DCs but strongly activated TLR2/6 
signalling, illustrating that the congruency between the two cell-assays is not 
universally supported and may vary, depending on the stimulus tested. 
 
Figure 6.4. hTLR2/6 assay. HEK293 cells 
were incubated with the small-intestinal 
strains at a cell to bacteria ratio of 1:10, 
PAM2CSK as a positive control and 
medium as a negative control. This figure is 
representative out of two hTLR2/6 assays.  
 
 
 
 
 
 
 
 
 
 
 
 
Co-stimulation of dendritic cells with streptococci and Veillonella 
Based on the frequent co-occurrence of the Streptococcus and Veillonella spp. in 
various habitats associated with the human body (84, 381), we considered it relevant 
to evaluate the cytokine responses that were elicited in iDCs that were co-stimulated 
with one of the small intestinal Streptococcus strains in combination with the V. 
parvula strain.  
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The amounts of cytokines IL-8, IL-6, IL-10, TNF-α, and IL-12p70 produced in DCs 
stimulated with a combination of the two species was consistently different from the 
levels anticipated on basis of mono-stimulation with the individual strains (Figure 
6.5). However, this was not the case for IL-1β that was secreted in low amounts by 
mono- and co-stimulated DCs, in all stimulation assays (Table S6.2). As an example 
of the specific co-stimulatory effects, the production of cytokine IL-12p70 by DCs 
could be elicited by stimulation with several of the streptococci, but this stimulation 
effect was suppressed by co-stimulation with V. parvula. This suppression may be 
influenced by the amounts of IL-10 induced in the co-stimulation assays and 
autocrine signalling via the IL-10R (56). This observation was especially clear in the 
comparison of the stronger IL-12p70 inducing streptococcal mono-stimulations (S. 
mitis and the strains representing S. salivarius linage 1 and 4) with the corresponding 
co-stimulations that included V. parvula (Figure 6.5). This result implies that V. 
parvula can suppress the pro-inflammatory stimulation elicited by the streptococci. 
This proposed suppression of pro-inflammatory responses by V. parvula co-
stimulation, appeared specific for the Streptococcus co-stimulations in this study, as 
the strong IL-12p70 induction elicited by mono-stimulation with E. gallinarum 
appeared unaffected by co-stimulation with V. parvula (Figure 6.5; Table S6.2). 
Furthermore, the amounts of TNF-α secreted upon co-stimulation of iDCs with V. 
parvula and the streptococci (except for S. salivarius strain 1 and 4) were 
considerably increased in comparison to those observed with mono-stimulations with 
the streptococci or V. parvula alone. Finally, while mono-stimulation with the 
Streptococcus strains induced variable amounts of IL-8 and generally low amounts of 
IL-6 production in DCs, and V. parvula mono-stimulation only induced these 
cytokines only in moderate amounts (Figure 6.5), co-stimulation of DCs commonly 
led to higher amounts of secreted IL-8, IL-10, and IL-6 (Figure 6.5; Table S6.2). The 
latter observation was especially obvious for co-stimulation with V. parvula and the S. 
bovis or S. salivarius strains 1, 3, and 4, which by themselves induced among the 
smallest amounts of IL-8 and IL-6 of all tested bacteria (Table S6.1 and S6.2), but in 
combination with V. parvula induced high amounts of these cytokines in iDCs (Figure 
6.5; Table S6.2). Interestingly, the postulated synergy between V. parvula and the 
streptococci with respect to stimulation of production of IL-8, IL-6, IL-10, and TNF-α 
might again be relatively specific for these combinations of bacteria, as co-stimulation 
of iDCs with V. parvula and L. plantarum WCFS1 suppressed production of these 
cytokines, leading to the lowest IL-8, IL-6, IL-10, and TNF-α amounts observed in 
these co-stimulation analyses (Figure 6.5; Table S6.2). These observations suggest 
that immune cell stimulation with combinations of some streptococci and V. parvula 
leads to responses that are specific for the combined bacterial stimuli, including both 
(autocrine signalling-mediated) immune-suppressive and -synergistic effects that 
could not be predicted from respective mono-stimulations with either of the bacteria.  
Extrapolation of these in vitro immune (co-)stimulation profiles to the in vivo situation 
that encompasses the exposure of the immune system to bacterial communities 
rather than single strains is far from trivial. 
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Figure 6.5. Cytokine secretion by dendritic cells derived from 2 human donors after mono-
stimulation with tested strains and co-stimulation with V. parvula. Cytokine levels are expressed 
as relative values of the highest inducing strain (100% cytokine levels (pg/ml): IL-8: 30054 ; IL-1β: 55; 
IL-6: 5451; IL-10: 155; TNF-α: 2613; IL-12p70: 300; Table S2). Lines represents the average secreted 
cytokine amounts and faded colours represent the interval between the upper and the lower SEM. 
SEM values higher than 100% are not visualized.  
*: Cytokine responses determined using DCs derived from 2 different human donors 
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Nonetheless, certain trends could be seen in our in vitro results of streptococcal and 
V. parvula co-stimulation, suggesting at least a partial consistency in the co-
stimulatory capacities of two species. This notion is further illustrated by the high 
similarity of the immune profiles elicited by co-stimulation with V. parvula and S. 
salivarius strain 1 or 4 (Figure 6.5), which is in good agreement with the close 
relatedness of these streptococcal strains ((340); Chapter 4 and 5; see also above). 
This observation indicates that immune-cell co-stimulations with different bacterial 
strains are robust and reproducible. 
 
Discussion 
 
Individual GI commensals (e.g. Faecalibacterium prauznitsii (301) and Bacteroides 
fragilis (312, 327)) affect the host immune system in specific ways (see (153) for a 
recent review). Given that the human small intestine is an important region to study 
host-microbe interactions, we evaluated the immunomodulatory properties of 
Streptococcus, Veillonella, and Enterococcus strains isolated from the small 
intestine. The strains used (especially valid for the streptococci (340); Chapter 4) can 
be regarded as representatives of distinct phylogenetic lineages that were identified 
among a large panel of isolates obtained from the human small intestine ecosystem. 
The Streptococcus strains tested here, have previously been subjected to in depth 
analysis, including physiological studies focussing on their carbohydrate utilizing 
capacities ((340); Chapter 4), but also the determination of their complete genome 
sequences (Chapter 5). The current study revealed that these Streptococcus strains 
differ significantly in their ability to elicit cytokine production responses in iDCs as well 
as their capacity to activate NF-κB responses via TLR2/6. These findings corroborate 
previous reports that conclude that significantly different immunomodulatory 
properties can be observed in the comparison of closely related species (335) and 
strains (233). However, stimulation of iDCs with S. salivarius strain 1 and 4 induced 
similar amounts of different cytokines, which is in agreement with their highly 
conserved genetic content and physiological characteristics ((340); Chapter 4 and 
5)). Among the strains tested, S. salivarius strain 2 was the least effective in 
activating and maturating responses in iDCs, but at the same time was identified as 
one of the strongest inducers of TLR2/6 signalling, which is likely due to the 
difference in phagocytosis capacity between dendritic cells and HEK293 cells or that 
bacterial components are shielding certain MAMPs The cytokine responses of the 
small intestinal streptococci were quite similar to other Streptococcus strains, 
including pathogenic S. suis strains although these elicited higher IL-12 (up to 6948 
pg/ml) in DCs (231). However, the small intestinal Streptococcus strains tested here 
are not known to be virulent, although remnants of the virulence genes were found in 
their genomes (Chapter 5). Similarly, remnants of virulence related genes were also 
encountered in the genomes of strains of the yoghurt-associated species S. 
thermophilus (28), suggesting that benign streptococci may share functions with 
related pathogens. 
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Compared to the streptococci, the small intestinal E. gallinarum strain appeared to be 
consistently more potent in inducing cytokine production in iDC and was one of the 
strongest inducers of TLR2/6 signalling, which is in agreement with earlier studies 
that report on the highly immune-stimulating capacities of enterococci (20, 287).  
In contrast to the other streptococci tested in this study, DCs were relatively 
unresponsive to the S. bovis strain, which also induced negligible TLR2/6-mediated 
signalling. Interestingly, amounts of cytokines produced by DCs co-stimulated with S. 
bovis and LPS were higher compared to stimulation with LPS alone, indicating a 
synergistic immunostimulatory effect. The low immune response to S. bovis may 
therefore be due to the modification of conserved MAMPs reducing their capacity to 
signal through TLRs and NLRs or shielding effects (e.g. due to capsule 
polysaccharide). Close relatives of the S. bovis strain (e.g. S. gallolyticus subsp 
gallolyticus UCN34 (280)) have a less attractive reputation and are known to evade 
the host immune system and have been associated with GI tract malignancies (27). 
Notably, genome mining of the S. bovis strain (Van den Bogert, et al. Unpublished 
results; Chapter 5) revealed gene repertoires similar to the capsular operon encoded 
by S. gallolyticus subsp gallolyticus UCN34 (280) (data not shown), which was 
postulated to shield the bacterial cell from the host immune system (27). Further 
comparative analyses could elucidate the genetic relatedness (e.g. coding capacities 
for virulence factors) between the S. bovis strain tested here and potentially 
pathogenic close relatives. 
As Streptococcus and Veillonella spp. have been found to co-occur in various 
microbial ecosystems associated with humans and are proposed to have metabolic 
interactions (84, 381), the small-intestinal isolates from both genera were tested in 
co-stimulation experiments. This study revealed that combinations of streptococcal 
and Veillonella strains elicited an immune response profile that was distinct from the 
profile expected on basis of the corresponding mono-stimulations. The IL-12p70 
stimulatory effect of the Streptococcus strains appeared to be negated by the 
Veillonella strain, while (some) streptococci when combined with Veillonella 
substantially augmented IL-8, IL-6, IL-10, and TNF-α responses. Determining the 
exact mechanism underlying these co-stimulation effects is not trivial. Nonetheless, 
these observations may bear relevance for mucosal areas that encompass dense 
populations of immature DC that are stimulated by simultaneous stimulation by 
multiple bacteria derived from the intestine lumen (e.g., within Peyer’s Patches’ 
follicle areas), and where cross-talk between DCs may be an important determinant 
of the overall cytokine concentrations in the vicinity of these DC populations. 
Alternatively, if DCs (e.g., within the Peyer’s Patches) take up multiple bacteria or 
multiple fragments of bacteria via M cells then the co-stimulation results may imply 
that this would result in different cytokine responses as compared to those predicted 
on basis of single strain immune profiles measured in in vitro models. Our current 
knowledge and understanding of these interactions within the microbiota community 
as well as their interaction with the host (immune) system is still in its infancy, 
underpinning the need for further mechanistic studies in this area. 
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from the microbiota, would be a good starting point to identify potential 
immunomodulatory effects (including immunosuppression) for members of the 
microbiota. Deciphering of the underlying molecular mechanisms and identification of 
the bacterial effector molecules is a necessary subsequent step to unravel the 
molecular basis for individual bacteria-immune interactions. Insights in these 
individual molecular mechanisms of interaction for various bacterial species and 
strains could accelerate the deciphering of the complex and multifactorial interplay 
between the microbiota and the host immune system in vivo. In addition, high 
resolution in vivo measurements of the molecular responses to specific microbes can 
complement mechanistic in vitro studies by providing the necessary in vivo support 
for the molecular mechanisms unravelled with the help of in vitro systems. Mono-
association (or simplified community colonization) studies in gnotobiotic animal 
models could provide an attractive reductionist model to extrapolate in vitro findings 
to an in vivo situation (101, 137, 286, 303, 306, 369). Subsequent mono-association 
studies with derivatives of the same bacterial species or strains that lack one or more 
of their (immune) effector molecules could enable the in vivo establishment of the 
molecular interaction mechanisms proposed on basis of in vitro observations. As an 
example, approaches like this have elucidated how B. fragilis and its zwitterionic 
polysaccharide PSA are able to shape the host immune system (see (312, 327) for 
recent reviews). These reductionist in vivo and in vitro models offer a unique set-up 
to take the essential initial steps towards understanding the complexity of the 
interplay between the microbiota and the host in the intestine and its possible 
consequences for the overall physiology of the host organism, including its immune 
system status. Alternatively, the molecular responses elicited in the human intestine 
mucosa by specific bacteria can in some cases directly be determined in vivo, which 
is exemplified by the in depth analysis of transcriptional responses in the duodenal 
mucosa of healthy human volunteers upon the consumption of dietary lactobacilli 
(335, 336). Such measurements may serve to guide in vitro studies that aim to 
decipher the underlying molecular mechanisms. The latter approach has the 
considerable advantage that the starting point for the in vitro work is based on 
relevant in vivo observations in humans, and may therefore suffer less from the 
potentially poor extrapolation of molecular responses from animal models to humans. 
To this end, it would be of great interest to determine the transcriptional responses 
elicited in the human small intestine mucosa upon their exposure to the endogenous 
small intestinal streptococci, Veillonella and other bacterial groups residing in the 
lumen of this part of the human gut (31, 381). Such in vivo datasets could be 
employed to evaluate their possible alignment with the in vitro immunomodulatory 
observations described here. 
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Supplementary information 
 
Supplementary tables 
 
Table S6.1. Average and SEM cytokine response values from monocyte derived iDCs* 
stimulated with bacterial strains. 
Bacterial strain IL-8 IL-1β IL-6 IL-10 TNF-α IL-12p70 
S. mitis HSISM1 8247 ± 1229 16 ± 3 1381 ± 634 29 ± 16 1457 ± 691 1416 ± 799 
S. bovis HSISB1 5231 ± 1783 17 ± 4 161 ± 54 7 ± 2 86 ± 30 115 ± 53 
S. salivarius 
HSISS1 16555 ± 2115 41 ± 5 2221 ± 403 58 ± 17 4732 ± 1220 1076 ± 358 
HSISS2 17147 ± 3018 41 ± 8 1104 ± 380 78 ± 30 2058 ± 811 556 ± 219 
HSISS3 10337 ± 1718 32 ± 4 696 ± 132 45 ± 10 2452 ± 783 81 ± 23 
HSISS4 11406 ± 2202 29 ± 3 1690 ± 400 46 ± 16 4933 ± 1134 1176 ± 539 
V. parvula HSIVP1 13547 ± 4944 17 ± 4 3869 ± 1616 78 ± 40 1969 ± 1166 23 ± 14 
E. gallinarum HSIEG1 17598 ± 2512 30 ± 8 4775 ± 2619 206 ± 147 5151 ± 2550 2397 ± 1109
L. plantarum WCFS1** 27782 ± 1065 30 ± 3 4132 ± 85 128 ± 73 1229 ± 202 31 ± 9 
*: iDCs were obtained from five different healthy human donors 
**: Cytokine responses determined using DCs derived from 2 different human donors 
 
Table S6.2. Average and SEM cytokine response values from monocyte derived iDCs* 
stimulated with bacterial strains with and without V. parvula co-stimulation. 
 Bacterial strain IL-8 IL-1β IL-6 IL-10 TNF-α IL-12p70
S
in
gl
e 
st
im
ul
at
io
n 
S. mitis HSISM1 9076 ± 3231 22 ± 0 301 ± 149 9 ± 2 197 ± 138 127 ± 64 
S. bovis HSISB1 8377 ± 3648 24 ± 4 66 ± 38 9 ± 3 16 ± 3 8 ± 2 
S. salivarius 
HSISS1 21125 ± 1561 33 ± 0 1597 ± 983 49 ± 16 2063 ± 576 239 ± 74 
HSISS2 23782 ± 3977 49 ± 14 280 ± 200 18 ± 1 151 ± 74 46 ± 12 
HSISS3 6933 ± 2972 24 ± 3 666 ± 414 41 ± 4 1208 ± 644 44 ± 14 
HSISS4 7571 ± 3399 24 ± 2 931 ± 322 33 ± 2 2613 ± 653 219 ± 113
V. parvula HSIVP1 6497 ± 3187 23 ± 2 1301 ± 97 26 ± 19 158 ± 91 4 ± 4 
E. gallinarum HSIEG1 20916 ± 2055 47 ± 13 279 ± 119 18 ± 10 146 ± 77 248 ± 224
L. plantarum WCFS1 27782 ± 1065 30 ± 3 4132 ± 85 128 ± 73 1229 ± 202 31 ± 9 
C
o-
st
im
ul
at
io
n 
S. mitis HSISM1+ 
V. parvula HSIVP1 22783 ± 1981 22 ± 1 3391 ± 260 62 ± 35 760 ± 139 73 ± 34 
S. bovis HSISB1+ 
V. parvula HSIVP1 17253 ± 933 29 ± 1 1621 ± 121 33 ± 19 315 ± 183 10 ± 4 
S. salivarius + 
V. parvula HSIVP1 
HSISS1 24158 ± 606 38 ± 0 4604 ± 1537 135 ± 16 1391 ± 229 94 ± 36 
HSISS2 19222 ± 2100 28 ± 0 2637 ± 692 54 ± 0 838 ± 87 58 ± 22 
HSISS3 30054 ± 1937 55 ± 7 5451 ± 1446 154 ± 9 1516 ± 29 26 ± 1 
HSISS4 26390 ± 670 34 ± 0 4404 ± 1241 155 ± 50 1982 ± 347 98 ± 11 
E. gallinarum HSIEG1+ 
V. parvula HSIVP1 26498 ± 2349 30 ± 1 4228 ± 1129 97 ± 26 1834 ± 35 300 ± 49 
L. plantarum WCFS1+ 
V. parvula HSIVP1 4954 ± 1417 27 ± 4 35 ± 24 9 ± 6 5 ± 5 4 ± 4 
*: iDCs were obtained from two different healthy human donors 
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General discussion 
 
The different anatomical regions of the human gastrointestinal (GI) tract harbor 
distinct bacterial communities that vary in density and diversity (203, 341). The fecal 
microbiome composition, reflecting the distal end of the colon, has been associated 
with host health and the dynamics of the microbial system residing in this readily 
accessible region of the GI tract has been well documented (66, 203, 382). However, 
similar information is largely missing for the small intestinal microbiome, while its 
influence on host physiology is highly plausible (58). Therefore, the work in this thesis 
aimed at providing a better understanding of the composition and dynamics of the 
human small intestinal microbiota and to provide insight in the metabolic potential as 
well as immunomodulatory properties of some of its typical commensal inhabitants. 
 
Evaluation of ileostomy subjects as small intestinal model system 
The small intestine, located between the stomach and the colon, is poorly accessible, 
and sample collection from this part of the human intestine for characterization of its 
microbiota is challenging (32). Ileostomy subjects, employed in the work described in 
this thesis, have their terminal ileum connected to an abdominal stoma as a result of 
colectomy. This stoma allows non-invasive and repetitive sampling of the contents of 
the ileum (31, 32). Moreover, the microbiota present in ileostoma samples is likely to 
correspond better to the small intestine samples from an individual with a normal GI 
tract, as compared to samples collected during (emergency) surgery (3) or samples 
collected from sudden death victims at autopsy (128). 
Ileostoma effluent has been used since the 1960s in studies focusing on the small 
intestinal microbiota and revealed a high number of lactic acid bacteria (e.g. 
streptococci) relative to fecal samples based on estimations from classical plating 
(94, 111). Later studies, employing culture-independent technologies, confirmed the 
abundance of lactic acid bacteria in ileostoma effluent (31, 125). The ileostoma does 
seem to be potentially vulnerable to oxygen penetration, leading to disruption of the 
normal anaerobic environment (125). However, the results described in chapter 3 
and earlier findings from our laboratory (31, 381) showed that the small intestine of 
ileostomy subjects supports substantial abundances and activity of strict anaerobes 
(e.g. Clostridium, Coprococcus, Veillonella, Turicibacter, and members of the 
Peptostreptococcaceae). Nonetheless, in-depth characterization of small intestinal 
samples from individuals with a normal GI tract is essential to define a “healthy” 
human small intestinal microbiota. Such samples were successfully obtained using 
an intraluminal naso-ileal catheter of which the tip is placed nasogastrically and 
moves to the small intestine by peristaltic movement. In this way, luminal fluid could 
be obtained by aspiration following flushing of the small intestine with physiological 
salt solution through a port of the catheter. However, it is important to note that 
consecutive flushing of the small intestinal lumen drastically influenced the outcome 
of microbial profiling (Figure 7.1, Van den Bogert, et al. Unpublished results), 
suggesting that frequency and volume of flushing should be minimized to obtain the 
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information about the microbial composition that resides in the ‘normal’ small 
intestine. Notably, subjects are overnight fasted before the positioning of the catheter 
in the small intestine, which may take as much as 6 hours. This procedure requires 
gastroenterologist supervision, and its position needs to be verified by short-interval 
fluoroscopic control. As a consequence, the catheter sampling methodology is quite 
invasive and is not suitable for the collection of multiple samples from the same 
individual over time, which is required to address the effect of host diet on microbiota 
diversity and dynamics. Nevertheless, the samples obtained by this method enabled 
the comparative analysis of microbiota composition, revealing that jejunal and 
proximal-ileum samples resembled the microbiota in ileostoma effluent, while 
samples obtained from the terminal ileum were more similar to those obtained from 
the colon or fecal origin. This analysis indicated that the ileostoma effluent appears to 
be a suitable reflection of bacterial communities that can be encountered in the 
proximal regions of the small intestine (341, 381) (see also figure 1.3, Chapter 1). 
 
 
 
Figure 7.1. Relative contribution of detected phylogenetic groups and 16S rRNA copy numbers 
in ileal fluid samples collected after consecutive flushing of the small intestine with 10 ml 
physiological salt solution through a port of an intraluminal naso-ileal catheter. Profiles were 
generated by phylogenetic microarray analysis using the Human Intestinal Tract Chip (HITChip) (266). 
In the legend, phylogenetic groups that contribute at least 1% to one of the profiles are indicated. The 
16S rRNA copy numbers were quantified by total qPCR as describe in chapter 2 (Van den Bogert, et 
al. Unpublished results). 
  
A recent innovation in the area of micro-electronics, the IntelliCap 
(http://www.research.philips.com/initiatives/intellicap/index.html), enables delivery of 
drugs or food components to specific sites in the GI tract as well as has sensors to 
measure pH and temperature. This technology is currently being adapted for in vivo 
sampling and has great potential to collect (small) intestinal samples in a non-
invasive manner. 
In conclusion, the catheter sampling methodology is instrumental for the 
determination and definition of the “healthy” small intestinal microbiota. The ileostomy 
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model, on the other hand, provides a suitable in vivo model system that offers non-
invasive and repetitive sampling of luminal effluent, enabling the analysis of microbial 
community dynamics of the small intestinal microbiota over time, or as a result of 
dietary interventions. 
 
Advanced typing of intestinal microbiota 
Technological as well as computational advances during the past decades provided 
a suite of methodologies that enabled culture-independent and comprehensive 
analysis of the microbial ecology of the GI tract (see (219) and (358) for recent 
reviews). Chapter 2 describes the comparison of two popular technologies, barcoded 
454-pyrosequencing and phylogenetic microarray analysis using the HITChip (266). 
Both technologies generated consistent microbial composition profiles for samples 
obtained of terminal ileum and fecal origin, reiterating that both technologies facilitate 
robust microbial profiling and essentially generate equivalent biological conclusions 
in terms of microbial composition. However, analogous to other phylogenetic 
microarrays (49, 219, 339), the HITChip analyses offer a broader dynamic range of 
detection relative to the commonly applied depth of analysis in 454-pyrosequencing-
based microbial profiling. Therefore, HITChip analysis appears to remain the 
preferred methodology for profiling of the microbiota in more distal regions of the 
human GI tract. In contrast, the comparison of microbiota composition profiles 
generated by HITChip analysis and pyrosequencing using ileostoma effluent samples 
revealed a relatively poor correlation between the two methods. Since the small 
intestinal microbiota is less well characterized (see above), this discrepancy is most 
likely attributable to the fact that microarrays are constrained to the detection of 
phylogenetic groups that were included in the database used for microarray-probe 
design. By contrast, 454-pyrosequencing enables de novo community profiling, and 
was therefore used for subsequent profiling efforts of the small intestinal communities 
in this thesis (Chapter 3). To enhance the depth of analysis of sequence-based de 
novo microbiota profiling, the Ion Torrent and Illumina sequencing platforms could be 
considered. Though the former is in its infancy and produces shorter read-lengths 
relative to 454-pyrosequencing (~200 bp), it is becoming an attractive technology for 
16S rRNA based ecological surveys due to the substantially lower cost (108, 160, 
185, 362). The Illumina sequencing platform produces a number of sequence reads 
that is several orders of magnitude higher as compared to 454-pyrosequencing and 
thus offers a greater depth of analysis. However, the current relatively short 
sequence read-length generated by the Illumina platform provides only limited 
reliability in subsequent taxonomic classifications and diversity assessments, which is 
further compromised by the increasing sequence-error rates for reads longer than 60 
bp (39, 50). The continuous improvement of sequence read-length quality for this 
sequencing platform may change this situation in the upcoming years.  
Community profiling approaches, including those mentioned above, that are PCR-
based strongly depend on the phylogenetic coverage of oligonucleotide primers used 
for amplification (16, 98). This notion is supported by the assessments of the 
coverage published for ‘universal’ 16S rRNA primers (16, 127, 138, 341) as well as 
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by our findings in chapter 2, which demonstrated that a widely used primer (27F-
Nondeg) does not adequately amplify the 16S rRNA gene of bifidobacterial origin. 
Nevertheless, our study demonstrated that the choice of primer did not strongly affect 
the overall outcome of microbial profiling and did not consistently skew richness and 
diversity estimates (Chapter 2), although it should be noted that the four primer pairs 
used in our survey targeted the same region of 16S rRNA genes. This notion has 
been extended by several comparative studies that indicated that the region of the 
16S rRNA gene is a critical determinant for the outcome of microbial composition 
profiling as well as estimates of ecological metrics (37, 88, 186). At present, a 
consensus with respect to the most suitable 16S rRNA gene region for microbial 
ecosystem fingerprinting in environmental samples is still lacking (50, 120). As a 
consequence, direct comparison of the results obtained in different studies are 
hampered by the different regions of the 16S rRNA gene they targeted. This issue 
may be overcome by further advances in sequence technologies that provide longer 
sequence-read lengths, such as the XL+ (up to 1,000 bp and beyond) and XLR70 (up 
to 600 bp) chemistry kits for the GS FLX+ platform (Roche; www.454.com), although 
these kits have not yet been tested for 16S rRNA based community profiling. The 
Pacific Biosystems (PacBio) sequencing platform offers similar sequence-read 
lengths, but the high error-rate of this technology hampers appropriate data 
interpretation (108). 
With the application of pyrosequencing in molecular ecology came the need for 
visualization and interpretation software suites to handle the vast datasets that are 
obtained. The Quantitative Insights Into Microbial Ecology (QIIME; see chapter 3 
and 4) pipeline (38) and Mother (290) are two popular analysis pipelines that 
integrate preexisting software tools (e.g. the Ribosomal Database Project (RDP) 
classifier (355)) into a single workflow that enables assessment and visualization of 
the microbial composition and diversity analysis within and between samples using 
numerous ecological metrics, including the phylogeny-based distance metric, 
UniFrac (210, 211). Microbiologists are facing an important challenge to keep these 
software suites up-to-date to meet the advances in sequencing technologies and 
complexity of ecological studies. 
 
The human small intestinal microbiota 
The diversity and dynamics of the small intestinal microbiota were investigated 
through 16S rRNA (gene) based community profiling using ileostoma effluent from 
several subjects (Chapter 3 and 4). In line with earlier findings from our laboratory 
(31, 339, 381), the subjects harbored a personal ileostoma effluent microbiota that 
displayed pronounced compositional fluctuations during the course of several days 
and even between samples obtained within a day (Chapter 3). Fluctuations were 
observed at the genus and species level, but also expand to the genetic lineage level 
as was demonstrated for members of the Streptococcus genus (Chapter 4). These 
observations contrast the more stable microbiota composition encountered in fecal 
samples (229, 266, 376), which is commonly dominated by members of the genera 
Bacteroides, Prevotella, and the Clostridium clusters IV and XIVa (11, 31, 266, 381).  
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There appears to be an ileostoma core microbiota consisting of few bacterial genera, 
including the Streptococcus and Veillonella (Chapter 3), of which the former can 
display a substantial level of phylogenetic richness in individuals (Chapter 4). These 
genera were also commonly detected in the active fraction of ileostoma community, 
indicating that they are typical active inhabitants of the human small intestine 
(Chapter 3). Next to the mentioned core microbiota members, most ileostoma 
samples (but not all) contained representatives of the genera Actinomyces, 
Clostridium, Escherichia, Haemophilus, and Turicibacter, which could actually 
constitute a sizeable fraction of the overall population in specific individuals, as was 
the case for members of the genus Escherichia (Chapter 3). The concept of the 
existence of a phylogenetic core in the small intestinal microbiota should be explored 
using a larger group of (ileostomy) subjects, but is unlikely to be sustained when 
individuals with different health status, geographic origins, and/or of different age 
groups are included (370) (see chapter 1 and (212) for a recent review). It is more 
likely that an individual small intestine microbiota core is existent, which is the fraction 
of the microbiota that is consistently present within a specific niche associated with a 
particular healthy individual, and which has previously been shown to exist for fecal 
microbial communities (267). Such an individual core is supported by the findings 
described in chapter 4 and 5, showing that subjects harbour the same streptococcal 
lineages for at least a year. 
The microbiota in the human small intestine benefits from a high nutrient availability 
derived from the host’s diet, which can sustain a microbiota of which the greater part 
actively participates in this microbial ecosystem, and thus may affect the host’s 
mucosal functions. This notion is supported by the strong congruence between the 
phylogenetic profiles of the total and active fractions within the ileostoma microbiota 
as was assessed by pyrosequencing of 16S rDNA and rRNA, respectively (Chapter 
3). This appears to be a characteristic that is specific for the small intestinal 
microbiota, since substantial compositional differences were reported between the 
active and total communities (257) as well as the viable (active) and injured or dead 
(non-active) communities (18) within the fecal microbiota. Further investigation of the 
activity of the small intestinal microbiota by metatranscriptome analysis of ileostoma 
effluent from different subjects revealed host-specific activity patterns. However, 
there was a strong conservation in expressed functions between subjects, supporting 
the notion of a functional core (188, 329). A considerable fraction of the shared 
expressed genes belonged to typically conserved functions associated to translation, 
ribosomal structure, and biogenesis as well as functions related to transport and 
metabolism of ‘simple’ carbohydrate substrates. The latter functions were 
predominantly assigned to the streptococcal members of the microbiota in samples 
where this genus was highly predominant, but in samples where the streptococci 
were less abundant was shown to be taken over by other members of the microbial 
community (e.g. members of the Escherichia genus; Leimena and Van den Bogert, et 
al. Unpublished results). The latter supports the importance of the capacity to 
effectively ferment diet-derived simple carbohydrate substrates for the small intestinal 
microbes, which is not necessarily restricted to, but commonly predominated by a 
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single phylogenetic group like the members of the common Streptococcus genus 
(Chapter 3; Leimena and Ramiro-Garcia, et al. Submitted).  
Refined analysis of the representatives of the Streptococcus genus revealed that the 
small-intestinal streptococci predominantly belong to the S. mitis, S. bovis, and S. 
salivarius species groups and that they exhibited a substantial divergence in their 
carbohydrate import and utilization capacities (Chapter 4 and 5). Thereby, the 
functional characteristics of these streptococci reflect their adaptation to the small-
intestinal habitat, in which a variety of diet-derived carbohydrates can be 
encountered. Veillonella do not have the capacity to ferment these primary 
carbohydrates, but seem to be important members of the small intestine as they are 
renowned utilizers of lactic acid as a carbon and energy source, and thus seem to 
depend on the lactate production by the carbohydrate fermenting streptococci 
(Chapter 3 and 5). This consistent metabolic contribution by Veillonella also requires 
less flexibility of this population, which may explain why their populations display a 
reduced level of diversity or richness (Chapter 4).  
The findings presented in Chapter 3, 4, and 5 demonstrate that comprehensive 
microbiota analysis necessitates ecosystems biology approaches (264) that combine 
data from “(meta-) omics” approaches to provide further insights into the function and 
biodiversity of the intestinal microbiota and interactions between its community 
members. The wealth of knowledge this provides can be utilized to predict the effect 
of environmental changes, such as a change of diet, on the intestinal microbiota 
composition, and function, as well as their metabolic output as a community, which 
may impact on the host mucosal functions. As the human small intestine represents 
the first region where food components and the intestinal microbiota meet, this region 
of the intestinal tract appears to be an important region to study these host-microbe 
interactions (see below).  
 
Phylogenetic relatedness between small intestinal and oral cavity derived 
Streptococcus and Veillonella populations 
The abundant streptococci and Veillonella in the small intestine and other sections of 
the upper GI tract (1, 9, 23, 256) could originate from their populations in the oral 
cavity (353). To support this suggested origin, a total of 120 bacterial isolates were 
obtained from saliva, teeth, and tongue samples from the same ileostomy subject 
employed in chapter 4. The oral bacterial isolates were subsequently assigned to the 
genera Streptococcus [93], Veillonella [26], and Lactobacillus [1] (Table 7.1), which 
were each represented by a single phylotype. Genetic fingerprinting (Chapter 4) 
differentiated the oral streptococci into 5 lineages, 2 of which were common in all of 
the obtained oral samples and the remaining lineages were obtained from either 
saliva (1 lineage) or tooth surfaces (2 lineages). However, none of the saliva, teeth, 
and tongue samples contained all of the Streptococcus lineages. This supports the 
notion that anatomic sites and their associated micro-environments support a distinct 
microbial community (57, 147), and site specific sampling is required to adequately 
describe the entire oral microbiota and its localized distribution.  
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Although the number of samples that was obtained for this study was limited, these 
findings are in line with results published by Zaura, et al. (372), where it was shown 
that the microbial composition of three individuals differed between samples obtained 
from various sites in the oral cavity. Similarly, studies by Aas, et al. (1) and Diaz, et 
al. (71) demonstrated that some bacterial species in the oral cavity are common to 
most intra-oral sites, while others are site specific. Remarkably, the oral bacterial 
isolates cluster together with salivarius group streptococci, Veillonella parvula, and L. 
fermentum that were isolated from ileostoma effluent (Chapter 4). Among the 6 
genetically distinct lineages of the Streptococcus salivarius phylotype that were 
identified, one lineage was only obtained from ileostoma effluent while another two 
were only isolated from the oral cavity. Notably, the remaining three lineages 
appeared to be present in both ecosystems (Table 7.1; Figure 7.2 and 7.3). This 
suggests that the microbiota of the small intestine and the oral cavity both contain 
distinct as well as shared microbial lineages when they are classified at the sub-
phylotype level. 
 
Figure 7.2. Groupings of Streptococcus, Enterococcus, Veillonella, Lactobacillus, and 
Bacteroides spp. (inner circles) isolates obtained from ileostoma effluent and the oral cavity 
into phylotypes (middle circles) and genomic lineages (outer circles). Numbers in faded colored 
groupings represent bacterial isolates for which AFLP analysis and/or Rep-PCR genomic 
fingerprinting did not reveal discriminative lineages. I0/I1: isolates obtained from ileostoma effluent at 
time point 0 and/or 1. O: isolates obtained from oral cavity. a: isolates obtained from Mitis Salivarius 
agar (Chapter 4); b: isolates obtained from Veillonella selective agar ((274, 275); Chapter 4); c: AFLP 
analysis identified a single Streptococcus isolate as a separate genomic lineage, while Rep-PCR 
genome fingerprinting grouped this isolate to Streptococcus lineage 9 (Table 7.1; Figure 7.3; Chapter 
4); d: S. mitis group; e; S. bovis group; f: S. salivarius group; g: E. faecium group; h: E. gallinarum 
group; i: E. avium group; j: E. faecalis; k: V. parvula; l: L. fermentum; m: B. fragilis. 
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Although speculative, this ‘genomic-lineage’ level comparison between the oral and 
small intestinal microbiota indicates that bacteria do not necessarily persist 
exclusively in a specific body habitat, but can also pass from one body site to another 
within their host. This observation may suggest that the Streptococcus and 
Veillonella populations are not necessarily autochtonous members of the small 
intestine microbiota (353), but the observation that they are not only abundantly 
present but also highly active (Chapter 3 and 4), implies that these Streptococcus 
populations do play a prominent role in the primary carbohydrate metabolism 
occurring in the small intestinal ecosystem. 
 
 
 
Figure 7.3. UPGMA clustering of Rep-PCR profiles with Pearson correlation coefficients from 
randomly selected salivarius group streptococci lineages cultured from ileostoma effluent and 
the oral cavity. Similarities among profiles were calculated with an optimization of 0.69%. Based on 
analysis of replicates with the Rep-PCR protocol, 84% similarity was used as a threshold for the 
discrimination between individual genetic lineages (data not shown). Numbering of lineages is based 
on table 1. *: AFLP analysis identified a single Streptococcus isolate as a separate genomic lineage, 
while Rep-PCR genome fingerprinting grouped this isolate to Streptococcus lineage 9 (Table 7.1; 
Figure 7.2; Chapter 4). 
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Screening for novel small intestinal bacteria 
In agreement with the earlier findings by Booijink, et al. (booijink 2010), the 
discordant profiles from pyrosequencing and HITChip analysis for ileostoma effluent 
(see above and Chapter 2), indicated that the small intestinal ecosystem harbors a 
range of bacteria with 16S rRNA gene sequences that have not been detected 
previously in the human gut. This notion was further explored employing classical 
cloning and sequencing of random 16S rRNA genes from ileostoma effluent samples 
(Chapter 2). Though fewer than expected (31), sequences from novel intestinal 
phylotypes were obtained that mainly belonged to Veillonella spp.. The lower number 
of novel intestinal phylotypes may be explained by the fact that this approach can be 
biased by DNA extraction procedure, coverage of primers used in amplification of the 
16S rRNA gene, differential PCR amplification, and/or cloning efficiencies. This may 
especially be true when one aims to amplify and clone 16S rRNA genes of lowly 
abundant microbial communities (151, 378). The cloned 16S rRNA gene sequences 
of the novel intestinal Veillonella phylotype showed ≤97.2% identity to those from 
type strains represented in the SILVA reference database release 111 (261). 
Although not the primary objective of the study, the selective cultivation conditions 
employed in chapter 4 failed to obtain isolates of this novel intestinal Veillonella 
phylotype from ileostoma effluent (Van den Bogert, et al. Unpublished results). One 
explanation for this apparent discrepancy could be that the cloned 16S rRNA gene 
sequences were derived from dead cells that originate from the upper GI tract (353). 
However, isolates from the novel intestinal Veillonella phylotype were also not 
obtained from oral samples (see above) that were obtained from the same ileostomy 
subject (Van den Bogert, et al. Unpublished results). An alternative explanation may 
be that it is well known that oxygen sensitivity and culture conditions vary between 
anaerobic bacterial species (295) The novel Veillonella phylotype may have been 
selectively eliminated from cultivation due to different nutrient requirements or by 
detrimental oxygen exposure in the ileostoma bag and/or during transport to the 
laboratory. One alternative to obtain novel intestinal isolates, which circumvents 
molecular approaches, was recently introduced by Lagier, et al. (190) and termed 
microbial culturomics. Analogous to other “omics”-approaches (see Chapter 1 and 
(341, 382) for reviews), culturomics gains insights into the microbial composition by 
high-throughput comprehensive culture-dependent methods (114). In a proof-of-
concept focusing on 3 fecal samples, culturomics by means of 212 different culture 
conditions enabled cultivation of an astonishing 32,500 bacterial colonies that could 
be differentiated into 340 species. These included 174 species that, to date, have not 
been associated with the human GI tract, and encompassing 31 new species (190). 
This shows that this approach complemented by innovative cultivation technologies 
(Chapter 1) have great potential to isolate rare and so far uncultured bacteria. 
However, it should be noted that this is time-consuming, laborious, and costly and at 
the same time may not provide a reliable representation of the overall microbial 
composition in the original samples. The latter is related to cultivation biases 
associated with the use of selective media that favor growth of specific microbial 
groups (Chapter 4; (76, 239)). 
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Exploring the uncultured fraction of microbial communities is by no means a trivial 
endeavor, but the new concept of culturomics and other cultivation technologies 
(Chapter 1) combined with molecular approaches, offers avenues to study the 
physiological characteristics and functional properties of rare and so far uncultured 
species, and may shed light on the (host-) microbial relationships that shape the 
(small intestinal) ecosystem. 
 
Metabolic relationship between small intestinal community members 
In agreement with metagenome analyses of small intestinal microbial communities 
(381), small intestinal Streptococcus isolates displayed a substantial variation in their 
encoded carbohydrate transport systems and metabolic capacities dedicated to the 
degradation of simple carbohydrates (Chapter 4 and 5). Furthermore, genes related 
to lactate fermentation (e.g. lactate-import permease) encoded by Veillonella were 
commonly expressed in ileostoma effluent (Chapter 3; Leimena, et al. Unpublished 
results), supporting the previously postulated notion (381) that small intestinal 
Veillonella may utilize the fermentation end-products of streptococci as energy 
source. The draft genome sequence was determined for the small-intestinal V. 
parvula isolate we were able to culture (Chapter 4) to investigate its metabolic 
capacity with a special focus on lactate utilization.  
Classification of the genes encoded by the V. parvula genome to Cluster of 
Orthologous groups (COG; (321)), revealed that metabolic functions accounted for 
28.3% of the V. parvula genes. Bearing in mind that most Veillonella species cannot 
ferment carbohydrates (65) it is no surprise that the genome of the V. parvula strain 
encoded less genes assigned to carbohydrate transport and metabolism (2.4%) 
compared to the small intestinal streptococci (3.5-6.9%; Van den Bogert, et al. 
Unpublished results). Notably, relative to the small intestinal Streptococcus genomes, 
a large fraction of the V. parvula genome was assigned to functions in energy 
production and conversion. The latter COG category encompasses most of the 
genes necessary for conversion of lactate to propanoate (Figure 7.4). This pathway 
also includes the characteristic methylmalonyl-CoA decarboxylase that is composed 
of five different polypeptides α, δ, ε, γ, β (132, 141). The α and β subunits function as 
a carboxyltransferase and decarboxylase, respectively (133). Furthermore, the β 
subunit is tightly bound to the membrane and presumably involved in Na+ 
translocation (131, 141). The γ subunit is a biotin containing protein. The δ subunit is 
necessary for assembly and functioning of the methylmalonyl-CoA decarboxylase 
complex (140). The ε subunit has a high sequence homology to the C-terminal end of 
the δ subunit and is likely the result of a gene duplication event, but other than 
stabilizing the enzyme complex has no known catalytic function (140, 141). The 
methylmalonyl-CoA decarboxylase complex generates a transmembrane 
electrochemical (Na+) gradient (131). Propionigenium modestum utilizes a similarly 
established sodium gradient for ATP synthesis employing a Na+ translocating ATP 
synthase. However, Veillonella spp. are not known to have such a system and 
possibly use the sodium gradient for lactate import analogous to citrate transport by 
Klebsiella pneumoniae (33, 72, 131). 
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Figure 7.4. Metabolic pathway for propanoate fermentation by V. parvula HSIVP1 
Enzymes: 1, Lactate permease; 2, Lactate dehydrogenase (HSIVP1_1868); 3, Formate lyase 
(HSIVP1_1027); 4, Phosphotransacetylase (HSIVP1_1771); 5, Acetate kinase (HSIVP1_664); 6, 
Pyruvate carboxylase (HSIVP1_150); 7, Malate dehydrogenase (HSIVP1_1554); 8, Fumarase 
(HSIVP1_1491); 9, Succinate dehydrogenase (HSIVP1_1758/1759); 10, Succinate-CoA transferase 
(HSIVP1_684); 11, Methylmalonyl-CoA mutase (HSIVP1_1810/1811/682/683); 12, Methylmalonyl-
CoA racemase (HSIVP1_680); 13, Methylmalonyl-CoA decarboxylase 
(HSIVP1_675/676/677/678/679). 
 
The metabolic relationship (food-chain) between small intestinal streptococci and 
Veillonella may be part of a more elaborate relationship between these bacteria. In 
vitro investigations, using members of both genera (S. gordonii and V. atypica) found 
in the oral cavity in dental plaque biofilms, revealed that V. atypica produces a 
diffusible signal that, through a pathway involving the transcriptional regulator ccpA, 
enhances expression of the S. gordonii amyB gene. This gene encodes an α-
amylase that is postulated to play a role in the breakdown of intracellular glycogen 
(Chapter 5), releasing sugar for fermentation and, as a result, increases lactate 
production for Veillonella. The precise signaling mechanism involved in this cross-
species microbial communication is not completely understood, but the sugar 
maltose, which is possibly incorporated in the lipopolysaccharide present in the V. 
atypica outer membrane, may play an important role since it has been shown to 
induce amyB transcription (84, 158). It is of obvious interest to investigate whether 
this signaling interaction also occurs between the small intestinal Streptococcus and 
Veillonella communities. Preliminary analysis of the metatranscriptome data did not 
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reveal a specific association between the relative abundance of the Veillonella genus 
and the level of expression measured for the amylase gene. The quantitative 
resolution of the metatranscriptome datasets may not be sufficient to eventually 
detect such a correlation, while also a substantially larger sample-set may be needed 
to conclude on such a correlation with statistical significance. 
 
Metabolic potential of small intestinal enterococci 
Besides the Streptococcus and Veillonella isolates recovered from ileostoma effluent, 
a total of 66 Enterococcus isolates were also obtained (Chapter 4). Most 
Enterococcus isolates were obtained from Mitis Salivarius (MS-agar) plates (Chapter 
4) and encompassed 7 distinct genetic lineages. An additional 11 Enterococcus 
isolates were cultivated from Veillonella selective agar (VSA) and belonged to a 
distinct group of gallinarum species enterococci (Chapter 4). Interestingly, evaluation 
of the carbohydrate fermentation capabilities of one randomly picked isolate from this 
E. gallinarum group (Enterococcus sp. HSIEG1; Table 7.2), showed that this isolate 
was able to ferment a wide variety of carbohydrates, including ribose, xylose, and 
tagatose, which were not fermented by any of the small intestinal Streptococcus 
isolates (Chapter 4). The broad fermentation capacity of the E. gallinarum strain was 
also reflected by the genetic repertoire represented in its genome sequence (Table 
7.3), which encoded almost 2-fold more genes (9.8%) that were annotated to function 
in carbohydrate transport and metabolism relative to the genomes of the small-
intestinal Streptococcus genomes (3.5-6.9%; Van den Bogert, et al. Unpublished 
results).  
The E. gallinarum genome encoded single copies of the generic cytoplasmic factors 
enzyme I (EI), and phosphor-carrier protein (HPr; see also chapter 5) that are 
involved in phospho-transfer to over 30 PTS transporter functions with predicted 
specificities that include glucose/maltose, mannose, fructose, galactose, mannitol, 
lactose, sucrose, and β-glucosides (Van den Bogert, et al. Unpublished results). 
Moreover, the E. gallinarum genome encoded several ABC sugar transporters, 
including those involved in maltose/maltodextrin transport. Next to these transport 
associated functions, the genome also encodes the necessary enzymes pathways to 
metabolize most of these sugars, which is in good agreement with the growth 
capacities determined for this strain (Table 7.2), showing that the genome predictions 
are accurately matching with the observed physiological characteristics. The 
Enterococcus gallinarum strain encoded the required enzymes for glycolytic 
conversion energy generation, and also encoded a complete and intact pentose 
phosphate pathway. Pyruvate disscipation pathways predicted for E. gallinarum 
include the capacity to produce L-lactate (using lactate dehydrogenase [EC 1.1.1.27]) 
or several other fermentation metabolites, like formate, acetate, ethanol, acetoin, and 
2,3-butanediol. 
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Table 7.2. API strip scores for isolate from E. 
gallinarum HSIEG1 recovered from ileostoma 
effluent using Veillonella selective agar* 
  Test Reaction 
CONTROL 0  
Glycerol 1  
Erythritol 2  
D-Arabinose 3  
L-Arabinose** 4  
D-Ribose** 5  
D-Xylose** 6  
L-Xylose 7  
D-Adonitol 8  
Methyl-βD-Xylopyranoside 9  
D-Galactose** 10  
D-Glucose** 11  
D-Fructose** 12  
D-Mannose** 13  
L-Sorbose 14  
L-Rhamnose 15  
Dulcitol 16  
Inositol 17  
D-Mannitol 18  
D-Sortbitol 19  
Methyl-αD-Mannopyranoside 20  
Methyl-αD-glucopyranoside 21 w 
N-AcetylGlucosamine 22  
Amygdalin 23  
Arbutin 24  
Esculin ferric citrate 25  
Salicin 26  
D-Cellobiose** 27  
D-Maltose** 28  
D-Lactose (bovine origin) 29  
D-Melibiose** 30  
D-Saccharose (sucrose) ** 31  
D-Trehalose** 32  
Inulin 33  
D-MeLeZitose 34  
D-Raffinose 35  
AmiDon (starch) 36 d 
Glycogen 37  
Xylitol 38  
Gentiobiose 39  
D-Turanose 40  
D-Lyxose 41  
D-Tagatose** 42  
D-Fucose 43  
L-Fucose 44  
D-Arabitol 45  
L-arabitol 46  
Potassium GlucoNaTe 47  
Potassium 2-KetoGluconate 48  
Potassium 5-KetoGluconate 49  
Black: positive reaction; Grey w: weak reaction 
d: variable reaction between duplicate tests of 
the same isolate; White: negative reaction 
*: See chapter 4 for API 50 CH test 
methodology  
**: The genome of E. gallinarum HSIEG1 coded 
for necessary enzymes to metabolize this sugar 
Despite the large metabolic capacity of 
the Enterococcus strain described here, 
small intestinal enterococci were 
generally present at low abundance in 
the small intestine microbiota (31) with 
relative abundances ranging from 
<0.1% to 1.5% (Leimena and Van den 
Bogert, et al. Unpublished results; 
Chapter 3). Possibly, the generally low 
abundance of enterococci in the oral 
cavity ((372); see above), esophagus, 
and stomach microbiota (23, 256), 
limits their influx in the proximal small 
intestine whereby they may be 
outcompeted by the streptococci that 
are continuously entering the small 
intestine ecosystem from more proximal 
regions of the digestive tract (353). 
Alternatively the common low 
abundance of enterococci in the small 
intestine may be due to incompatibility 
of these microbes with the 
physicochemical conditions of this 
habitat, which may relate to interactions 
between small-intestinal community 
members, efficiency in uptake and 
conversion of nutrient components, and 
bile-sensitivity or susceptibility to the 
pancreatic enzymes that are secreted 
in this habitat. This latter explanation 
may readily be tested by comparative 
analyses of the compatibility of the 
small intestinal Streptococcus and 
Enterococcus isolates (Chapter 4) with 
in vitro assays that aim to mimic 
specific small intestinal conditions 
(337), or in more advanced small 
intestine model systems like the TNO 
intestinal model (TIM) (222) or 
Simulator of Human Intestinal Microbial 
Ecosystems (SHIME) (338). 
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Table 7.3. Genome statistics for V. parvula HSIVP1 and Enterococcus sp. HSIEG1 isolates  
 V. parvula HSIVP1* Enterococcus sp. HSIEG1* 
DDBJ/EMBL/GenBank Accession ASKE00000000 ASKG01000000 
Total number of Contigs 27 157 
Contig Sum (bp) 2,144,824 3,257,043 
Max contig size 759,850 143,405 
Min contig size 1,153 1,017 
Average contig size 79,437 20,745 
contig N50 171,200 37,770 
Total number of scaffolds 3 6 
Scaffold Sum (bp) 2,177,813 3,447,543 
Max scaffold size 1,454,078 1,848,264 
Min scaffold size 31,789 41,260 
Average scaffold size 725,937 574,590 
Scaffold N50 1,454,078 1,848,264 
GC content (%) 38.51 40.45 
Number of predicted proteins  2,014 3,901 
Genes assigned to COG 1,633 3,087 
Genes assigned to KEGG 1,087 1,566 
*: The version described in this chapter is version XXXX01000000 
 
Influence of small intestinal bacteria on the human host 
Previous studies have shown that individual GI commensals (e.g. Faecalibacterium 
prauznitsii (301) and Bacteroides fragilis (312, 327)) affect the host immune system 
in specific ways and can thereby play an important role in homeostasis (Chapter 1; 
see (153) for a recent review). To obtain an impression of the capacity of the small-
intestinal streptococci and Veillonella to affect the host immune system, their 
immunomodulatory properties were evaluated using in vitro models that employ 
human blood-derived immature dendritic cells (Chapter 6). These assays revealed 
that the different streptococci induced distinct cytokine profiles with variable induction 
capacities of the pro-inflammatory cytokines IL-8, TNF-α, and IL-12p70, which may 
be related to their varying capacity to activate NF-κB responses via TLR2/6 (Chapter 
6). Notably, the V. parvula isolate was also tested in these assays and was shown to 
induce only low amounts of IL-12p70 in iDCs, but strongly induced the production of 
IL-6. Considering the co-occurrence (Chapter 3 and 4) and the proposed metabolic 
relationship of Streptococcus and Veillonella (see above), we hypothesized that the 
host immune system may react differently to a combination of strains from both 
genera. Indeed, stimulation of iDCs with pairs of Streptococcus and Veillonella 
isolates appeared to negate IL-12p70 production by dendritic cells, while augmented 
IL-8, IL-6, IL-10, and TNF-α responses. These observations support the idea that the 
composition of the intestinal microbiota may modulate an individual’s immune status 
and homeostasis, which may affect their responsiveness during infection, or other 
conditions that involve immunological responses like cancer, (food-)allergies, or 
autoimmunity.  
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Future perspectives 
The work in this thesis deepens our understanding of the human small intestinal 
microbiota in terms of composition, dynamics, and activity as well as provides an 
initial analysis of the physiological, genetic, and immunemodulatory characteristics of 
streptococci and Veillonella as typical members of the small intestinal ecosystem. 
These studies are valuable additions to the accumulated data that generally focuses 
on the homeostatic interaction between the gut microbiota and the host in the 
terminal part of the GI tract. 
As we speculated that diet composition is a major driver of the low degree of 
temporal stability of the small intestine microbiota, one of the main questions to be 
addressed is if dietary components can be used to effectively modulate the 
microbiota and thereby the host immune status (Chapter 3). In vitro model systems 
are instrumental in the first steps unraveling the underlying mechanisms (see (193) 
for a review), but they do not accurately mimic the in vivo situation that preserves the 
contributions of other microbial members in the consortium, cross-talk between 
immune cells (DCs) within densely populated immune follicles like the Peyer’s 
Patches (55, 271), and simultaneous exposure of immune cells to MAMPs derived 
from multiple rather than single microbial cells or species (168). Therefore, in vivo 
models are crucial to decipher the mechanisms underlying the immunomodulatory 
responses elicited by individual microbes, as well as by combinations of them, in 
order to understand the molecular communication between the small intestine 
microbiota and the mucosal immune system. Such studies are seldom performed 
with human subjects (335, 336) due to the experimental and ethical limitations. 
These issues may be overcome by using gnotobiotic animals that provide an 
attractive model to extrapolate in vitro findings to an in vivo situation (101, 137, 286, 
303, 306, 369). Conventionalization studies by El Aidy, et al. (85, 86) in germfree 
mouse models demonstrated that the jejunal mucosa quickly and strongly responds 
to the colonizing microbiota with a repression of processes involved in lipid 
metabolism and gluconeogenesis and induction of anabolic metabolism, including 
lipogenesis, nucleotide genesis, amino acid synthesis and glycolysis. Interestingly, 
transcriptional signature genes of the mucosal response to the colonizing microbiota 
included genes of which human orthologs play a role in metabolic disorders (e.g. type 
2 diabetes and insuline resistance), suggesting that the proximal small-intestinal 
host-microbe interactions are critical modulators of our overall well-being. The 
findings reported by El Aidy, et al. may relate to the improvement in insulin sensitivity 
of patients with metabolic syndrome after infusion with the intestinal microbiota from 
lean individuals (352) and explain the mechanism underlying the observation that 
diabetic obese patients show a dramatic improvement in glycemia after implantation 
of a duodenal–jejunal bypass liner (EndoBarrier) that hinders nutrient jejunal nutrient 
absorption and exposure of the local microbiota and its metabolites (63). 
The genomic and physiological characteristics of the small-intestinal isolates 
(Chapter 4 and 5) can be of significant value to predict the effect of different dietary 
substances on Streptococcus population dynamics in the human small intestine. Only 
a minority of the small-intestinal streptococcal isolates had the capacity to utilize 
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arabinose, which is richly present in for example oatmeal. Therefore, we hypothesize 
that consumption of oatmeal causes a distinct shift in composition and activity of the 
(streptococcal) populations in the small intestine compared to subjects consuming 
foods low in arabinose like yoghurt. To address this, ileostomy subjects are an 
adequate in vivo model system for a dietary intervention study, because of the 
possibilities for repetitive and non-invasive sampling of luminal effluent that can be 
executed by the ileostoma volunteers themselves. The intervention can be focused 
on breakfast in which study participants are asked to consume a yoghurt breakfast 
for one week, followed by an oatmeal breakfast for one week. After these weeks the 
collected effluent samples are analyzed to assess microbial diversity and population 
dynamics (by 16S rRNA gene sequence based community profiling), while activity 
patterns of the microbiota can be determined by metatranscriptome analysis of 
mRNA enriched samples from the effluent. The study-design would benefit from a 
large group of (at least 10) subjects that also includes individuals with an intact 
intestinal tract, to further establish a consensus on the ‘normal’ composition and 
activity of the microbiota in the human small intestine. Catheter and capsule (e.g. 
IntelliCap; see above) sampling methodologies could be instrumental in such 
endeavour, albeit that they come with the challenge to collect and avoid deterioration 
of a sufficient volume of luminal content that accurately represents the small-
intestinal composition and transcriptome. Improvements in sample preparation 
protocols and sequencing technologies potentially could eventually overcome these 
issues of technical limitations and may enable sequencing of minimal amounts of 
nucleic acids (171). Alongside these advancements, sequencing technologies will 
generate more sequences with longer read-lengths at lower costs, allowing the 
reconstruction of microbial ecosystems at greater depth of analysis than previously 
possible (288). 
To further our knowledge of the interplay between diet, microbiota and the mucosal 
tissues in the small intestine (85), it would be particularly interesting to determine the 
change in transcriptional responses in the small intestine mucosa during the dietary 
intervention. To this end, mucosal expression profiles can be generated by whole-
genome microarray based analysis of biopsies taken by gastrointestinal endoscopy 
similar to the approach used by van Baarlen, et al. (335, 336) to study in vivo 
mucosal responses in the duodenum of healthy human volunteers upon the 
consumption of dietary lactobacilli. Interestingly, these studies revealed that the 
bacteria induced mucosal responses that resembled that induced by pharmaceutical 
compounds used to, for example, regulate immune responses, treat high blood 
pressure, or stimulate tissue vascularity (335). DNA extracted from the biopsies can 
be used to analyse the diversity of the mucosa-associated microbiota that can 
significantly differ from that of the intestinal lumen (80, 201, 383). 
Furthermore, food components and the intestinal microbiota influence intestinal 
morphology in terms of crypt depth, villus height, and vascularization (see (302) for a 
recent review), as well as tight junction structures that influence intestinal 
permeability (167) (see (332) for a review). The latter is postulated to play a role in 
development of intestinal disorders (e.g. inflammatory bowel diseases; (51)). 
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Histological and histochemical analyses of the collected biopsies will further our 
understanding of the morphological and molecular changes of the small intestinal 
mucosa as a result of exposure to dynamics in microbiota and food composition. 
The next challenge will be to identify mechanistic connections between multi-
disciplinary data sets from human intervention studies and to draw conclusions about 
the homeostatic relationship between diet, microbiota, and immune responses. The 
field of bioinformatics will be especially important to provide algorithms that reduce 
computational complexity for efficient data mining. Ultimately the research in this area 
may open avenues towards rational design of food compositions that aim to 
modulate the small intestine microbiota composition and activity and thereby aiming 
to regulate mucosal (and systemic) immunity. 
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Samenvatting 
 
In onze darmen leven veel verschillende micro-organismen, voornamelijk bacteriën, 
die gezamenlijk ‘microbiota’ worden genoemd. Door onderzoek weten we dat 
darmbacteriën bijdragen aan onze gezondheid, wat ertoe heeft geleid dat er veel 
interesse is om erachter te komen hoe de bacteriën dit doen. De studies hebben zich  
hoofdzakelijk gericht op de bacteriën die leven in de dikke darm. De bacterie 
populaties in de dikke darm verschillen echter van de bacteriën die leven in andere 
plekken van het darmkanaal, zoals de dunne darm. Hoewel de dunne darm de eerste 
plek is waar ons voedsel in contact komt met darmbacteriën, weten we nog weinig 
over de bacteriën in onze dunne darm. Dit komt doordat het moeilijk is om monsters 
te verkrijgen uit de dunne darm, door de ligging tussen de maag en de dikke darm. 
Het onderzoek beschreven in dit proefschrift heeft zich gericht op het verkrijgen van 
een beter inzicht in de samenstelling en dynamiek van de bacteriën in de dunne 
darm van volwassenen. Ook is onderzocht wat de functionaliteit is van bepaalde 
dunne darmbacteriën, die bij veel mensen voorkomen, en hoe ze ons 
immuunsysteem kunnen beïnvloeden. Om de problemen met het verzamelen van 
dunne darm monsters te omzeilen, zijn er mensen met een ileostoma benaderd. De 
dikke darm van deze mensen is operatief verwijderd als gevolg van darmontsteking 
of kanker, waarna het einde van de dunne darm is bevestigd aan een stoma in de 
buikwand. De inhoud van de dunne darm komt terecht in een stoma zakje. Dit 
‘ileostoma effluent’ wordt vervolgens gebruikt als onderzoeksmateriaal.  
De samenstelling van bacteriën in het ileostoma effluent van het stoma zakje kan 
bepaald worden met kweekmethoden, maar tegenwoordig worden hiervoor veelal 
moleculaire technieken gebruikt. Hierbij wordt er gebruik gemaakt van genetisch 
materiaal (DNA) geïsoleerd uit de monsters. DNA is voor te stellen als twee om 
elkaar heen gedraaide ketens die elk bestaan uit een opeenvolging van 4 
verschillende moleculen (nucleotiden). Zoals met letters van een alfabet woorden 
gevormd worden, wordt met de volgorde (sequentie) van nucleotiden genen 
samengesteld waarin is vastgelegd welke eiwitten de cel kan maken. 
In hoofdstuk 2 zijn er allereerst twee moleculaire technieken, namelijk 
pyrosequencing en een fylogenetische microarray vergeleken met betrekking tot hun 
capaciteit om de bacteriesamenstelling in fecale en dunne darm monsters te 
bepalen. Beide technieken berusten op het detecteren van een specifiek bacterieel 
gen (16S rDNA) dat codeert voor één component van de ribosomen: de 
eiwitfabriekjes van de cellen. Hoewel alle bacteriën het 16S rDNA gen dragen, 
verschilt het van soort tot soort. In de voorbereiding van de monsters voor beide 
technieken wordt allereerst het 16S rDNA uit de monster vermeerderd door middel 
van Polymerase Chain Reaction (PCR), zodat er genoeg materiaal is voor de 
vervolgstappen. Hiervoor worden ‘primers’ gebruikt die kleven aan de uiteinden van 
het 16S rDNA en aangeven dat dit deel van het DNA door een enzym moet worden 
vermeerderd. Met pyrosequencing wordt de sequentie van het 16S rDNA bepaald, 
welke vervolgens wordt gebruikt voor de identificatie van bacteriën in elk monster. 
Het aantal specifieke sequenties is indicatief voor de bacteriesamenstelling per 
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monster. De fylogenetische microarray doet dit op een andere manier. Op een 
glazen plaatje staan duizenden stukjes DNA geprint, ook wel probes genoemd, en 
zijn specifiek voor het 16S rDNA van een bepaalde groep bacteriën. Ze zijn 
ontworpen op basis van bekende sequenties van 16S rDNA genen, waarvan we 
weten dat de bacteriën die deze genen dragen voorkomen in ons darmkanaal. Als 
het vermeerderde 16S rDNA uit de monsters over de glazen plaatjes worden 
verspred blijven ze plakken aan de probes. Vervolgens kan met een nauwkeurige 
scanner bepaald worden welke probes gebonden zijn, wat aangeeft welke en 
hoeveel bacteriën er in het oorspronkelijke monster zaten. Aangezien PCR een 
cruciale stap is in de voorbereiding van de monsters, zijn verschillende primers 
getest om te bepalen hoe primers de uitkomst van de bacteriesamenstelling 
beïnvloeden. De analyses toonden aan dat de verschillende primers, en beide 
technieken, vergelijkbare uitkomsten gaven wat betreft de bacteriesamenstelling in 
fecale monsters en monsters verkregen uit het einde van de dunne darm. De 
bacteriesamenstelling in ileostoma effluent verschilde echter wel voor 
pyrosequencing en de fylogenetische microarray. Dit komt (hoogstwaarschijnlijk) 
doordat de probes op de fylogenetische microarray gebaseerd zijn op het 16S rDNA 
van bacteriën die voorkomen in de dikke darm (en dus niet alle bacteriën uit de 
dunne darm kunnen detecteren). Pyrosequencing kan nu juist deze bacteriën 
identificeren waarvan we van te voren niet weten dat ze in monsters voorkomen.  
In hoofdstuk 3 hebben we daarom pyrosequencing toegepast om de 
bacteriesamenstelling te bepalen in ileostoma effluent monsters van vier 
volwassenen. Daarnaast gaan we in hoofdstuk 3 dieper in op welke bacteriën actief 
zijn in de dunne darm en wat ze daar doen. Dit is onderzocht op zowel ribosomaal 
RNA (rRNA) niveau als messenger RNA (mRNA) niveau. rRNA en mRNA worden 
beide afgelezen van het DNA, maar verschillen in functie. Het rRNA dient als 
component van ribosomen en wordt aangemaakt wanneer de bacterie meer eiwitten 
gaat produceren. Het mRNA wordt aangemaakt wanneer een specifiek gen in de 
bacterie wordt aangezet. Het mRNA wordt vervolgens door ribosomen afgelezen als 
instructie voor de productie van een specifiek eiwit. Net zoals bij het rDNA kan de 
sequentie van rRNA en het mRNA worden bepaald. Met de sequenties van het  
rRNA krijgen we inzicht in welke bacteriën actief zijn en met de mRNA sequenties 
krijgen we een idee wat voor genen zijn aangezet en wat de bacteriën dus aan het 
doen zijn. De analyses in hoofdstuk 3 toonden aan dat de samenstelling van de 
bacteriën op rDNA, rRNA en mRNA niveau vergelijkbaar was, wat aangeeft dat de 
dominante bacteriën in de dunne darm actief zijn. Hoewel Streptococcus bacteriën in 
elk ileostoma monster van alle personen werden aangetroffen, was er een sterk 
verschil in hoeveelheid van deze bacteriën per monster. Naast streptococci werd in 
het merendeel van de monsters Veillonella bacteriën gedetecteerd wat aangeeft dat 
ze een prominente rol spelen in de dunne darm van volwassenen. Dit geeft aan dat 
er een potentiële metabole interactie plaatsvindt tussen deze bacteriën, wat inhoudt 
dat de streptococci bijvoorbeeld een suiker kunnen gebruiken als energiebron en 
omzetten in een product waar Veillonella van kan leven. 
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In hoofdstuk 4 zijn Streptococcus en Veillonella bacteriën uit ileostoma effluent 
verder onderzocht door ze te kweken en te karakteriseren. Streptococcus bacteriën 
uit ileostoma effluent, zijn op basis van hun 16S rDNA in te delen in drie groepen, 
namelijk: de S. mitis, S. bovis, en de S. salivarius groep. Deze groepen kunnen 
verder ingedeeld worden in 7 stammen aan de hand van verdere typeringsmethoden. 
Dit geeft aan dat er meer verschillende streptococcus bacteriën in de dunne darm 
leven dan dat er op basis van 16S rDNA analyses aangetoond kan worden. De 
bacteriën behorende tot de stammen kunnen verschillende suikers gebruiken om te 
groeien, waaruit is af te leiden dat de hoeveelheid bacteriën per Streptococcus stam 
in de dunne darm waarschijnlijk afhangt van ons voedsel. Dit komt overeen met de 
observatie dat er maar 1 van de 7 stammen in een ileostoma effluent monster van 
een jaar later werd teruggevonden. Er werd maar 1 Veillonella stam gekweekt uit 
ileostoma effluent. Deze Veillonella stam en 3 van de 7 Streptococcus stammen 
werden ook verkregen uit mond monsters van dezelfde persoon, waar ook het 
ileostoma effluent van was afgenomen. Dit geeft aan dat de Streptococcus en 
Veillonella bacteriën uit de mond en de dunne darm verwant zijn, en dat ingeslikte 
bacteriën het eerste gedeelte van ons darm kanaal kunnen bewonen.   
Het verschil in metabole capaciteit is in hoofdstuk 5 onderzocht door de genomen 
van bacterieisolaten behorende tot 6 Streptococcus stammen, te onderzoeken. Elk 
genoom codeerde voor verschillende enzymen, de bacteriën nodig hebben om 
suikers op te nemen en te gebruiken als energiebron. Deze resultaten komen goed 
overeen met observaties uit hoofdstuk 4, welke laten zien dat de verschillende 
streptococcus stammen kunnen groeien op verschillende suikers. 
In hoofdstuk 6 proberen we een beter inzicht te krijgen hoe bacteriën van de 
verschillende Streptoccocus stammen ons immuunsysteem konden beïnvloeden, en 
werden dendritische cellen blootgesteld aan de Streptococcus stammen. 
Dendritische cellen zijn normaal gezien gelokaliseerd onder de cellen van de dunne 
darm wand en kunnen met lange tentakels (dendrieten) door de darmwand heen 
prikken en kijken welke bacteriën er in de dunne darm aanwezig zijn. Als de 
dendritische cellen bacteriën zien die daar niet horen, kunnen ze met signaal 
moleculen (interleukinen) bepalen hoe het immuunsysteem wordt geactiveerd. De 
hoeveelheid, en welke interleukinen geproduceerd worden door de dendritische 
cellen is afhankelijk van aan welke Streptococcus stam  ze werden blootgesteld. 
Aangezien Streptococcus en Veillonella vaak samen voorkomen in de dunne darm, 
werden dendritische cellen ook blootgesteld aan een combinatie van deze bacteriën. 
De hoeveelheid interleukinen die bij deze test geproduceerd werden, verschilt van 
wat voorspeld kon worden op basis van tests met alleen Streptococcus of Veillonella. 
Dit geeft aan dat het ontzettend moeilijk is om te bepalen hoe ons immuunsysteem 
reageert op de totale samenstelling van de bacteriën in de dunne darm. 
De studies van de dunne darm microbiota gepresenteerd in dit proefschrift dienen als 
aanvulling op de kennis van de microbiota in ons darmkanaal. De verkregen data kan 
gebruikt worden als basis en richtlijn voor vervolgstudies die zich richten op de 
interactie tussen zowel ons voedsel en immuunsysteem, als de microbiota in de 
dunne darm. 
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